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Enteroaggregative Escherichia coli (EAEC) utilises an atypical type I secretion system, 
AatPABCD, for the secretion of dispersin (Aap). AggR is known to regulate the transcription 
of the aat system and aap in EAEC 042. Using RNA-Seq, the transcriptomes of EAEC 042 
and EAEC 042DaggR were compared for differential gene expression. As well as new targets 
for AggR activation, aap was found to have the greatest difference in transcription. Whilst the 
function of Aap is understood, the role of the homolog, CexE, in enterotoxigenic E. coli 
H10407 is not. It was found that CexE could not complement the aap mutant phenotype instead 
having the opposite effect, resulting in an increase in aggregation. Aggregation can indicate a 
role in biofilm. It was found that a cexE mutant could not form a biofilm. The investigation of 
CexE structure revealed that CexE could be secreted by the Aat system. Therefore, Aat-
mediated secretion of CexE was investigated. A modification by AatD of Aap/CexE proteins 
was identified and a new model for Aat secretion is proposed. In summary, the function of Aap 
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1.1. General introduction 
Secretion systems are used by bacteria to affect their environment by translocation of 
molecules across their cell envelope. The substrates of these system range from simple proteins 
for nutrient acquisition to multi-protein complexes with the purpose of subverting eukaryotic 
cell physiology. Since the discovery of the first secretion system the field of bacterial secretion 
has grown. Currently, there are numerous different secretion systems that have been identified 
and confirmed experimentally in both Gram-negative and Gram-positive bacteria. 
 
The complexity of the Gram-negative cell envelope requires multi-protein systems to secrete 
molecules across the hydrophobic membranes to the cell surface and the environment. This 
thesis will describe the six best characterised Gram-negative secretion systems before focusing 
on the type I secretion system (T1SS) found in many pathogenic Escherichia. coli. The focus 
of this thesis will be on an atypical T1SS, the Aat system, found in strains belonging to 
enteroaggregative (EAEC) and enterotoxigenic E. coli (ETEC) pathotypes. In EAEC 042 the 
Aat system is known to be required for the secretion of Aap (Nishi et al., 2003). However, there 
is limited knowledge on the function and secretion of the Aap related protein, CexE, in ETEC. 
Therefore, this thesis set out to investigate the CexE protein in ETEC strain H10407 and the 
Aat secretion system. 
 
1.2. Membrane physiology of Gram-negative bacteria  
1.2.1. Gram-negative cell envelope 
The Gram-negative cell envelope consists of two lipid membranes separated by a periplasmic 
space containing the peptidoglycan. The outer leaflet of the outer membrane is composed of 
lipopolysaccharide (LPS). LPS molecules are large amphipathic molecules that are composed 




Figure 1.1: Gram-negative cell envelope. The outer membrane of a Gram-negative cell is an 
asymmetric barrier of phospholipids and lipopolysaccharide (LPS). The LPS is comprised of a 
lipid A molecule attached to a polysaccharide chain (top right). The length of the O-antigen 
repeats change between strains. Proteins in the outer membrane possess a β-barrel. The 
periplasm is a region between the outer and inner membrane. It contains the peptidoglycan of 
the Gram-negative cell (middle right). The peptidoglycan is covalently bound to Lpp, a 
lipoprotein in the inner leaflet of the outer membrane. The inner membrane also contains 
lipoproteins. This lipid bilayer is made of many different phospholipids, a schematic of which 




layer prevents large and hydrophobic molecules from entering the cell. There are three regions 
of LPS: lipid A; polysaccharide core and O-antigen. The lipid A moiety anchors the LPS in the 
outer leaflet of the outer membrane. Lipid A contains 6 fatty acid chains instead of the 2 to 4 
that are typical for other membrane lipids (Delcour, 2009). The hydrophilic O-antigen is 
antigenic. It is the most variable part of the LPS with a great diversity between strains. LPS 
molecules are negatively charged and electrostatically repel one another. This is overcome by 
the binding of divalent cations such as Ca2+ and Mg2+ (Amro et al., 2000). The outer membrane 
is asymmetric as the inner leaflet is populated by phospholipids.  
 
Phospholipids are the major components of both the inner leaflet of the outer membrane and 
the inner membrane. These are amphipathic lipids that are commonly glycerophospholipids. 
They are composed of two fatty acids, a glycerol moiety, a phosphate group, and a variable 
head group (Fig. 1.1). In E. coli, there are three predominant phospholipids 
phosphatidylethanolamine, phosphatidylglycerol, and cardiolipin. Phosphatidylethanolamine 
is the predominant membrane phospholipid at around 75% of all membrane lipids  while other 
phospholipids like phosphatidylglycerol and cardiolipin constitute 20% of membrane lipids 
(Raetz and Dowhan, 1990). The inner and the outer membrane are the major barriers for the 
import, export, or secretion of hydrophilic molecules. With the region between the inner and 
outer membrane termed the periplasm.  
 
The periplasm is a gel-like matrix that contains a thin peptidoglycan layer. Peptidoglycan 
prevents the rupture of the cytoplasmic membrane from turgor pressure and gives the bacterial 
cell its structure. It is composed of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 
(MurNAc) monomers linked by a β-1,4 glycosidic bond. Peptide bridges are attached to 
MurNAc connecting the peptidoglycan chains (Fig. 1.1, middle right). The chirality of the 
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peptides in these bridges is unusual as they are rare D-amino acids. The peptidoglycan layer is 
anchored to the outer membrane by Lpp (Braun’s lipoprotein); one of the most abundant 
proteins in E. coli. Its lipidated N-terminus resides in the inner leaflet of the outer membrane 
while it is covalently bound to the peptidoglycan layer (Braun and Wolff, 1970). Many 
proteins, like Lpp, reside in the periplasm or are associated with the outer membrane in E. coli 
and thus must pass through the inner membrane. These proteins are secreted via the general 
secretory (Sec) pathway.  
 
1.2.2. General secretory pathway 
The general secretory (Sec) pathway secretes proteins from the cytoplasm into the periplasm 
or inserts them into the inner membrane in Gram-negative bacteria. The majority of non-
cytoplasmic proteins are translocated by the Sec pathway (Orfanoudaki and Economou, 2014). 
These proteins contain an N-terminal secretion signal sequence that targets them for secretion 
by the inner membrane complex SecYEG. This sequence is composed of one or more positive 
charges with a hydrophobic region of 8 to 12 amino acids (Papanikou et al., 2007). In general, 
the signal sequence is recognised either by ribonucleoprotein signal recognition particle (SRP) 
or the cytoplasmic chaperone SecB (Fig. 1.2). SRP is typically recruited by more hydrophobic 
signal sequences and targets the translating ribosome for co-translational secretion (Akopian 
et al., 2013). The SRP membrane receptor FtsY docks with the ribosome-protein-SRP complex 
and targets it to SecYEG (Luirink and Sinning, 2004). The translation of the protein from the 
ribosome drives the translocation of the protein. Through a lateral gate mechanism the 
transmembrane helix exits the SecYEG translocon (Gogala et al., 2014). For non-inner 
membrane proteins the cytoplasmic chaperone SecB prevents the aggregation of the translated 




Figure 1.2: Secretion of proteins into the periplasm. The Sec machinery consists of 
SecYEG, SecDF-YajD, and YidC. SecYEG is the pore of the complex through which the 
peptides are secreted. SecDF-YajD and YidC have auxiliary role in peptide translocation. A-
D; Co-translational pathway; A, SRP scans ribosomes for a signal peptide that is targeted for 
the Sec translocon. B, FtsY is recruited and the peptide-SRP-FtsY-ribosome complex is 
targeted to the Sec machinery. C, FtsY interacts with membrane and SRP feeds the nascent 
peptide into the Sec translocon. Proteins recognised by SRP are typically targeted to the inner 
membrane. E-G; Post-translational pathway; E, a protein is produced by a ribosome. F, the 
peptide is bound by the chaperone SecB to prevent folding. G, the SecB-peptide is targeted to 
the SecA-SecYEG translocon. SecA provides the energy for translocation. The protein is 
released into the periplasm.   
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SecA. SecA is bound to SecYEG and it guides the nascent protein into the SecYEG complex 
while providing the energy for translocation (Lecker et al., 1990).  
 
SecYEG forms an hourglass like structure with a plug on the cytoplasmic side, thought to 
prevent undesired movement of molecules across the membrane (Berg et al., 2004). Accessory 
proteins such as SecDF-YajC and YidC improve translocation efficiency (Schulze et al., 2014). 
SecDF-YajC has been suggested to assist secretion by providing energy through the use of the 
proton motive force (Schulze et al., 2014). YidC is a catalyst for the insertion of hydrophobic 
α helices into the inner membrane (Dalbey et al., 2014). After translocation the signal peptides 
are cleaved, by signal peptidases, allowing the release of the translocated proteins (Paetzel et 
al., 2002). Proteins are then allowed to fold or continue to further maturation processes. 
 
1.2.3. Transport of lipoproteins to the outer membrane 
Lipoproteins are distinct membrane proteins as their N-terminus is attached to lipid moieties 
allowing them to localise to the inner and outer membrane (Fig. 1.3). Lipoproteins possess a 
characteristic signal peptide that contains a lipobox at the C-terminus; a characteristic set of 
residues that results in a cysteine at the N-terminus of the protein after signal sequence cleavage 
(Heijne, 1989). The signal peptide is inserted into the inner membrane by the Sec pathway (Fig. 
1.3A). Prolipoprotein diacylglyceryl transferase (Lgt) catalyses the formation of a thioester 
bond between the sulfhydryl moiety of the N terminal cysteine and diacylglyercol, which is 
transferred from a  phosphatidylglycerol (Sankaran and Wu, 1994). The signal peptide is 
cleaved by Lsp. The N-terminal NH group is made available for acylation by apolipoprotein 
N-acyltransferase (Lnt). Lnt catalyses the transfer of an acyl chain of 





Figure 1.3: Maturation and transport of lipoproteins. A, a nascent peptide with a lipobox 
is secreted into the periplasm. B, Lgt adds two fatty chain groups to the +1 cysteine. Lsp cleaves 
the protein leaving the NH group of the cysteine. A final fatty acid from 
phosphatidylethanolamine is added to the NH group of the cysteine by Lnt. C, if the protein 
does not have a Lol avoidance signal it is sent to the outer membrane by the Lol pathway. LolE 
captures the lipoprotein from the membrane and with LolD and LolC transfers it to LolA. LolA 
transports the lipoprotein across the hydrophilic periplasm. D, LolB removes the lipoprotein 
from LolA and inserts it into the inner leaflet of the outer membrane.  
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The full maturation of a tri-acylated lipoprotein is essential for entry into the localisation of 
lipoproteins (Lol) pathway. The Lol pathway is responsible for the translocation of lipoproteins 
to the outer membrane based on the residue after the cysteine, known as the +2 rule. The 
presence of an asparagine residue at the +2 positions retains the protein in the inner membrane 
(Yamaguchi, 1988). The presence of any other residue in the +2 position results in a 
translocation to the outer membrane. The tri-acylated lipoprotein is removed from the inner 
membrane by the LolCDE complex and passed to LolA (Yakushi et al., 2000). This complex 
is composed of single copies of LolC and LolE and two copies of LolD. Together these proteins 
function as an ABC transporter. However, unlike typical ABC transporters they do not 
translocate molecules across a membrane. LolC and LolE have a similar sequence and topology 
but a different structure (Yasuda et al., 2009). LolE is suggested to capture the lipoprotein with 
a hydrophobic region, which is similar to LolA and LolB (Mizutani et al., 2013a). This causes 
a structural change that increases the affinity of LolD for ATP (Ito et al., 2006). LolC recruits 
a LolA that is not loaded with a lipoprotein (Okuda and Tokuda, 2009). The binding of the 
lipoprotein to LolE is weaken by the binding of ATP to LolD (Mizutani et al., 2013a). This 
leads to the transfer of the lipoprotein to LolA, by a mouth to mouth mechanism, and the release 
of LolA (Okuda and Tokuda, 2009). LolA with a lipoprotein is recruited to the outer membrane 
by LolB. The lipoprotein is passed from LolA to LolB and is inserted into the inner leaflet of 
the outer membrane. The insertion of a lipoprotein into the inner leaflet of the outer membrane 
is typically the end of lipoprotein translocation. However, some surface exposed lipoproteins 
have been described recently (Majdalani et al., 2005; Cowles et al., 2012; Webb et al., 2013). 
 
1.2.4. β-barrel assembly machinery complex 
Integral outer membrane proteins predominantly adopt a β-barrel conformation. The β-barrel 
assembly machinery (BAM) complex inserts these proteins into the outer membrane of Gram-
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negative bacteria. These β-barrel proteins are characterised by anti-parallel β-sheets that form 
a barrel-like shape. Each β strand is composed so that the hydrophobic side chains face the 
outer membrane lipids while the hydrophilic side chains face the lumen of the barrel. The first 
and last β-strand form the junction for the β-barrel. Proteins that are inserted into the outer 
membrane are translated in the cytoplasm and transported across the inner membrane by the 
Sec pathway. In the periplasm, they are bound by chaperones, such as SurA and Skp, and 
targeted to the BAM complex (Sklar et al., 2007). The BAM complex is made of five proteins, 
BamA-E. BamA is the major component of the BAM complex, which is a β-barrel protein 
itself. The structure of BamA revealed a lateral gate that is likely used for the insertion of β-
barrel proteins into the outer membrane (Noinaj et al., 2013). The BamA protein contains five 
polypeptide transport associated (POTRA) domains some of which act as the scaffold for the 
four associated lipoproteins BamB, BamC, BamD, and BamE. Although BamA and BamD are 
essential for the outer membrane protein insertion and cell viability while, the other Bam 
proteins may play a role in the insertion of more complex β-barrel proteins (Wu et al., 2005; 
Malinverni et al., 2006). The mechanism by which the BAM complex mediates the β-barrel 
insertion into the outer membrane is not yet fully understood.  
 
1.3. Protein secretion systems of Gram-negative bacteria 
The process of secretion across the two membranes of bacteria presents certain physical and 
biochemical challenges. Not only does the substrate protein have to traverse two membranes 
and the periplasmic space but the final steps must be accomplished without the expenditure of 
energy. To overcome these obstacles Gram-negative bacteria have developed secretion systems 
which make use of the Sec pathway, lipoproteins, and the BAM complex to create multimeric 
machines for the secretion of their substrates. There are many different secretion systems but 
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the best characterised are known as types I-VI. The type I secretion system (T1SS) will be 
considered in greater detail later on in this Chapter.  
 
1.3.1. Type II secretion systems 
The T2SS is a complex structure consisting of 12 to 15 different proteins that form a single 
machine totalling 40 to 70 proteins (Korotkov et al., 2012). T2SS consist of 4 major complexes 
the outer-membrane complex, inner-membrane platform, the secretion ATPase, and the 
pseudopilus (Korotkov et al., 2012) (Fig. 1.4). The type II secretion system (T2SS) secretes 
folded periplasmic proteins that were translocated by the Sec or Tat machinery. The Tat 
machinery is similar to the Sec pathway but it secretes folded proteins from the cytoplasm into 
the periplasm. The number of substrates of the T2SS varies, some systems are required for a 
single substrate while others secrete a number of different proteins. A well characterised 
example of a T2SS substrate is the heat labile toxin of ETEC. This is a AB5 toxin, which is 
similar to the cholera toxin, that causes watery diarrhoea. Korotkov et al. (2012) suggested the 
“piston model” as the mechanism of T2SS (Fig. 1.4). In this model, the inner membrane 
platform complexes with the secretion ATPase, the outer membrane complex forms separately. 
The pseudopilins forms at the inner membrane platform. The substrate is then pushed out of 
the cell by the pseudopilins like a piston. 
 
1.3.2. Type III secretion systems 
The type III secretion system (T3SS) is a syringe like apparatus that is used by bacteria to 
secrete proteins, known as effectors, into host cells. The T3SS has a core of 9 proteins with 10 
to 20 auxiliary proteins depending on the function of the system (Green and Mecsas, 2016). In 
general, the T3SS is comprised of three major components: the base complex; the needle; and 




Figure 1.4: Type II Sectrion System. The T2SS makes use of either the Sec (pictured)  or Tat 
pathways to secrete the substrate protein into the periplasm. The folded protein then enters the 
T2SS. The T2SS is proposed to use a “piston” mechanism to secrete proteins from the 
periplasm to the extracellular milieu; the psudopilins complex on the inner membrane platform 




Figure 1.5: Type III Sectrion System. In the T3SS, effector proteins are directly secreted into 
the target cell. The base complex allows the formation and extention of the needle from the 
bacterial cell. When the the needle contacts the target cell the translocon forms. This makes a 
pore in the membrane of the target cell through which the effectors enter and subvert cellular 




machinery and spans the two Gram-negative membranes (Murray et al., 1998). The base 
complex is the foundation for the extension of a filament like structure called a needle (Murray 
et al., 1998). The core of the needle is hollow allowing the passage of effectors (Demers et al., 
2014). The tip of the needle is necessary for the sensing of host cells and the insertion of the 
translocon (Picking et al., 2005). The translocon is required for the final stage of the T3SS, 
upon host cell contact the translocon assembles forming a pore in the host cell membrane and 
the effector proteins are secreted (Hakansson et al., 1993; Olsson et al., 2001). The secretion 
of these effectors is used to modulate host cell biology by many pathogens. Enteropathogenic 
(EPEC) uses a diverse range of effectors to causes disease for example: Map affects 
mitochondrial structure and function (Ma et al., 2006); EspF disrupts eukaryotic tight junctions 
(Guttman et al., 2006); and Cif which prevents cell cycle progression (Samba-louaka et al., 
2008). 
 
1.3.3. Type IV secretion systems 
Similar to the T3SS the type IV secretion system (T4SS) spans both the cell envelope and the 
host cell membrane (Fig. 1.6). There are many functions of the T4SS: conjugation for the 
transfer of plasmids and transposons (Grohmann and Espinosa, 2003); DNA uptake (Hamilton 
and Dillard, 2006); DNA delivery to host cells (Bundock et al., 1995); and secretion of 
virulence proteins into host cells (Backert and Meyer, 2006). Despite their variation in 
substrates and function all of the T4SS machinery are related. There are three major 
components of the T4SS, the inner membrane complex, the outer membrane complex and 
generally a pilus. As the names suggest the inner and outer membrane complexes span the 
respective inner and outer membranes. The Inner membrane complex provides the energy for 
the system and the outer membrane complex inserts into the inner membrane complex and 




Figure 1.6: Type IV Sectrion System. The inner membrane complex and outer membrane 
complex form in the bacterium’s envelope. This allows the extension of the pilus, which is 
made up of many copies of the pilin protien. When attached to the target cell the T4SS can 




cytoplasm to the inner membrane complex, then to the outer membrane complex. It is not 
known if the pilus functions as an attachment device that eases substrate secretion or is 
necessary for the translocation of substrates to host cells (Fronzes et al., 2009; Babić et al., 
2008).  
 
1.3.4. Type V secretion systems 
The type V secretion systems (T5SS) covers five sub-classes of secretion pathway, Type 5a-e 
(Fig. 1.7). Of these the best characterised is Type 5a, which were originally referred to as 
autotransporters as it was originally thought that the single primary protein sequence was 
sufficient for secretion to the cell surface. However, it is now known that multiple other protein 
complexes are required for the secretion of the T5SS proteins including the Sec machinery, 
Tam complex, periplasmic chaperones, and the BAM complex (Selkrig et al., 2012; Ruiz-perez 
et al., 2009; Rossiter et al., 2011b). All five sub-classes of T5SS use a β-barrel inserted in the 
outer membrane by the BAM complex for substrate secretion (Voulhoux et al., 2003). The 
substrate of a T5SS is known as the passenger domain. Type 5a, c, d, and e the passenger 
domain and β-barrel are encoded in the same gene. The passenger domain can be cleaved from 
the β-barrel domain and released into the extracellular milieu. In type 5b, also known as two 
partner secretion, the β-barrel and passenger domain are encoded as two genes in an operon. 
The β-barrel of the type 5b can be slightly more complex than type 5a and involved in 
modification of the passenger domain after transport (Henderson et al., 2004). Type 5c are 
obligate trimers that primarily form adhesins (Linke et al., 2006). Type 5d are similar to the 
type 5a but have an additional passenger domain homologous to regions in type 5b (Fan et al., 
2016). The final subclass of autotransporter is the type 5e or inverse autotransporters. In 




Figure 1.7: Type V Sectrion System. The T5SS is split into 5 subclasses. Type 5a is encoded 
by a single gene which has the β-barrel at the N-terminus and the passenger doamin at the C-
terminus. This is typical of all T5SS except for type 5e, which is inverted compared to type 5a. 
The type 5b consists of two two proteins, a β-barrel and a passenger domain. The β-barrel of 
the type 5b may modify the passenger domain after transport. The type 5c consists of three 
proteins that form a trimeric β-barrel and long passenger domain that extends from the cell 
surface. Type 5d are similar to type 5a but they also have an extra domain that is invovled in 




al., 2012). The T5SS are used by commensal and pathogenic bacteria for the secretion of 
numerous proteins including enzymes, toxins, adhesins, and intracellular motility. 
 
1.3.5. Type VI secretion systems 
The type VI secretion systems (T6SS) is a dynamic system that uses a needle like element for 
the translocation of proteins. They can secrete proteins into both eukaryotic and prokaryotic 
cells. However, bacterial cells are the more common target (Russell et al., 2014). They are used 
by bacteria for a number of purposes including invasion/protection of a community, signalling, 
and killing of non-co-operators and phage infected cells (Russell et al., 2014). They possess a 
structure that is believed to be derived from that of a phage tail (Pukatzki et al., 2007). The 
T6SS is assembled at the inner membrane in an extended conformation (Fig. 1.8). In a contact 
dependent process, this conformation contracts quickly to “fire” into the target cell where the 
effector proteins are released (Hood et al., 2010). After the T6SS has “fired” the complex is 
disassembled. These steps are repeated for successive “firing” of the T6SS (Basler et al., 2013). 
These system are very common in Gram-negative organisms and are thought to aid the 
virulence of many pathogens (Green and Mecsas, 2016).  
 
1.4. Type I secretion systems 
Composed of only three proteins an outer membrane protein, membrane fusion protein, and 
ATP binding cassette (ABC) transporter, the T1SS seems relatively simple compared to the 
multi complexes of the T2SS, T3SS, T4SS, and T6SS. The membrane fusion protein links the 
outer membrane protein to the inner membrane localised ABC transporter. The connection of 
all three creates a pore which allows the substrate to exit the cell in an energy dependent 




Figure 1.8: Type VI Sectrion System. The T6SS is similar to the phage tail. The T6SS forms 
in the cytoplasm. The phage-like tail contracts firing into the target cell. Effector proteins are 




substrates from 100 to 9,000 amino acids including proteases, toxins, S-layer proteins, 
haemophores, lipases, and adhesins (Delepelaire, 2004).  
 
Prior to the discovery of the T1SS the mechanism bacterial secretion was unknown. The first 
member of the T1SS was HlyBD-TolC, which is present in  Uropathogenic E. coli (UPEC). 
HlyBD-TolC is required for the secretion of the pore forming toxin haemolysin encoded by 
hlyA (Welch, 1991). HlyA is part of the repeat in toxins (RTX) family which make up the 
majority of proteins secreted by the T1SS. Proteins in this family contain very similar repeats 
of nine residues that form a unique β-roll structure to bind Ca2+ ions with aspartate and glycine 
residues (Baumann et al., 1993). The RTX members remain unfolded in low Ca2+ environments 
such as the cytoplasm. The proteins can fold into their mature form at the higher Ca2+ 
concentration of the extracellular milieu (Chenal et al., 2009). HlyA is encoded in the four gene 
operon hlyC, hlyA, hlyB, and hlyD (Felmlee et al., 1985). HlyC is a cytoplasmic acyltransferase 
required for HlyA function but not secretion (Nicaud et al., 1985); whereas HlyB and HlyD are 
an ABC transporter and membrane fusion protein, respectively, that are required for secretion. 
The final part of the T1SS for HlyA is the outer membrane protein TolC, which is encoded 
separately on the chromosome as it is a promiscuous protein involved in efflux and secretion 
of many different substrates.  
 
1.4.1. Mechanism of type I secretion systems 
HlyB, which is the ABC transporter, is located in the inner membrane in a transient complex 
with the membrane fusion protein HlyD (Thanabalu et al., 1998). Both HlyB and HlyD 
recognise the signal sequence of substrate (HlyA). HlyA has been translated and remains 
unfolded in the cytoplasm (Fig. 1.9). HlyA is acylated at K564 and K690 by HlyC (Stanley et 




Figure 1.9: Secretion of HlyA by the prototypical T1SS HlyBD-TolC. A, the unfolded HlyA 
is acylated by HlyC at K564 and K690. This is required for function but not the secretion of 
HlyA. B, the HlyB and HlyD form a complex at the inner membrane. C, the C-terminus of 
HlyA is recognised by the HlyBD complex. This causes a conformational change that leads to 
the recruitment of TolC. D, HlyBD-TolC forms a single pore for the secretion of HlyA.   
 
 22 
acids that targets it to the HlyBD complex (Koronakis et al., 1989). HlyB is composed of a 
transmembrane domain (TMD), a nucleotide binding domain (NBD), and a C39-like peptidase 
domain (CLD). HlyA interacts with both the CLD and NBD of HlyB and the cytoplasmic N-
terminal region of HlyD. This causes a conformational change in HlyD leading to the 
recruitment of TolC (Balakrishnan et al., 2001). Interestingly the CLD contacts HlyA 
independent of the C-terminal secretion sequence (Lecher et al., 2012). The C-terminus of 
HlyA enters the HlyBD-TolC pore first (Lenders et al., 2015). The NBD of HlyB uses ATP to 
power the secretion of HlyA and the TMD is thought to provide the pore through the inner 
membrane for the secretion of HlyA. In the higher Ca2+ concentration environment of the 
extracellular milieu the RTX motifs are able to bind Ca2+ which enables the folding of HlyA as 
it exits the HlyBD-TolC pore.  
 
Similar to the T1SS are the efflux pumps which require three proteins to export molecules 
across the cell membrane. They are comprised of: an inner membrane protein, which can be a 
resistance-nodulation-division (RND) transporter or an ABC transporter; a membrane fusion 
protein; and an outer membrane protein. Little information on the stoichiometry and protein-
protein interactions of the T1SS and efflux pumps is known. For efflux pumps, the interaction 
of the resistance-nodulation-division (RND) transporter with the outer membrane protein and 
the point of contact of the membrane fusion protein with the outer membrane protein is still a 
matter of debate. The most studied efflux pump is that of AcrB (RND transporter), AcrA 
(membrane fusion protein), and TolC. Work by Du et al. (2014) using cryo-EM and structures 
of the efflux pump AcrAB-TolC suggest that there is no interaction of AcrB with TolC and 
that there is a slight overlap with AcrA and TolC (Fig. 1.10). The model showed a 3:6:3 
stoichiometry for AcrB:AcrA:TolC. It has been suggested based on the interactions of AcrA 




Figure 1.10: Cryo-EM structures of AcrAB-TolC and MacAB-TolC. The structures were 
downloaded from the 5NG5 and 5NIK PDB files for AcrAB-TolC and MacAB-TolC, 
respectively (Wang et al., 2017; Fitzpatrick et al., 2017). For the enlarged images, one TolC 
subunit and two membrane fusion subunits were removed to show the interaction between the 




there can be no similarities drawn between the AcrB and HlyB  as the functional region of 
AcrB is predominantly periplasmic while HlyB is cytoplasmic (Wang et al., 1991). A more 
relevant system to that of the T1SS maybe that of MacAB-TolC (Fig. 1.10), as instead of an 
RND transporter MacB is an ABC transporter (Modali and Zgurskaya, 2011). The 
stoichiometry of the complex was 2:6:3 for MacB, MacA, and TolC respectively (Fitzpatrick 
et al., 2017). MacB is a dimer similar to HlyB. The overlap overserved for AcrB and TolC was 
again observed for MacA-TolC (Fitzpatrick et al., 2017). While a comparison of MacAB-TolC 
complex to HlyBD-TolC is flawed, as the periplasmic domain of MacB is much larger than 
that of HlyB, it is currently the best model available for the T1SS.  
 
1.4.2. ATP binding cassette transporters  
ABC transporters use ATP to provide the energy to translocate a molecule across a membrane 
either as an importer or an exporter. They are ubiquitous throughout all domains of life with a 
large variety of substrates. There have been significant amounts of study devoted to the 
function of ABC transporters. An ABC transporter complex is comprised of two TMD and two 
NCB that enable the translocation of a target substrate against a gradient in an energy dependent 
manner. The sequence conservation of the TMDs is very low, however the NBD is typically 
conserved, as it contains motifs required for ATP hydrolysis such as Walker A, Walker B and 
C-loop (Walker et al., 1982; Ames et al., 1992). There is still debate over the mechanism of 
action for the ABC transporters. These mechanisms are typically focused on the secretion of 
small molecules with comparatively little investigation into the mechanism of those involved 
in T1SS. 
 
In the T1SS, it is thought that the ABC transporter forms a pore in the inner membrane that 
allows the secretion of the unfolded substrate protein. Unlike other bacterial ABC transporters, 
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the TMD and NBD are encoded in the same gene in T1SS ABC transporters (Davidson et al., 
2008). For this reason the ABC transporter of the T1SS are often referred to as “half-size 
transporters”. Kanonenberg et al. (2013) split the T1SS ABC transporters into three groups 
based on their domains auxiliary to the TMD and NBD: C39 peptidases; C39-like peptidases 
(CLD); and neither. C39 peptidases are required for the secretion of bacteriocins. Bacteriocins 
are small peptides that are toxic to closely related bacteria. These are the smallest molecules 
secreted by the T1SS (Duquesne et al., 2007). Unlike the usual RTX the secretion signal 
sequence is present in the N-terminus of the substrate (Duquesne et al., 2007). The N-terminal 
leader peptide interacts the C39 peptidase to allow the cleavage of a GG motif in the C-terminus 
prior to mature protein release (Havarstein et al., 1995). Colicin V, which forms a pore in 
prokaryotic cells, is one such peptide secreted by these T1SS (Fath et al., 1994). Interestingly, 
unlike HlyBD-TolC, the colicin V secretion system, CvaA (ABC transporter), CvaB 
(membrane fusion protein), and TolC (outer membrane protein), can form a complex without 
the substrate (Hwang et al., 1997). The second group are the CLD ABC transporters which 
have an N-terminal C39-like domain. This domain is similar to that of the C39 peptidases 
however the catalytic residue is mutated (Lecher et al., 2012). For example, in the case of HlyB 
the catalytic cysteine of the C39 peptidases is mutated to a tyrosine. The third group contain 
neither a C39 peptidase or a CLD. While the substrates of this class can have RTX motifs, they 
typically do not, and are sustainably smaller than the proteins of the RTX family (Delepelaire, 
2004). The most well studied example of this group of ABC transporters is HasD. HasD in 
conjunction with HasE (membrane fusion protein) and HasF (outer membrane protein) is 
responsible for the secretion of HasA, a small (19 kDa) haemophore from Serratia marcescens 
(Letoffe et al., 1994). Curiously, unlike the substrates of the RTX family, HasA will fold in the 
cytoplasm without the chaperone SecB thus preventing secretion (Debarbieux and 




1.4.3. Membrane fusion proteins 
There is no evidence to suggest that the membrane fusion protein can fuse membranes in any 
way. Membrane fusion proteins were so named as they are similar to viral fusion proteins  with 
the misnomer still persisting in the field (Dinh et al., 1994). The membrane fusion proteins of 
the T1SS are not as well investigated as their efflux pump counter parts, however it is clear 
that the N-terminal domain of HlyD extends into the cytoplasm and interacts with HlyA to 
recruit TolC. It appears that this extension of the N-terminus into the cytoplasm maybe 
common of T1SS membrane fusion proteins (Holland et al., 2016). The membrane fusion 
proteins of the efflux pumps are typically lipoproteins attached to the inner membrane. Other 
membrane fusion proteins such as EmrA also have a N-terminal transmembrane helix but, 
unlike HlyD, do not have a cytoplasmic domain (Borges-Walmsley et al., 2003). The recent 
structure of the periplasmic region of HlyB was very similar to that of EmrA (Kim et al., 2016). 
The authors identified a long α helical extension into the periplasm as well as a lipoyl domain 
that was not identifiable by sequence homology. A lipoyl domain is known to alter the function 
of a number of enzymes, typically fusing two halves together. An analogous membrane fusion 
protein AcrA has a lipoyl domain and forms a hexamer that creates a ring and is the narrowest 
point in the AcrAB-TolC pump (Kim et al., 2015). HlyD itself has been identified as a trimer 
and a hexamer (Thanabalu et al., 1998; Lee et al., 2012). A hexamer of the HlyD structure was 
found to be superimposable onto AcrA lipoyl domains forming a similar ring (Kim et al., 2016). 
The periplasmic region of HlyD is very flexible (Kim et al., 2016); this is true of all membrane 
fusion protein structures thus far determined. This is likely due to the function of the membrane 




1.4.4. T1SS outer membrane proteins 
There are many different outer membrane proteins that function as part of a T1SS. TolC has a 
bifunctional role in the T1SS and efflux pumps. Gram-negative bacteria typically contain a 
gene for tolC or a closely related homolog. The most important function of TolC appears to be 
in efflux with AcrAB and other efflux pumps. The deletion of tolC renders E. coli sensitive to 
low concentrations of detergents (Whitney, 1971). Interestingly, only a small fraction of 1,500 
TolC copies are required to maintain efflux in E. coli (Krishnamoorthy et al., 2013; Tikhonova 
and Zgurskaya, 2004). This leaves TolC to interact with other systems outside of efflux.  
 
The structure of TolC was determined to be a trimer consisting of a 12 stranded anti-parallel 
β-barrel inserted into the outer membrane with 12 α-helices extending into the periplasm (Fig. 
1.11) (Koronakis et al., 2000). The TolC trimer forms an open water filled barrel and towards 
the periplasmic end this barrel tightens to 3.9 Å (Koronakis et al., 2004). This periplasmic 
closing means that TolC does not require a plug like many other β-barrel proteins found in the 
outer membrane. TolC is proposed to open by an “iris-like” mechanism which is mediated by 
the membrane fusion proteins (Andersen et al., 2002). This involves a twisting of the α helices 
to allow the periplasmic opening to widen to a diameter of around 20 Å (Andersen et al., 2002). 
This mechanism has been shown to be required for HlyA secretion (Eswaran et al., 2003).  
 
The TolC protein is unusual for a T1SS outer membrane protein as other similar proteins do 
not appear to have the same promiscuity. However, there is very little investigation into the 
structure and mechanism of other T1SS outer membrane proteins. The majority of the 
knowledge about these pores is from analogous efflux pump outer membrane proteins. From 
the structures of other efflux pump outer membrane proteins the overall fold is very similar  




Figure 1.11: Structures of outer membrane proteins involved in efflux. The monomers in 
each structure are coloured separately. The PDB file for each structure is below the name of 
the protein. Structures are presented in profile with pore they form underneath. TolC is a 
versatile protein involved in both efflux and T1SS in E. coli. VceC, CmeC, and OprM form 
multidrug efflux pumps in Vibrio cholera, Campylobacter jejuni, and Pseudomonas 
aeruginosa, respectively. In E. coli CusC is required for the efflux of copper and silver ions. 
The structures were solved, from top left to bottom right, by Koronakis et al. (2000), Andersen 
et al. (2002), Federici et al. (2005), Su et al. (2014), Kulathila et al. (2011), and Monlezun et 
al. (2015).  
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Interestingly not all conform to the “iris-like” opening observed for TolC. VceC is an outer 
membrane efflux protein in Vibrio cholerae (Colmer et al., 1998). The structure of VceC was 
determined by Federici et al. (2005), who showed that the “iris-like” mechanism was not 
applicable to VceC. Instead, the authors showed a straightening of one of the helical pairs in 
the periplasmic portion of the protein was responsible for the opening of the channel. The 
functions and structures of TolC and VceC are similar but their mechanisms of action are 
different. Suggesting that while the fold of other T1SS outer membrane proteins maybe similar 
their mechanism may have diverged. 
 
1.4.5. Atypical type I secretion systems 
The paradigm of HlyA secretion by HlyBD-TolC is not true for all substrates of the T1SS. 
Perhaps due to the simplicity of the system it is easily malleable. There are very few rules that 
can extend across the entirety of the T1SS. The secretion of colicins and HasA does not follow 
the prototypical mechanism for T1SS but the construction of their respective translocon is 
consistent. That is to say, the proteins required for secretion are an ABC transporter, a 
membrane fusion protein and an outer membrane protein. However, other T1SS have evolved 
from this paradigm.  
 
A slight variation on the common RTX repeat is present in a different group of substrates. The 
multifunctional-autoprocessing repeats in toxins (MARTX) are giant proteins, which can be 
up to 9,000 residues in length, that are multifunctional for pathogenic bacteria (Satchell, 2011). 
These proteins are like simple AB toxins, in that they contain both the cytotoxic element and 
mechanism to bind host cells. However, instead of a single effector, MARTX proteins contain 
multiple effectors in the same protein which are analogous to the effectors of the T3SS. 
Interestingly, the species encoding these MARTX proteins do not have a T3SS (Gavin and 
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Satchell, 2015). The MARTX proteins and their secretion system are encoded in two proximal 
but divergent operons (Lin et al., 1999). The first operon encodes three proteins: RtxH, a 
protein of unknown function; RtxC, an acyltransferase that does not appear to be required for 
toxin function; and RtxA the MATRX toxin (Lin et al., 1999). While the substrate itself is 
atypical the major difference in this system is the organisation of the translocon. The second 
operon encodes three other proteins: RtxB, an ABC transporter; RtxD, a membrane fusion 
protein; and RtxE, a second ABC transporter. The outer membrane protein used by this system 
is TolC. RtxB and RtxE are thought to form a heterodimer that is required for the secretion of 
the RtxA substrate (Boardman and Satchell, 2004). The mechanism and requirement for two 
ABC transporters for the secretion of RtxA is as yet unknown. 
 
Another atypical T1SS is for the secretion of another large substrate SiiE. SiiE (595 kDa) is an 
adhesion in Salmonella enterica. SiiE does not contain the RTX motif but does require Ca2+ to 
fold it’s 53 IgB-like repeats (Griessl et al., 2013). SiiE contains these many repeats so that it 
can extend past the S. enterica LPS (Gerlach et al., 2008). The secretion system of SiiE and the 
protein itself are encoded in a single operon, siiABCDEF. SiiC, SiiD, and SiiF function as the 
outer membrane protein, membrane fusion protein, and ABC transporter, respectively (Morgan 
et al., 2004). SiiA and SiiB are inner membrane proteins and use proton motive force to 
facilitate SiiE secretion (Wille et al., 2014). However, why these proteins are required for SiiE 
secretion and how they interact with the SiiCDF is not known.  
 
The final example of an atypical T1SS is the Aat system. The Aat system is composed of five 
proteins, AatPABCD, that are required for the secretion of dispersin (Aap) in enteroaggregative 
E. coli (EAEC) (Nishi et al., 2003). While Aap has been well characterised, which will be 
discussed further in this chapter, its homolog CexE and the mechanism of Aat secretion has 
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not. CexE is a small protein encoded in enterotoxigenic E. coli (ETEC). EAEC and ETEC with 
other pathotypes, make up a large group of the E. coli species that have acquired pathogenic 
determinants.  
 
1.5. Pathogenic Escherichia coli 
The products secreted by these systems have a myriad of functions and mechanisms with many 
of them used by pathogenic bacteria to gain an advantage in the host. The majority of E. coli 
strains are mammalian gut commensals, however there are many strains that can cause a variety 
of disease including gastroenteritis, urinary tract infections, and meningitis. These pathogenic 
E. coli are grouped into pathovars, which do not follow evolutionary lineages but are instead 
dictated on their mechanism of pathogenesis (Wirth et al., 2006). The best described pathovars 
fall into two groups, diarrheagenic E. coli (DEC) and extraintestinal pathogenic E. coli 
(ExPEC). DEC is made up of the enteropathogenic E. coli (EPEC), enteroheamorrhagic E. coli 
(EHEC), enteroinvasive E. coli (EIEC), ETEC, and EAEC. Other DEC pathovars exist but they 
are not as well characterised as these five. The best characterised E. coli pathovars will be 
briefly described with a focus on ETEC and EAEC.  
 
ExPEC infect regions outside of the GI tract, the most notable member of this group is the 
uropathogenic E. coli (UPEC) (Fig. 1.12). UPEC are asymptomatically carried in the intestine. 
UPEC cells gain access to the urethra where they attach to epidermal cells using the fimbrial 
adhesin, FimH (Martinez et al., 2000). Binding triggers an actin remodelling resulting in the 
internalisation of the UPEC cell (Eto et al., 2007). Upon invasion, UPEC cells can form 
intracellular bacterial communities (IBC) that protect them from the host immune system and 
allow recurrent infection (Anderson et al., 2003). Motile UPEC cells can leave the IBC and 




Figure 1.12: Major features of different pathovars pathogenesis. A, UPEC cells use FimH 
to attach to host cells in the urinary tract. B, internalised cells form intracellular bacterial 
communities (IBC). C, the UPEC cells spread using motility and filamentous growth. E, EIEC 
cells enter enterocytes via the basolateral membrane. F, they escape the phagosome using 
T3SS. G, they can spread between cells using actin polymerisation. H, EPEC cells create 
attaching and effacing lesions using T3SS. I, EPEC cells use bundle forming pili to create 
microcolonies. K, EHEC cause attaching and effacing lesions similar to EPEC but secretes 
different T3SS effectors. L, antibiotics kill EHEC cells containing the Shiga toxin. The toxin 
is released from the cells and enters the host causing haemolytic uraemic syndrome. 
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innate immune system, UPEC cells are capable of filamentous growth that allows the infection 
of nearby cells (Justice et al., 2006). In response to the immune system UPEC cells secrete 
haemolysin A (HlyA) using the previously described T1SS. The secretion of HlyA leads to 
host epithelial exfoliation, epithelial cell apoptosis, and suppression of inflammatory responses 
(Wiles et al., 2008; Dhakal and Mulvey, 2013).  
 
The ExPEC do not represent the majority of E. coli pathovars, which are most commonly 
associated with the digestive tract. Unlike the other E. coli pathovars that will feature below, 
the EIEC include obligate intracellular bacteria that are non-motile nor have adherence factors. 
It is typically considered that EIEC and Shigella should form a single pathovar due to their 
similar mechanisms of pathogenesis and genetic relatability. However, Shigella is still retained 
due to the association with shigellosis. EIEC/Shigella transverse the epithelium via microfold 
(M) cells. They are taken up by macrophages. After replicating and causing apoptosis of the 
macrophage, EIEC/Shigella invade the basolateral side of epithelial cells (Fig. 1.12). These 
stages of infection are accomplished by the Mxi-Spa type III secretion system (T3SS) encoded 
on a virulence plasmid, pINV, carried by all members of this pathovar (Schroeder and Hilbi, 
2008; Hale, 1991). The Mxi-Spa T3SS is required for the secretion of at least 25 effector 
proteins involved modulating many systems in the host cell (Buchrieser et al., 2000). The host 
cell pathways targeted by the effectors include invasion, phagosome escape, cell survival, 
intracellular motility and intercellular dissemination (Schroeder and Hilbi, 2008). While cell 
invasion by E. coli pathogens is not common the use of a T3SS is not limited to the 
EIEC/Shigella pathovar.  
 
EPEC and EHEC use a T3SS, which is encoded in the locus for enterocyte effacement (LEE), 
for the formation of attachment and effacing lesions on intestinal epithelial cells (McDaniel et 
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al., 1995). These lesions are characteristic for a group of pathogens that includes, as well as 
EPEC and EHEC, rabbit diarrhoeagenic E. coli (RDEC) and Citrobacter rodentium. EPEC and 
EHEC are similar in their method of lesion formation but they differ on other aspects of 
pathogenesis. EPEC form micro colonies via the bundle forming pilus that is strengthened by 
the E. coli common pilus (Saldana et al., 2009). EPEC use the T3SS effector Tir and intimin 
to mediate close interaction with the host cell (Fig. 1.12). Tir is translocated and presents on 
the host cell membrane allowing attachment by the outer membrane protein intimin (Kenny et 
al., 1997). Other effectors secreted by the T3SS into the host cell cause cytoskeletal 
rearrangement, modulate the immune system, and aide the causation of diarrhoea (Croxen and 
Finlay, 2010).  
 
EHEC strains are a commensal of cattle in agriculture. Like EPEC strains, EHEC causes 
attachment and effacing lesions with the use of Tir and intimin (Fig. 1.12). The main difference 
between EHEC and EPEC strains is the Shiga toxin. The Shiga toxin can increase the amount 
of nucleolin on the host cell which is then used by EHEC cells to adhere via intimin (Robinson 
et al., 2006). The Shiga toxin is responsible for the causation of haemorrhagic fever and 
haemolytic uraemic syndrome, which can lead to kidney failure. The Shiga toxin is AB5 toxin 
that interestingly does not have a secretion system. Instead the toxin is released due to lysis of 
the cells by the lambdoid phage due to DNA damage (Toshima et al., 2007).  
 
1.6. Enteroaggregative E. coli 
EAEC were first described by Nataro et al., (1987) as forming a “stacked-brick” aggregative 
adherence pattern on the human laryngeal carcinoma (HEp-2) cells. The formation of “stacked-
brick” biofilms is the gold standard the detection of EAEC strains (Fig. 1.13). EAEC strains 




Figure 1.13: EAEC pathogenesis. Upon an increase of nutrient availability due to entering 
the GI tract Fis is produced. Fis activates the expression of aggR which activates the expression 
of the AAF and aap. EAEC cells use the AAF and Aap to form a “stacked-brick” biofilm from 
which they can release toxins that cause disease in the host. This leads to mucoid diarrhoea. 
Critical to the biofilm formation are the AAF. These are encoded by four genes aafA, aafB, 
aafC, and aafD. The AAF is produced using the chaperone-usher pathway. The proteins are 
secreted into the periplasm. AafC inserts into the outer membrane. The minor subunit AafB is 
at the tip of the fimbriae. The AafA form the main body of the organelle. AafD is the chaperone 
protein that transports the fimbrial subunits to AafC. In this manner, the fimbriae are extended. 
The negative charge of the outer membrane is counter acted by Aap. Aap binds to the outer 
membrane allowing the positively charge AAF to extend away from the cell. The genes 
encoding these proteins are     
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gastrointestinal tract (Hicks et al., 1996). EAEC strains are associated with an acute or 
persistent watery mucoid diarrhoea, with a low-grade fever, and little to no vomiting (Nataro 
and Kaper, 1998). Some outbreaks of EAEC are associated with bloody diarrhoea due the 
acquisition of the Shiga-toxin (Rohde et al., 2011). EAEC strains have also been suggested as 
the cause of some urinary tract infections (Boll et al., 2013). Since the early observations of 
EAEC pathogens they have emerged as a pathogen of global importance. Early in EAEC 
research, EAEC strains were considered to only be endemic in developing countries infecting 
children and travellers in these regions (Okeke et al., 2000; Adachi et al., 2001). However, 
recent evidence indicates that EAEC strains are becoming a common cause of food poisoning 
in industrialised nations (Clements et al., 2012). 
 
The characteristic “stacked-brick” pattern of EAEC strains is different from many other E. coli 
pathogens. This is commonly referred to as aggregative adherence. The proteins required for 
aggregative adherence are encoded on a large plasmid, which is termed pAA. The pAA plasmid 
contains the majority of the virulence genes with a few pathogenicity islands present on the 
chromosome of most EAEC strains. The majority of the molecular characterisation of EAEC 
pathogenesis has been investigated with the strain EAEC 042. This strain was chosen as the 
prototypical EAEC strain due to its ability to cause diarrhoea in volunteer studies (Nataro et 
al., 1995). EAEC strains elicit disease by attaching to the intestinal cells using the aggregative 
adherence fimbriae (AAF) which are responsible for the characteristic aggregative adherence 
pattern. Once attached they form a biofilm where the cells secrete toxins that elicit host cell 
damage. The AAF appear to be the main mechanism for EAEC biofilm formation as other 
factors like curli, flagella, and Antigen 43 are not required (Sheikh et al., 2001). The toxins 
secreted by EAEC include plasmid encoded toxin (Pet) which is a T5SS serine protease that 
degrades of the host cell cytoskeleton (Canizalez-Roman and Navarro-García, 2003). Another 
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EAEC toxin, Pic, is associated with a number of roles including mucinase activity, serum 
resistance, and haemagglutination (Henderson et al., 1999). Pic has also recently been 
associated with the evasion of complement mediated killing (Abreu et al., 2015). The secretion 
of these toxins induces an inflammatory response leading to mucoid diarrhoea.  
 
The AAF are the main mechanism by which EAEC attach and are able to cause disease. The 
AAF consist of 4 proteins. The major subunit and minor subunits are secreted proteins. The 
major subunits form a linear strand using donor strand complementation with the minor subunit 
as a cap on the linear strand (Berry et al., 2014). The AAF extend from the cell attaching to 
other cells and to host epithelial cells (Czeczulin et al., 1997). The AAF mediate attachment to 
host by the electrostatic binding of fibronectin (Berry et al., 2014). The genes encoding the 
AAF are activated by another important factor in EAEC pathogenesis, AggR. 
 
1.6.1. AggR  
One of the genes typically encoded on the pAA plasmid is aggR. AggR is required for the 
activation of expression of virulence genes in EAEC. Due to the importance of AggR, EAEC 
are broadly characterised as typical and atypical EAEC by the respective presence or absence 
of aggR (Nataro, 2003). AggR is a member of the AraC family of promoters (Gallegos et al., 
1997). The members of this family are characterised by an 100 amino acid sequence that 
contains two helix-turn-helix motifs at the C-terminus which typical bind upstream of the 
promoters to activate expression (Egan, 2002). These family members contain two domains an 
N-terminal multimersation or co-factor binding domain and the C-terminal DNA binding 
domain that joined by a flexible linker (Mahon et al., 2010).  
 
AggR is closely related to CfaD, RegA, and PerA which are all virulence regulators in ETEC, 
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C. rodentium, and EPEC, respectively. These are mostly responsible for the activation of 
transcription. The initial activation of AggR expression is by Fis (Sheikh et al., 2001). After 
initial production AggR is capable of autoactivation (Morin et al., 2010). Like the other 
virulence activators AggR is repressed by Aar (Fig. 1.14), which is a member of the AraC 
family of negative regulators (Santiago et al., 2014). Aar is able to bind AggR and prevent its 
dimerisation which is required for activation of gene expression (Santiago et al., 2016). AggR 
activates the expression of its own repressor. 
 
The AggR regulon in EAEC 042 contains 44 genes (Morin et al., 2013). The genes that AggR 
activates the expression of encode proteins known to be required for EAEC 042 pathogenesis 
such as AAF. The genes that are activated by AggR are typically on the pAA plasmid. 
However, interestingly a number of pathogenicity islands on the EAEC 042 chromosome were 
also identified (Morin et al., 2013); including a T6SS of which the function is currently 
unknown (Dudley et al., 2006). Advances in transcriptome profiling techniques like RNA-Seq 
have identified more genes under the regulatory control of the related regulator, CfaD (Hodson 
et al., 2017). The results of the CfaD profiling suggest that the complete view of the AggR 
regulon in EAEC 042 may not be complete. 
 
1.6.2. Dispersin  
One gene known to be activated by AggR is aap. The aap gene encodes a small extracellular 
protein of 12.5 kDa with an N-terminal signal sequence, that is cleaved at residue 21 to form a 
10.2 kDa mature protein. Aap ensures the correct orientation of the AAF (Sheikh et al., 2002). 
Insertional mutants of aap aggregate at a faster rate than the wild-type (Sheikh et al., 2002). 
When the aap mutants were inspected by electron microscopy the AAF were seen to be lying 




Figure 1.14: Regulation of AggR by Aar. A, Fis is transcribed in response to a change in 
nutrients when entering a new environment, such as ingestion into the mammalian gut. Fis 
activates the expression of aggR. The AggR protein consists of a C-terminal DNA-binding 
domain and an N-terminal signaling domain. B, AggR dimerises and activates the expression 
of proteins in its regulon. This includes activation of itself and of a regulator protein Aar. Aar 
binds to the N-terminal domain of AggR preventing it from dimerising and activating the 
expression of genes in its regulon.  
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2002). Aap does not form part of the AAF organelle (Sheikh et al., 2002). Instead it binds the 
outside of the outer membrane electrostatically thus altering the charge and allowing the 
positively charged AAF to extend from the cell (Velarde et al., 2007). The pI of the major 
subunit of the AAF is high, ranging from 8.92 to 9.74 therefore at physiologically pH ranges 
they are positively charged (Velarde et al., 2007). The correct orientation of the AAF is ensure 
by the modulation of the cell surface charge by Aap which coats the outside of the cell (Sheikh 
et al., 2002; Velarde et al., 2007). The main cause of the negative charge on the outer membrane 
is the LPS which Aap is able to bind (Velarde et al., 2007).  
 
Fascinatingly, aap mutants are more resistant to ciprofloxacin, which inhibits DNA-gyrase and 
topoisomerase IV preventing DNA synthesis (Mortensen et al., 2011). In fact, the production 
of Aap increases the uptake of ciprofloxacin (Mortensen et al., 2013). The effect of Aap on the 
uptake of other fluoroquinolones is unknown. The uptake of ciprofloxacin is normally 
associated with outer membrane porins like OmpF (Hirai et al., 1986). This potentially suggests 
a disruption in the outer membrane caused by Aap. However, the mechanism by which an 
increased amount of ciprofloxacin is taken up by Aap producing cells remains cryptic. 
 
Aap is not limited to EAEC strains. Sequencing has identified homologous genes to aap in 
aEPEC, C. rodentium ICC168 and ETEC (Srikhanta et al., 2013; Petty et al., 2010; Crossman 
et al., 2010). These strains also encode an atypical T1SS, the Aat system, which is required for 
the secretion of Aap. 
 
1.6.3. Aat system 
The secretion of Aap is dependent on an atypical T1SS composed of five proteins AatPABCD 
(Nishi et al., 2003). This system is drastically different from those of the other atypical T1SS 
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as Aap is first secreted into the periplasm by the Sec pathway (Fig. 1.15). Comparatively little 
is known about the Aat system, with very little characterisation of any of the proteins involved. 
Nishi et al. (2003) identified AatP as the transmembrane permease, AatA as a TolC homolog, 
and AatC as a ATPase. The authors went further and predicted the AatA structure based on 
that of TolC. After Nishi et al. (2003) first showed that AatA was a TolC homolog, Iwashita et 
al. (2006) confirmed this by mutagenesis. They showed that F381, L382, and L383 were 
required for the function of AatA. Single mutations could still secrete but the mutant of all 
three could not. They showed that it was important that the residues at 382 and 383 were non-
polar and suggested this would be where the membrane fusion protein would interact. These 
mutants were in the equatorial domain of the predicted AatA structure, which in TolC is known 
to be important for the interactions with the membrane fusion proteins. TolC is known not to 
be required for the secretion of Aap but does contribute to aggregation of EAEC 042 (Imuta et 
al., 2008). A possible function of AatB and AatD was not identified.  
 
After the first investigations into the Aat system by Nishi et al. (2003) there was no further 
understanding of the mechanism of Aap secretion. Recently the advances in sequencing 
technology have identified Aat homologs in a variety of strains and pathovars. Interestingly 
the probe used to identify EAEC strains by DNA hybridisation, CVD432, anneals to the aat 
region of the pAA2 plasmid (Jensen et al., 2014). While known to be in ETEC and EAEC, the 
Aat system was also observed in NCTC86, the strain first isolated by Theodor Escherich 
(Dunne et al., 2017). A CRP binding site has been identified in ETEC H10407 was identified 
at the end of the aatC gene (Haycocks and Grainger, 2016). This site was the promoter for a 
gene that encoded a small protein of 62 amino acids with homology to the DUF1602, which 




Figure 1.15: Alteration of the mechanism of Aat action proposed by Nishi et al. (2003). A, 
the nascent Aap peptide is secreted into the periplasm by the Sec machinery. B, the protein 
folds in the periplasm. C, in an as yet not understood mechanism Aap enters the Aat pore. D, 
Aap is secreted into the extracellular milieu. Aap attaches to the negatively charged LPS. This 
alters the charge allowing the extension of the AAF. Nishi et al. (2003) did not suggest that 
AatB was a membrane fusion protein. However, AatB is commonly listed as a membrane 
fusion protein in protein databanks. AatP is the transmembrane protein. AatC is the ATPase. 
AatA is the outer membrane protein. The function of AatD is not known. 
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The authors speculated that this may have a function in Aat-mediated secretion of Aap, 
however this ORF is not conserved in other aatC genes.  
 
There has been no investigation into the function of these proteins other than they are known 
to be required for Aap secretion. Why an atypical secretion system is required for a small 
protein like Aap, which does not have any known catalytic activity, when the other examples 
of atypical secretion are large multi-domain proteins is not understood. There are still many 
questions left to be answered about the mechanism and requirement of this atypical T1SS 
which has been identified in many pathovars including ETEC. 
 
1.7. Enterotoxigentic E. coli 
ETEC is the pathovar most associated with traveller’s diarrhoea and military personnel abroad 
(Nada et al., 2013). ETEC is the most commonly isolated enteric pathogen accounting for more 
than 210 million cases and 380,000 deaths each year, predominately in children under the age 
of 2 years in developing countries (Steffen et al., 2005). The majority of ETEC infections are 
acquired from contaminated water. ETEC colonises the small intestine as there is little 
competition from commensal bacteria, which are predominantly present in the colon 
(Swidsinski et al., 2005).  
 
Once ETEC cells are ingested they must attach to host epithelial cells to cause disease (Fig. 
1.16). ETEC strains are remarkable due to the huge variability in the adhesins they used to 
adhere to host cells. These are adhesins in ETEC are termed colonisation factors (CFs). ETEC 
CFs are divided into four main groups: fimbrial (pilus); fimbrillar, helical and afimbrail. Pili 
CFs, e.g. CFA/I which is also known as CS1 in ETEC H10407, are more ridged compared to 




Figure 1.16: Pathogenesis of ETEC. A, ETEC cells adhere to the host epithelium using CFA/I 
(CS1) and EtpA at the tip of flagellum. B, closer adherence is mediated by the outer membrane 
proteins Tia and TibA. The LT and ST toxins are secreted. C, the LT toxin is internalised which 
leads to an increase in intracellular cAMP. The ST toxin activates the guanylyl cyclase receptor 
resulting in an increase in cGMP in the host cell. D, the increase in cGMP and cAMP in the 
cell opens the cystic fibrosis transmembrane conductance regulator (CFTR). Cl− exit the cell. 
This causes the loss of Na+ ions to the lumen. The difference in ion concentration in the lumen 
results in water loss. This causes the watery diarrhoea associated with ETEC infection.  
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helically intertwined filaments, e.g. CS5 and CS7. An example of the afimbrial CFs is CS6 
encoded by B7A. CS6 does not form an observable macromolecular structure when produced. 
It is similar to CS3 and is thought to be a very short filament structure (Ludi et al., 2008). 
Another example of an afimbrail adhesion is EtpA. EtpA is incorporated onto the tip of the 
flagellin and when in contact with host cells can mediate attachment (Roy et al., 2009). The 
CFs are not equally prevalent with CFA/I, CS3, CS5 and CS6 accounting for 50-80% of ETEC 
clinical isolates (Bourgeois et al., 2016). These CFs are required for attachment but they do not 
cause disease as once the cell is adhered to human enterocytes it secretes toxins.  
 
ETEC generally harbours one or more of its two major toxins the heat sable toxin (ST) and the 
heat labile toxin (LT). Infections with strains producing the ST are associated with a higher 
risk of death than those producing the heat labile toxin alone (Kotloff et al., 2013). The number 
of ST receptors in the GI tract decreases with age (Sears and Kaper, 1996). This is thought to 
be responsible for the predominant ST toxin association with children (Sears and Kaper, 1996). 
The LT is a AB5 toxin closely related to the cholera toxin. Both the heat stable and heat labile  
toxin activate the opening of the cystic fibrosis transmembrane conductance regulator. This 
leads to the flow of water out of the cell, resulting in water diarrhoea (Sears and Kaper, 1996). 
While other ETEC factors can also influence disease such as EatA, which is a serine protease 
T5SS that increases toxin uptake, production of ST and/or LT is characteristic of ETEC strains 
(Kumar et al., 2014). 
 
The prototypical ETEC strain is H10407. Similar to the prototypical EAEC strain 042, ETEC 
H10407 elicits diarrhoea in human volunteers (Evans et al., 1978; Coster et al., 2007). The 
sequencing of ETEC H10407 by Crossman et al., (2010) identified cexE as a homolog of aap. 
Like Aap, CexE encodes a predicted Sec signal sequence and is activated by a virulence 
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activator, CfaD, which is similar to AggR (Pilonieta et al., 2007). Like AggR and the genes 
encoding the AAF, CfaD is known to activate the genes encoding the CFA/I. CexE with LT 
and EtpA are associated with outer membrane vesicles (Roy et al., 2010). After immunisation 
of mice with outer membrane vesicles, the ability of ETEC H10407 to colonise those mice was 
impaired (Roy et al., 2011). An immune response to CexE was identified in the immunised 
mice. Thus, CexE appears to be a potential vaccine target for ETEC. The similarity of the 
protein coding sequence of CexE to Aap suggests a similar function. However, the major 
subunits of the ETEC CFs are not positively charged at a neural pH (Velarde et al., 2007). The 
pIs of the major subunit CFs of ETEC are much lower those of the EAEC AAF. Despite this 
the pI of the CexE protein is similar to that of Aap. Therefore, it is likely that CexE does not 
perform the same function in this pathovar.  
 
1.8. Bacterial biofilms 
The formation of biofilms by EAEC and ETEC strains aide their ability to infect, colonise, and 
cause disease in the host (Hicks et al., 1996; Ahmed et al., 2012). Biofilms are heterogeneous 
in nature, where many species of bacteria can compete or cooperate. The majority of biofilm 
dry weight is comprised of the extracellular matrix, around ~90%, with bacterial cells 
accounting for around ~10% (Flemming and Wingender, 2010). The extracellular matrix is 
composed of polysaccharides, proteins (such as fimbriae, pili, and flagella), and extracellular 
DNA (eDNA) (Flemming et al., 2016). The eDNA forms a major part of the biofilm providing 
structural support, nutrition, protection from antibiotics, and enabling horizontal gene transfer. 
There is currently three known mechanisms for eDNA release: cell lysis, outer membrane 
vesicles, and T4SS (Allesen-Holm et al., 2006; Baumgarten et al., 2012; Hamilton et al., 2005). 
Cell lysis and outer membrane vesicle release do not have a specificity for the genomic DNA 
released, however DNA secreted by the T4SS in Neisseria gonorrhoea is enriched for a region 
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of the genome that contains the origin of transfer (Jakubovics et al., 2013). eDNA is not 
released alone; proteins are secreted that interact with the eDNA. 
 
DNase are secreted that modify the structure of the biofilm or degrade the DNA to be used as 
a nutrient source (Gödeke et al., 2011; Pinchuk et al., 2008). These DNase are either anchored 
to the cell or secreted into the extracellular milieu. Other proteins have a structural role as they 
bind eDNA in the biofilm. The DNABII family of proteins are typically intracellular; binding 
and condensing the nucleoid. However, in UPEC proteins belonging to the DNABII family are 
required for the formation of biofilms by binding eDNA (Devaraj et al., 2015). As well as 
proteins polysaccharides, such as Pel from Pseudomonas aeruginosa, can covalently bind 
eDNA thus strengthening the biofilm (Jennings et al., 2015). eDNA, with proteins and 
polysaccharides, allows bacteria to form multicellular communities for protection,  absorption 
of nutrients, and colonisation. 
 
1.9. Aims 
There are still many questions to be answered about EAEC and ETEC pathogenesis. The 
development of new technologies can help further the understanding of the virulence 
transcriptome. Using new profiling techniques like RNA-Seq the AggR regulon will be further 
characterised. While it is already known that aap and the aat system are activated by the AggR 
virulence regulator other targets that were not apparent in the original microarray dataset may 
become clear.  
 
The homolog of the virulence regulator AggR, CfaD, is known to activate the gene encoding 
the CexE protein (Pilonieta et al., 2007). However, the function of CexE is not understood. A 
low sequence identity of 18% to Aap, identified by Crossman et al. (2010), makes it unlikely 
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that they are functionally similar. Also the mechanism of charge modulation proposed by 
Velarde et al. (2007) for Aap would not be relevant for CexE due to the differences in charge 
of the fimbriae in ETEC. Additionally, the role of the Aat system in CexE secretion remains 
unclear. Crossman et al. (2010) hypothesised that the Aat system was likely to be required for 
the secretion of CexE, however no experimental conformation was provided. The differences 
in EAEC and ETEC pathogenesis and the low sequence identity suggest that this cannot be 
taken for granted.  
 
While the substrates of the Aat system in ETEC are unknown, there are still further questions 
about its mechanism. Outside of the requirement of the Aat system for the secretion of Aap 
there is no knowledge of the actual mechanism of action (Nishi et al., 2003). The comparatively 
high transcription of these systems in response to virulence regulators suggests that they are 
important for bacterial pathogenesis (Morin et al., 2013; Hodson et al., 2017). Investigating 
these mechanisms can lead to possible ways to combat these strains which cause significant 
amounts of morbidity and mortality worldwide. 
 
Therefore, the aims of this study were:  
1. Further investigate the AggR regulon in EAEC 042  
2. Identify a function for CexE in ETEC H10407  
3. Determine the structure of CexE 
4. Attempt to understand the mechanism of the Aat system 
 
A mixture of approaches will be used to achieve these aims. RNA-Seq will be used to further 
characterise the AggR regulon. The role of CexE will be suggested by using an ETEC H10407 
deletion mutant and biochemical techniques. The differences in the structure of Aap and CexE 
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will be assessed by determining the structure of CexE. Finally, the Aat system in EAEC 042 
and ETEC H10407 will be investigated to try to understand the function and suggest a new 














CHAPTER 2:  




2.1. Bacterial strains, growth conditions and culture media 
2.1.1. General growth conditions 
Bacterial strains used in this study are listed in Table 2.1. Bacterial strains were regularly 
cultivated in lysogeny broth (LB) which consisted of 10 g/L tryptone, 5 g/L yeast extract and 
10 g/L NaCl. Bacterial strains were routinely grown on solid media before inoculation of liquid 
cultures. In all cases, solid media consisted of LB with 1.2% (w/v) agar (LBA). An overnight 
culture was prepared by inoculating a single colony into 5 ml LB contained in a 20 ml glass 
universal which was then incubated at 37ºC, unless otherwise stated, with aeration overnight 
and the appropriate antibiotic. For the storage of bacteria strains, 800 µl of overnight culture 
was inoculated into 800 µl LB with 30% glycerol and stored at −80ºC. Strains were streaked 
onto LBA plates to single colonies. Overnight cultures were inoculated into Erlenmeyer flasks, 
containing a fifth of their total volume of LB, to an OD600 of 0.05 and grown at 37ºC, unless 
otherwise stated, with aeration and the appropriate antibiotic to the required optical density. 
 
2.1.2. Antibiotic preparation and supplementation 
Antibiotics were used to supplement the growth medium for plasmid retention. Kanamycin 
sulphate and carbenicillin disodium salt stocks were made to a concentration of 100 mg/ml in 
deionised H2O and filtered using Millex-GP Syringe Filter Unit, 0.22 µm, polyethersulfone 
(Merck). The filtered stocks were aliquoted and stored at −30ºC. Final working concentrations 
were prepared to a concentration of 100 µg/ml in the appropriate medium. Kanamycin sulphate 





Table 2.1: Strains used in this study. 
Strain Description Source 
ETEC H10407 Prototypical enterotoxigenic 
Strain. CFA/1+, LT+, and ST+ 
Evans and Evans (1973) 
ETEC H10407∆aatP ETEC H10407 with aatP 
disrupted by a kanamycin cassette 
This study 
ETEC H10407∆aatA ETEC H10407 with aatA 
disrupted by a kanamycin cassette 
This study 
ETEC H10407∆aatB ETEC H10407 with aatB 
disrupted by a kanamycin cassette 
This study 
ETEC H10407∆aatC ETEC H10407 with aatC 
disrupted by a kanamycin cassette 
This study 
ETEC H10407∆aatD ETEC H10407 with aatD 
disrupted by a kanamycin cassette 
This study 
ETEC H10407∆cexE ETEC H10407 with cexE 
disrupted by a kanamycin cassette 
This study 
E. coli DH5α Cloning strain NEB 
E. coli BL21(DE3) Expression strain Invitrogen 
EAEC 042 Prototypical enteroaggregative 
strain. AAF/1+ and Pet+ 
Nataro et al. (1985) 
EAEC 042∆aap EAEC 042 with pJB5603 inserted 
into aap 
Sheikh et al. (2002) 
EAEC 042∆aggR EAEC 042 with pJB5603 inserted 
into aggR 
Sheikh et al. (2001) 
EAEC 042∆aatA EAEC 042 with pJB5603 inserted 
into aatA 
Nishi et al. (2003) 
EAEC 042∆aatC EAEC 042 with pJB5603 inserted 
into aatC 
Nishi et al. (2003) 
EAEC 042∆aatD EAEC 042 with pJB5603 inserted 
into aatD 
Nishi et al. (2003) 
EAEC 042∆aap::cexE:aph EAEC 042 with disrupted aap by 
cexE and kanamycin cassette. 
This study 




2.2. Molecular techniques 
Unless otherwise stated the manufacturer’s instructions were followed for all molecular 
techniques.  
 
2.2.1. Plasmid growth and isolation 
Strains containing plasmids were grown at 37ºC with aeration in LB supplemented with the 
relevant antibiotic. If plasmid replication was temperature sensitive, strains containing 
plasmids were grown at 30ºC with aeration in LB supplemented with the relevant antibiotic. 
Plasmids were isolated from the overnight culture via Qiagen Mini Prep Kit (Qiagen). Plasmids 
were eluted in nuclease free water and used the same day or stored at −30ºC. Table 2.2 details 
the plasmids used in this study. Unless stated in the description, all plasmids were grown at 
37ºC. For maintenance, plasmids were transformed into E. coli DH5a and stored as previously 
described. 
 
2.2.2. Polymerase chain reaction 
Primers for PCR can be found in Table 2.3 these were used at a concertation of 10 µM. For 
cloning of genes or mutagenesis, Phusion® High-Fidelity DNA Polymerase (NEB) was used. 
In all other cases MyTaq™ Red Mix (Bioline) was used. All reagents were stored at −30ºC and 
thawed on ice prior to use. Unless otherwise stated, the manufactures’ instructions were 
followed for all PCR. 
 
2.2.3. Agarose gel electrophoresis 
All PCR products and isolated plasmids were visualised by agarose gel electrophoresis. 
Agarose gels were prepared by melting 1% agarose in 1x TAE. The working concentration of 
1x TAE was made from a 1 in 50 dilution of 50x TAE (2 M Tris-base, 0.05 M EDTA (pH8.0),  
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Table 2.2: Plasmids used in this study. 
Plasmid Description Source 
pDOC-K Contains bla and kanR with FRT 
sites 
Lee et al. (2009) 
pKD4  Contains bla and kanR with FRT 
sites 
Datsenko and Wanner (2000) 
pKD46 Heat sensitive plasmid with λ Red 
recombinase genes expressed in 
response to L-arabinose 
Datsenko and Wanner (2000) 
pET26b(+) T7 expression vector with C-
terminal 6His tag, IPTG inducible, 
kanR 
Novagen 
pET26b-CexEH10407 pET26b with cexE from ETEC 
H10407 
This study 
pET26b-CexEICC168 pET26b with cexE from Citrobacter 
rodentium 
This study 
pET26b-Aap pET26b with aap from EAEC 042 
into 
This study 
pCfaD pBAD/myc-HisA with cfaD under 
PBAD from ETEC H10407  
Made by Sammi McKean 
pAggR pBAD30 with aggR under PBAD 
from EAEC 042  
Sheikh et al. (2001) 
pBAD24 L-arabinose expression vector with 
ampR 
Guzman et al. (1995) 
pJB39 Constitutive expression of gfp with 
ampR 
Browning et al. (2013) 
pBAD/myc-HisA L-arabinose expression vector with 
C-terminal Myc and 6His tag 
Invitrogen 
pSRCC(−41.5) pBR322 derivative containing 
consensus DNA site for CRP  





Table 2.3: Primers used in this study. 
Name Sequence Description 
CcexE-F GGCGGCCATATGAAAAA
ATATATATTAGGTGT 
Primer for cloning cexE from ETEC 
H10407 into pET26b(+) 
CcexE-R CGAAGCCTCGAGTTTAT
ACCAATAAGGGGTGT 
Primer for cloning cexE from ETEC 
H10407 into pET26b(+) 
ICC168/cexE/Clone-FW GGCGGCCATATGAAACT
TATAGGAAAATTCAT 
Primer for cloning cexE from Citrobacter 




Primer for cloning cexE from Citrobacter 
rodentium ICC168 into pET26b(+) 
042/aap/Clone-FW GGCGGCCATATGAAAAA
AATTAAGTTTGTTAT 












Forward primer for generating kanamycin 







Reverse primer for generating kanamycin 







Forward primer for generating kanamycin 







Reverse primer for generating kanamycin 







Forward primer for generating kanamycin 







Reverse primer for generating kanamycin 









Forward primer for generating kanamycin 







Reverse primer for generating kanamycin 







Forward primer for generating kanamycin 







Reverse primer for generating kanamycin 












Forward primer with homology inside of 
cexE gene in ETEC H10407 
cexE-R2 TTTACAGTCCGATGCAT
GGC 
Reverse flanking primer with homology 
inside of cexE gene in ETEC H10407 
aatP-F1 TACAATGTCGGGACTCA
ACC 








Forward primer with homology inside of 
aatP gene in ETEC H10407 
aatP-R2 AGTGCCAACACATCATA
CCG 
Reverse flanking primer with homology 
inside of aatP gene in ETEC H10407 
aatA-F1 CATCAGGTTGAGTTACT
CGC 








Forward primer with homology inside of 





Reverse flanking primer with homology 
inside of aatA gene in ETEC H10407 
aatB-F1 CATTCCGCTAAGTGGAT
TGC 








Forward primer with homology inside of 
aatB gene in ETEC H10407 
aatB-R2 ACGAACGATACCTGATA
GCC  
Reverse flanking primer with homology 
inside of aatB gene in ETEC H10407 
aatC-F1 GTAATCCACATGTGCAA
GGG 








Forward primer with homology inside of 
aatC gene in ETEC H10407 
aatC-R2 TCGCCACCAGATAGTAA
AGC 
Reverse flanking primer with homology 
inside of aatC gene in ETEC H10407 
aatD-F1 CTCCCTCTATAGTGTGT
AGC 








Forward primer with homology inside of 
aatD gene in ETEC H10407 
aatD-R2 TAAGTACAGTTCCTCCG
TGG 
Reverse flanking primer with homology 
inside of aatD gene in ETEC H10407 
polA-1 TGGCGATAAAGATATGG
C 
Forward qRT-PCR primer to the polA 
gene in EAEC 042 
polA-2 GTACTTATTCACCACCT
C 
Reverse qRT-PCR primer to the polA 
gene in EAEC 042 
aap-1 TGGAACGCAGATAATGT
G 
Forward qRT-PCR primer to the aap gene 
in EAEC 042 
aap-2 CATTAAGGCCTTGCATA
C 
Reverse qRT-PCR primer to the aap gene 
in EAEC 042 
filC-1 TGATGGTGAAACCATCA
C 
Forward qRT-PCR primer to the fliC gene 





Reverse qRT-PCR primer to the fliC gene 
in EAEC 042 
filA-1 ATATTGCCGATTATCGC
C 
Forward qRT-PCR primer to the fliA gene 
in EAEC 042 
filA-2 ACCAGTTCAATGCTATC
G 
Reverse qRT-PCR primer to the filA gene 
in EAEC 042 
bssS-1 TATGATGCGCTGATGTT
G 
Forward qRT-PCR primer to the bssS 
gene in EAEC 042 
bssS-2 CAACATCAGTGGTTAAC
C 
Reverse qRT-PCR primer to the bssS gene 
in EAEC 042 
4803-1 ATCCACATTTGTGGGTA
C 
Forward qRT-PCR primer to the 
EC042_4803 gene in EAEC 042 
4803-2 ATGTGATTCCATACCAG
C 
Reverse qRT-PCR primer to the 
EC042_4803 gene in EAEC 042 
flgB-1 GACGATGACCTCAACGC
AAC 
Forward qRT-PCR primer to the flgB 
gene in EAEC 042 
flgB-2 ATTACCGTCAAGCGAAG
GCT 
Reverse qRT-PCR primer to the flgB gene 
in EAEC 042 
phoA-1 CGAACCAGCAAAAACCC
CTG 
Forward qRT-PCR primer to the phoA 
gene in EAEC 042 
phoA-2 GGCTTGTCGATATTGCC
GTG 
Reverse qRT-PCR primer to the phoA 






Forward primer for amplification of the 
cexE gene from ETEC H10407 with 




Reverse primer for amplification of the 
cexE gene from ETEC H10407 with 






Reverse primer for kanamycin cassette 
amplification with homology to the aap 




Forward primer for kanamycin cassette 




Forward primer for amplification of the 





Reverse primer for amplification of the 
cexE kanamycin cassette fragment 
Fwd-aap GTCGAAACGAGTAACAC
TCG 
Forward flanking primer to the aap gene 
in EAEC 042 
Rev-aap TGTCCATATTACGAGGG
TGG 
Reverse flanking primer to the aap gene 
in EAEC 042 
T7F TAATACGACTCACTA
TAGGG 
Forward primer for amplification of 
pET26b(+) multiple cloning site 
T7R GCTAGTTATTGCTCA
GCGG 
Reverse primer for amplification of 





1 M glacial acetic acid in deionised water). The agarose was allowed to cool, when cool enough 
to be handled, Midori Green Advance (Nippon Genetics) was added. Agarose was poured into 
moulds to set. All DNA samples except for PCR products from a MyTaq™ Red Mix (Bioline) 
reaction were prepared by the addition of 5x DNA Loading Buffer Blue (Bioline). One lane 
was reserved for HyperLadder™ 1kb (Bioline). A voltage of 120 V was applied across the gel 
in 1x TAE buffer. Gels were electrophoresed until there was sufficient migration of the loading 
dye. Gels were visualised with UV light (300 nm) using a G:BOX (Syngene). 
 
2.2.4. Cloning 
Table 2.3 contains the primers used to amplify the genes for cloning. A primer pair was 
designed so that they contained 50 bp homology flanking the region to be cloned. At the 5′ end 
of each primer there was 6 bp sequence before a restriction enzyme cutting site. The strain 
containing the gene to be cloned was used as the template for the cloning PCR. The PCR 
product of the cloning primers was termed the insert. The plasmid into which the insert was to 
be cloned was isolated as previously described. The isolated plasmid was termed the vector. 
Both the vector and the insert were cut with NdeI (NEB) and XhoI (NEB) using the CutSmart® 
(NEB) protocol. The cut plasmid was treated with Antarctic Phosphatase (NEB). Cut DNA 
was purified by gel extraction from a TAE 1% agarose gel using the QIAquick Gel Extraction 
Kit (Qiagen). DNA was quantified using Qubit™ dsDNA HS Assay Kit (Thermo Fisher 
Scientific). T4 DNA Ligase (NEB) was used to ligate the insert DNA into the vector DNA. 
The following equation was used to determine the amount of insert DNA to be used for 5 µl of 
the vector DNA. 
 
A negative control with the insert volume replaced with nuclease-free water was used for the 
ligation. Ligation reactions were incubated for 1 hour at 16ºC. From the ligation reaction 10 µl 
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was used to transform 30 µl NEB® 5-alpha Competent E. coli (High Efficiency). Recovered 
cells were plated on LBA supplemented with the required antibiotic and incubated at 37ºC 
overnight. Colonies were screened for the successful insertion of the insert with colony PCR. 
PCR primers with homology to regions of the vector outside of the multiple cloning site were 
used. Colonies that produced PCR products larger than the empty vector were isolated. 
Plasmids were sequenced by the Biosciences Genomics DNA sequencing facility. Only strains 
containing plasmids that were 100% identical to the desired ligation of vector and insert were 
stored as previously described. 
 
2.3. Gentenic engineering of bacterial strains 
2.3.1. Production and transformation of chemically competent cells 
Overnight cultures were inoculated into 50 ml LB to an OD600 of 0.05 and grown at 37ºC with 
aeration. When cultures had reached an OD600 of 0.6 they were cooled on ice for 10 minutes. 
The cells were harvested by centrifugation at 3,400 g for 10 minutes at 4ºC. The culture 
supernatant was aspirated and tubes were inverted to remove any remaining supernatant. The 
pellet was resuspended in 50 ml ice-cold 50 mM CaCl2 and incubated on ice for 30 minutes. 
Cells were centrifuged at 3,400 g for 10 minutes at 4ºC. The pellet was resuspended in 500 µl 
ice-cold 0.1M CaCl2 with 15% glycerol for 30 minutes. Cells were either used immediately or 
stored at −80ºC.  
 
Chemically competent cells were incubated with the plasmid for 30 minutes on ice. Cells were 
heat-shocked at 42ºC for 90 seconds and returned to ice for 5 minutes. The cells were recovered 
in 1 ml of LB which was incubated for 1 hour at 37ºC before plating onto LBA supplemented 




2.3.2. Production and transformation of electrocompetent cells 
Overnight cultures were used to inoculate 50 ml LB. Cultures were grown to an OD600 of 0.6 
they were then cooled on ice for 10 minutes before centrifugation at 3,400 g for 15 minutes at 
4ºC. Pellets were resuspended in 50 ml ice-cold 10% glycerol. Resuspended cells were 
centrifuged at 3,400 g for 15 minutes at 4ºC. Pellets were washed twice with 20 ml ice-cold 
10% glycerol. The pellet was resuspended in 500 µl ice-cold 10% glycerol. Electrocompetent 
cells were used immediately. Plasmid or linear DNA fragments in deionised water were 
incubated with 50 µl of cells on ice for 5 minutes. The mix of cells and DNA were transferred 
to 2 mm ice-cold electroporation cuvette and electroporated at 22,000 V. Cells were 
immediately suspended in 1 ml SOC media (20 g tryptone, 5 g yeast extract, 8.56 mM NaCl, 
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4 and 20 mM D-glucose in 1 L H2O) and transferred 
to a 15 ml falcon tube. Cells were recovered for 1 hour at 37ºC, or 30ºC for temperature 
sensitive plasmids. Recovered cells were plated onto the appropriate antibiotic for selection on 
LBA and incubated overnight at 37ºC or 30ºC for temperature sensitive plasmids. 
 
2.3.3. Gene deletions in E. coli 
Gene deletions in E. coli were made using the protocol from Datsenko and Wanner (2000). 
The forward primer contained 50 bp homology to the 5′ of the target gene containing the start 
codon. The reverse primer contained 50 bp homology to the 3′ of the target gene starting from 
the 7th last codon. At the 3′ of both of the primers, there was homology to the kanamycin 
cassette. Both the pDOC-K and pKD4 plasmids was used for the template of the kanamycin 
cassette (Lee et al., 2009; Datsenko and Wanner, 2000). The primers were used to amplify the 
kanamycin cassette with flanking 50 bp of homology to the target gene and the resulting PCR 
reaction was electrophoresed on a 1% agarose gel. The PCR product at 1.5 kb was purified 
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using the QIAquick Gel Extraction Kit (Qiagen). The linear fragment was eluted in 50 µl 
deionised water.  
 
The strain in which the mutation was desired, was made electrocompetent as described above 
and transformed with pKD46. Cells were recovered at 30ºC and plated on LBA with 100 µg/ml 
carbenicillin. Plates were incubated overnight at 30ºC. Colonies that grew were transferred to 
fresh LBA. Overnight cultures of the colonies suspected of containing pKD46 were incubated 
at 30ºC with aeration. Plasmids were isolated as previously described from the overnights and 
visualised on 1% TAE agarose. Transformants that contained a band of the same size as pKD46 
were stored as previously described. An overnight culture of a strain containing pKD46 was 
used to inoculate 50 ml of 0.2% L-arabinose 100 µg/ml carbenicillin LB. Cultures were grown 
to an OD600 of 0.6 and cells were made electrocompetent as previously described. The 
electrocompetent cells were electroporated with 5 µl of the purified linear fragment containing 
the kanamycin cassette as previously described. Cells were recovered as previously described. 
Recovered cells were plated onto 100 µg/ml kanamycin LBA and incubated at 37ºC overnight. 
Colonies that grew were checked for insertion of the kanamycin cassette by colony PCR. 
Colonies that produced a PCR product of the expected size for the kanamycin cassette insertion 
were streaked on LBA containing 100 µg/ml kanamycin and incubated overnight at 37ºC. 
Single colonies were checked by PCR for the removal of wild-type contamination. Colonies 
that were free of contamination were stored as previously described.  
 
2.3.4. Sewing PCR for insertion of genes into E. coli 
Sewing PCR and Datsenko and Wanner (2000) was used to introduce a gene into the genome 
of an strain and replace a gene already present. The fragment was designed in such a way that 
the new gene would be expressed in the same manner as the gene it replaced. A schematic of 
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the process is presented in Fig. 2.1. Phusion® High-Fidelity DNA Polymerase (NEB) was used 
throughout. In Fig. 2.1, the gene, gene A, from the source strain was introduced into the 
recipient strain at the same position as gene B. Thus, gene A was expressed in the same 
conditions as gene B.  
 
In total 3 pairs of primers were designed, the colours referred to in the text match the colours 
of the primers in Fig.2.1. Primer pair 1, for the amplification of gene A were designed with 
homology to the 25 bp at the 5' of gene A (green) including the start codon and homology to 
the 50 bp upstream of the start codon of gene B (red). The primer partner was designed as the 
reverse complement of the 25 bp at the 3' of gene A (green) including the stop codon and 
priming site 1 of pKD4 (blue). Primer pair 2, for the amplification of the kanamycin cassette 
were designed with 25 bp homology to the 3' of gene A (green) including the stop codon and 
priming site 1 of pKD4 (blue). The primer partner was the reverse complement of priming site 
2 of pKD4 and the 50 bp downstream of the stop codon of gene B. A final pair of primers, 
primer pair 3, were designed with 20 bp homology to the 5' and 3' ends of the desired linear 
fragment to gene B (purple). PCR was used to amplify gene A and the kanamycin cassette using 
primer pairs 1 and 2, repetitively. The PCR products were visualised by agarose gel 
electrophoresis, as previously described. The PCR products of the anticipated size were 
purified by gel extraction using the QIAquick Gel Extraction Kit (Qiagen). The extracted DNA 
was eluted in nuclease-free water and quantified. The purified PCR products were made to 100 
ng/µl. For the sewing PCR, 4 reactions were prepared. The buffer for each reaction consisted 
of 6.5 µl nuclease-free water, 5 µl 5X Phusion HF Buffer (NEB) and 5 µl 10 mM dNTPs. Both 
of the PCR products of gene A and the kanamycin cassette amplification were added into 
separate reactions at a volume of 0 µl, 0.5 µl, 1 µl and 2.5 µl. Each reaction was made up to 




Figure 2.1: Schematic of sewing PCR. The colour represents their homology. Red is 
homologous to the recipient strain, green to gene A, blue to priming site 1 and 2 of pKD4 and 
purple to the 20 bp at the 5' and 3' of the linear fragment.  
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was added to each reaction. The following program was used, 98ºC for 5 minutes then 10 cycles 
of 98ºC for 10 seconds, 40ºC for 30 seconds and 72ºC for 2 minutes. The reactions were 
removed and 1.25 µl of each of primer pair 3 were added the reactions. The reactions were 
placed back in the thermocycler. The following program was used, 15 cycles of 98ºC for 10 
seconds, 45ºC for 30 seconds and 72ºC for 2 minutes followed by 10 cycles of 98ºC for 10 
seconds, 50ºC for 30 seconds and 72ºC for 2 minutes then a final extension of 72ºC for 5 
minutes. The reactions were stored at 4ºC.  
 
The reactions were separated by agarose gel electrophoresis. If a band at the size of the desired 
product was not present, reactions were set up again and the extension time for each cycle was 
increased by 30 seconds. This was repeated until the desired product was produced. The desired 
product was extracted using QIAquick Gel Extraction Kit (Qiagen). If a higher quantity of the 
product was required, a PCR using primer set 3 was set up using the manufacturer’s 
instructions. The linear fragment of gene A and the kanamycin cassette flanked by the regions 
of homology was used as the linear fragment for Datsenko and Wanner as described above.  
 
2.4. Protein analysis 
Unless otherwise stated the manufacturer’s instructions were used for all reagents. 
 
2.4.1. Preparation of whole cell lysate 
Cultures were normalised to 1 ml of culture volume at an OD600 of 0.8. Cells were harvested 
by centrifugation at 3,400 g. The culture supernatant was aspirated. The pellet was resuspended 
in 100µl Sample Buffer, Laemmli 2× Concentrate (Sigma). The protein sample was incubated 
at 100ºC for 5 minutes. The sample was cooled on ice. Undissolved particulates were removed 
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by centrifugation at 16,000 g for 2 minutes at room temperature. Sample were analysed by 
SDS-PAGE. 
 
2.4.2. Precipitation of culture supernatant proteins  
The culture supernatant was separated by centrifugation at 8,000 g for 10 minutes at 4 ºC. The 
culture supernatant was removed from the cell pellet and 4 ml of was filtered using Millex-GP 
Syringe Filter Unit, 0.22 µm, polyethersulfone (Merck). The culture supernatant was cooled 
on ice. Ice-cold 100% TCA was added to a final concentration of 20%. Samples were incubated 
on ice for 30 minutes. Proteins were pelleted by centrifugation at 14,000 g for 15 minutes at 
4ºC. The supernatant was removed and discarded from the sample. The pellet was washed 
twice with 1 ml ice-cold 100% methanol with centrifugation at 14,000 g for 15 minutes at 4ºC. 
The supernatant was removed, residual methanol was evaporated by incubating the sample at 
60ºC for 10 minutes with the lid off. The pellet was resuspended in 50 µl Sample Buffer, 
Laemmli 2× Concentrate (Sigma). If a colour change to yellow occurred saturated Tris-base 
was added until the original colour returned. Samples were incubated at 100ºC for 5 minutes. 
Samples were placed on ice. Undissolved particulates were removed by centrifugation at 
16,000 g for 2 minutes at room temperature. Samples were analysed by SDS-PAGE. 
 
2.4.3. SDS-PAGE 
Typically gels proteins were analysed using Tris-tricine SDS-PAGE. However, where stated 
NuPAGE™ 10% Bis-Tris Protein Gels, 1.0 mm, 10-well (Thermo Fisher Scientific) were used. 
Tris-tricine SDS-PAGE were poured using Mini-PROTEAN® Tetra Handcast Systems (Bio-
Rad) with 1 mm thickness. Gels were poured to consist of a resolving gel (10% acrylamide) 
and a stacking gel (4% acrylamide). The resolving gel was 17 ml Tris-tricine buffer 
concentrate, 17 ml ProtoGel 30% (GeneFlow), 12 ml deionised water and 5 ml 100% glycerol. 
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The stacking gel was 6 ml Tris-tricine buffer concentrate (3 M Tris-HCl, 0.3% sodium dodecyl 
sulphate (SDS) at pH 8.25), 3.2 ml ProtoGel 30% (GeneFlow) and 15 ml deionised water. 
Separate buffers were used for the anode and the cathode in the electrophoresis chamber. The 
10x cathode buffer (1 M Tris-HCl, 1 M tricine, 1% SDS at pH 8.25) and the 10x anode buffer 
(2 M Tris-HCl at pH 8.9) were diluted with deionised water to the 1x working concentration. 
Electrophoresis chambers were assembled with the gels according to the manufacturer’s 
instructions. A voltage of 150 V was applied to the gels for 35 minutes. The gels were visually 
inspected for the progress of the dye-front. If the dye front was not migrated satisfactorily 
further electrophoresis was applied. When the migration of the dye front was satisfactory, the 
gels were removed for analysis by Coomassie Brilliant Blue stain or western blotting.  
 
2.4.4. Coomassie Brilliant Blue staining 
Gels were stained using the Fast Coomassie (0.05% Coomassie Brilliant Blue, 20% Propan-2-
ol, 0.4 M Citric acid). Gels were microwaved at full power for 40 seconds. Incubated rocking 
at room temperature for 5 minutes and microwaved at full power for 40 seconds. Fast 
Coomassie was removed and the gel washed with hot water. The gel was covered with hot 
water and microwaved at full power for 40 seconds. This was repeated until the desired 
intensity of stain was achieved.  
 
2.4.5. Western blotting 
Gels of samples that were used for western blotting were always prepared in duplicate. One 
gel was strained with Coomassie Brilliant Blue, as described above. The other gel was 
transferred to nitrocellulose using iBlot 2 Dry Blotting System (Thermo Fisher Scientific). 
After transfer, any extraneous membrane that the protein was not transferred to was removed. 
The membrane was covered in Blotto (50 g skimmed milk powder, 2.42 g Tris-base, 8 g NaCl, 
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1 g sodium azide, pH 8.4 in 1000 ml deionised water). The membrane was incubated for a 
minimum of 30 minutes with rocking at room temperature. Primary antibody was diluted in 
Blotto. Antibody specific to Aap was diluted at 1 in 5,000 (Sheikh et al., 2002). Antibody 
specific to CexE was diluted 1 in 1,000 (this study). Antibody specific to the β′ subunit of 
RNAP (E. coli RNA Polymerase beta Monoclonal Antibody, NeoClone) at 1 in 10,000 and 6x-
His Tag Monoclonal Antibody (Thermo Fisher Scientific) at 1 in 5,000. Blotto was removed 
from membranes. Membranes were incubated with rocking in primary antibody for a minimum 
of 1 hour but typically overnight at 4ºC. Primary antibody was removed from the membranes. 
Membranes were washed three times in TBST (2.42 g Tris-base, 8 g NaCl, 1% Tween-20, pH 
8.4 in 1000 ml) for 5 minutes at room temperature. 
 
The binding of primary antibody to proteins on the membrane was detected by antibodies with 
conjugated Horseradish Peroxidase (HRP) or by alkaline phosphatase. When using HRP, the 
secondary antibody for Aap and CexE primary antibodies was Goat Anti-Rabbit IgG H&L 
(HRP) from abcam. The secondary antibody for RNAP and 6His tagged proteins was Rabbit 
Anti-Mouse IgG H&L (HRP) from abcam. All secondary antibodies were diluted 1 in 10,000 
in Blotto. Membranes were covered and incubated for a minimum of 1 hour at 4ºC with 
rocking. Membranes were washed 4 times with TBST as previously described. Western blots 
were developed using Novex™ ECL Chemiluminescent Substrate Reagent Kit (Thermo Fisher 
Scientific). Westerns were visualised using the ChemiDoc™ XRS+ System (Bio-Rad) or 
GeneGnome XRQ (Syngene).  
 
The secondary antibodies for alkaline phosphatase was Anti-Rabbit IgG (whole molecule)–
Peroxidase antibody produced in goat (Sigma) or Anti-Mouse IgG (whole molecule)–
Peroxidase antibody produced in rabbit. Antibodies were diluted 1 in 10,000 in Blotto. 
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Membranes were covered with secondary antibodies and incubated at 4ºC for a minimum of 1 
hour rocking. The secondary antibodies were discarded. Membranes were washed 4 times with 
TSBT as previously described. The TBST was removed and the secondary antibody binding 
was visualised using 1-Step™ NBT/BCIP Substrate Solution (Sigma). The reaction was 
stopped after the desired exposure by washing the membrane with water.  
 
2.4.6. Protein production optimisation 
Protein was produced in E. coli BL21(DE3) using the pET vector expression system. E. coli 
BL21(DE3) was made chemically competent as previously described. E. coli BL21(DE3) was 
transformed with pET26b encoding the protein to be purified. The gene was inserted into the 
plasmid so that it was produced with a 6 C-terminal histamine tag (6His). For protein 
production, overnight cultures were used to inoculate separate 50 ml LB. Cultures were grown 
to an OD600 of 0.3 at 37ºC with aeration. The optimal condition for protein production was 
determined for temperature and induction concentrations. Protein production was tested first 
for induction concentration. Isopropyl β-D-1-thiogalactopyranoside (IPTG) (Sigma) was used 
to induce the expression of cexE from pET26b. IPTG was dissolved to 0.5 M in 10 ml deionised 
water. IPTG was aliquoted and stored at −30ºC. Aliquots were thawed and separate cultures at 
an OD600 of 0.3 were induced by addition of IPTG to a concentration of 250 µM, 50 µM, 10 
µM or 0 µM. Cultures were grown at 37ºC with 180 rpm. Protein sample were taken at 4 hour 
and 24 hours, post induction. Protein samples were analysed by Coomassie Brilliant Blue 
staining and western blotting with anti-His antibodies, as previously described.  
 
2.4.7. Protein production and purification 
The optimal conditions for protein production were identified. Overnight cultures of 50 ml LB 
were used to inoculate the desired amount of LB (typically 2 L). Cultures were grown at 37ºC 
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with aeration. When the cultures reached an OD600 of 0.3 the cultures were transferred to the 
optimal temperature for protein production. The cultures were cooled for 30 minutes with 180 
rpm. IPTG was added to the optimal protein production concentration. The cultures were 
incubated overnight at the optimal protein production temperature. After overnight growth, 
cells were harvested by centrifugation at 6,000 g for 15 minutes at 4ºC. The cell pellet was 
resuspended in ice-cold binding buffer (50 mM NaP (77:33 ratio of Na2HPO4 to NaH2PO4), 
500 mM NaCl, 20 mM imidazole, 0.5 mM TCEP at pH 7.3). The volume that the cell pellet 
was resuspended in was 3 ml of buffer to 1 g of wet cells. Cells were lysed using EmulsiFlex®-
C3 (Avestin). The cell lysate was kept cold throughout the procedure. Cells that were not lysed 
were removed by centrifugation at 10,000 g for 10 minutes at 4ºC. The pellet was discarded. 
The cell membrane components were removed by centrifugation at 75,000 g for 1 hour at 10ºC. 
The pellet was discarded. The supernatant was filtered using Millex-GP Syringe Filter Unit, 
0.22 µm, polyethersulfone (Merck). A HisTrap™ HP 5 ml column (GE Healthcare Life 
Sciences) was washed first with 50 ml of distilled H2O then with 50 ml binding buffer using a 
peristatic pump. The filtrate was applied to the washed HisTrap™ HP 5 ml column. The filtrate 
was cycled through the column overnight at 4ºC. In the morning, the column was washed with 
5 column volumes of binding buffer. The protein was eluted from the column using 10 column 
volumes of the elution buffer (50 mM NaP, 500 mM NaCl, 500 mM imidazole and 0.5 mM 
TCEP at pH 7.3). Fractions were taken of each of the wash volumes and the elution volumes. 
Protein samples were analysed using Tris-tricine SDS-PAGE. Samples containing purified 
protein were concentrated using Vivaspin® 6 5,000 MWCO columns (Sartorius Stedim). 
Protein was buffer exchanged using membrane filtration into 50 mM NaP, 250 mM NaCl and 




2.4.8. Protein concentration determination 
The concentration of a protein sample was determined using the absorbance of the protein at 
280 nm. All absorbance readings were taken using 1 ml glass quartz cuvettes. The spectrometer 
was blanked using the buffer that the protein was in. The protein sample was diluted and placed 
into 1 ml glass quartz curette. The absorbance was measured at 280 nm. The concentration of 
the diluted protein was determined using the following equation. 
! = 	 $	%	 × 	'	
Where c is molarity, A is absorbance at a wavelength of 280 nm, ε is the extinction coefficient 
of the protein and b is the path length in centimetres. Protein extinction coefficients were 
calculated using ProtParam (ExPASy). Protein concentration was left in molarity or converted 
to mg/ml as required.  
 
2.4.9. Primary antibody production 
CexE-6His protein was purified as previously described. Purified CexE-6His protein was 
denatured with 6 M Urea (Sigma). The denatured CexE-6His protein was aliquoted into 200 
µl at a concentration of 200 µg/100 µl. Primary antibodies were produced by Eurogentec using 
the 28-day speedy protocol. The serum received was used as the primary antibody for the 
detection of CexE. 
 
2.5. Phenotypic analyses 
2.5.1. Aggregation assay 
Overnight cultures were grown in triplicate at 37ºC with aeration. The OD600 of the cultures 
was normalised to OD600 3 in 5 ml with LB. After normalisation, the initial reading for each 
cell suspension was taken. The cells kept stationary and allowed to aggregate at room 
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temperature. Samples of 100 µl were taken from just under the meniscus of the cultures. The 
OD600 of the sample was measured. After the desired time course the OD600 measurements 
taken from each culture were compared to the initial reading and a percentage of the initial 
reading calculated. 
 
2.5.2. Flow biofilm growth 
The plasmid pJB39 was isolated as previously described. ETEC H10407 and ETEC 
H10407DcexE were transformed by electroporation with pJB39 as previously described. To 
create the flow cells, cover glass slides were attached using silicone to the top of Perspex flow 
cells and allowed to dry overnight at room temperature. The flow biofilm system was 
connected as in the schematic (Fig. 2.2). Clear Translucent Silicone Hose Pipe Tubing 
(Advanced Fluid Systems) with 1 mm diameter was used throughout except for the initial 
tubing into the media, which was Clear Translucent Silicone Hose Pipe Tubing (Advanced 
Fluid Systems) with 2 mm diameter. The media reservoir bottle was connected to a peristatic 
pump by 2 mm tubing that was adapted to 1 mm tubing before the pump. The periplasmic 
pump was a Watson Marlow Multi channel cassette pump - 205CA. A single cassette was set 
up for each line. The pump was connected to bubble traps. Bubble traps functioned by allowing 
liquid to flow in at the bottom. The inlet for the bubble trap was raised whilst the outlet was 
below that of the inlet. The liquid was allowed to fill the trap. The tap was closed. Thus, any 
bubble that were came into the trap were caught before they could pass through the flow cell. 
Connectors flanked the flow cell allowing the flow cell to be removed for microscopic 
inspection and re-connected for continuation of the experiment.  The stopcock was used to 
remove bubbles that formed due to the re-connection of the connectors. The media that flowed 
through the flow cell was collected in waste before disposal. System was washed at 90 rpm for 




Figure 2.2: Schematic of flow biofilm system. The above schematic is for one chamber of a 
flow cell only. Each flow cell contained three chambers. The dimensions of one chamber is 40 
mm x 4 mm x 50 µm (length x width x height). Each chamber is connected in the same way 
through a separate line. After autoclaving, the M9 media was incubated at 37ºC to reduce 
bubble formation. A bubble trap was used in each line to reduce the amount of bubbles that 
entered the flow cell chambers. The amount of bubbles entering the flow cell chambers needs 
to be at a minimum; as bubbles can destroy the bacterial biofilm that forms in the chambers. 
The connectors were placed so that the flow cell could be removed from the system for imaging 
and then reconnected for further growth if required. The stop clock has one inlet and two 
outlets. The tap on the stop clock opens and closes the outlets; this allows bubbles that have 
formed in the connector due to reconnection to be removed before they can enter the flow cell. 
Prior to use, the system was connected and water pumped through overnight to check for leaks. 
After the system was sterilised with 0.5% sodium hypochlorite, the tube into the media 
reservoir was washed with 70% ethanol during transfer to the M9 glucose media. This was to 
ensure sterility during transfer into the culture media.   
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hypochlorite made up to 1 L in deionised H2O. The system was moved to the 37ºC incubator 
room. The system was washed at 20 rpm for 2 hours with 2 L deionised H2O. M9 glucose for 
the flow biofilm experiment was prepared as follows. Before the media was cooled after 
autoclaving the M9 salts (6 g/L Na2HPO4, 3 g/L KH2PO4, 0.5 g/L NaCl to pH 7.3) was 
incubated at 37ºC. The night prior to use, 4 ml 1M MgSO4, 200 µl 1M CaCl2 and 40 ml 20% 
D-glucose were added to the 2 L M9 salts. Media was incubated overnight at 37ºC. Just prior 
to use the required antibiotic was added. The system was filled with M9 glucose and left 
stationary for 2 hours. The cells were prepared for injection from triplicate overnight cultures 
of ETEC H10407 pJB39 and ETEC H10407DcexE pJB39, grown as previously described. In 
the morning strains were inoculated into fresh 5 ml LB. Cells were grown to an OD600 of 0.3. 
From the cultures, 1 ml of cells was taken and pelleted by centrifugation at 3,400 g. The cell 
pellet was washed three times with PBS. The cells were resuspended in M9 glucose, 300 µl 
was used to inoculate a flow cell chambers using a 23G needle. Holes in the tubing were sealed 
using silicone. The cells were left stationary in the flow cell for 1 hour. A flow rate of 1 ml/min 
was applied to the system. The system was left overnight at 37ºC. After 15 hours, the biofilm 
growth was viewed using the confocal microscope at the BALM facility in the University of 
Birmingham. 
 
2.6. RNA Sequencing 
Before handling RNA, areas were decontaminated and RNases were removed using 
RNaseZap™ RNase Decontamination Solution (Thermo Fisher Scientific). RNA was 
sequenced with the help of Dr. Pavelas Sazinas at the University of Warwick. 
 
2.6.1. mRNA isolation  
RNA was isolated from 50 ml Dulbecco’s Modified Eagle’s Medium - high glucose (Sigma), 
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referred to as DMEM high glucose from now on. Overnight night cultures were grown as 
previously described. From the overnight cultures 1 ml of cells was pelleted by centrifugation. 
The cell pellet was washed 3 times with PBS. The final suspension of the cell pellet was in 1 
ml DMEM high glucose. Pre-warmed DMEM high glucose media was inoculated to an OD600 
of 0.05. Cultures were grown at 37ºC with aeration to OD600 of 0.6. From each culture 2 ml of 
cells was harvested by centrifugation. RNA was isolated using RNeasy Mini Kit (Qiagen). 
RNA was eluted in 50 µl of the TE buffer supplied. Contaminating DNA was removed from 
the RNA samples using RNase-Free DNase Set (Qiagen). Complete removal of contaminating 
DNA was confirmed by PCR using the 27F and 1492R. RNA quantity was determined from 1 
µl of each sample using the Qubit™ RNA BR Assay Kit (Thermo Fisher Scientific) on a Qubit 
2.0 Fluorometer (Thermo Fisher Scientific). RNA quality was assessed from 1 µl of each 
sample using Agilent RNA 6000 Nano Kit (Agilent Genomics). The RNA 6000 Nano chip was 
run on the 2100 Bioanalyzer (Agilent Genomics). RIN values were determined. Any sample 
with a RIN value of less than 8 was discarded. From 3.5 µg of RNA from each sample 
ribosomal RNA (rRNA) was depleted using the Ribo-Zero rRNA Removal Kit (Bacteria) 
(Illuminaâ). Successful rRNA depletion was analysed using Agilent RNA 6000 Pico Kit 
(Agilent Genomics). The RNA 6000 Pico chip was run on the 2100 Bioanalyzer (Agilent 
Genomics). Successive rounds of rRNA depletion were used if the rRNA was not sufficiently 
depleted. Depleted RNA was quantified using Qubit™ RNA HS Assay Kit (Thermo Fisher 
Scientific) on a Qubit 2.0 Fluorometer (Thermo Fisher Scientific). 
 
2.6.2. RNA Sequencing 
RNA was reverse transcribed and prepared for sequencing using TrueSeq® Stranded mRNA 
LT Sample Prep Kit (Illuminaâ). The fragment size was checked using Agilent DNA 1000 Kit 
(Agilent Genomics). The DNA 1000 chip was run on the 2100 Bioanalyzer (Agilent 
 
 77 
Genomics). Each sample was quantified using the Qubit™ dsDNA HS Assay Kit (Thermo 
Fisher Scientific) on a Qubit 2.0 Fluorometer (Thermo Fisher Scientific). The samples were 
pooled and sequenced on MiSeq Desktop Sequencer (Illuminaâ). 
 
2.6.3. Sequencing analysis 
Raw sequencing reads were downloaded in FASTQ format. Trimmomatic-0.36 was used to 
filter out poor reads and was called as follows LEADING:3 TRAILING:3 
SLIDINGWINDOW:4:15 MINLEN:50 (Bolger et al., 2014). Burrows Wheeler Aligner 
(BWA) was used to align the reads to the genomic sequence (Li and Durbin, 2010). Index files 
for BWA was created using bwa index from the EAEC 042 chromosome (FN554766.1) and 
the pAA2 plasmid (FN554766.1) sequence by Chaudhuri et al., (2010). The reads that passed 
the Trimmomatic-0.36 filtering were aligned to the EAEC genome using bwa mem. The suite 
SAMtools was used to convert SAM files to BAM files (Li et al., 2009). The SAM files 
generated by bwa mem were converted to sorted BAM files using samtools view. BAM files 
were sorted using samtools sort. Finally, BAM files were indexed using samtools index. Reads 
that were not mapped uniquely were removed using samtools -bq 1 on the indexed sorted BAM 
files. The number of reads that aligned to a region encoding a gene was counted using 
featureCounts (Liao et al., 2014). The .gtf file required for featureCounts was made from the 
.gff3 file downloaded from NCBI for FN554766.1 and FN554766.1 using gffread from 
Clufflinks (Trapnell et al., 2010). Differential gene expression was analysed in the R package 
DESeq2 (Love et al., 2014). 
 
2.6.4. Quantitative reverse transcriptase PCR  
Triplicate overnight cultures of EAEC 042 pBAD24, EAEC 042DaggR pBAD24 and EAEC 
042DaggR pAggR were used to inoculate 4 ml DMEM high glucose to an OD600 of 0.05. Cells 
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were grown to an OD600 of 0.4 at 37ºC with aeration. The production of AggR was induced by 
the addition of 1 ml 10% L-arabinose dissolved in DMEM high glucose. Thus, the final 
concentration of L-arabinose in the culture was 2%. The cells were grown for a further hour at 
37ºC with aeration. RNA was extracted using RNeasy Mini Kit (Qiagen). Contaminating DNA 
was removed using TURBO DNA-free™ Kit (Ambion). Isolated RNA was quantified using 
Qubit™ RNA BR Assay Kit (Thermo Fisher Scientific). From each sample 1.75 µg of RNA 
was used for reverse transcription. The reverse transcription reaction was set up with the Tetro 
cDNA Synthesis Kit (Bioline) using Random Hexamers.  
 
2.7. Phylogenetic analysis of Aap and the Aat proteins 
The protein sequences of the Aat proteins from EAEC 042 were used to search the NCBI non-
redundant protein sequences database using PSI-BLAST. Significant hits were downloaded. 
The results were parsed using a custom python script so that a single sequence was represented 
by single code. Sequences were clustered using cd-hit (Li and Godzik, 2006). Either HHpred 
and HMMER (hmmer.org) were used to identify homologs (Alva et al., 2016; Finn et al., 
2011). HMMER searches were against the UniprotKB or Swissprot databases. Protein 
sequences were aligned using Clustal Omega (Sievers et al., 2011). RAxML was used for the 
calculation of distances between sequences using the maximum likelihood method 
(Stamatakis, 2014). The correct model for the calculation of maximum likelihood based on the 
protein sequence alignment was determined using the ProteinModelSelection.pl script included 
in the RAxML distribution. Trees were drawn using iTOL (Letunic and Bork, 2016). 
 
2.8. NMR 
Dr. Timothy Knowles set-up and collected the experimental data at the Biomolecular NMR 
facility at the University of Birmingham. NMRFAM-Sparky was used for all NMR 
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experimental analysis (Lee et al., 2015).  
 
2.8.1. Protein production and purification 
Prior to the 13C and 15N labelled growth the optimal conditions for CexE-6His production were 
determined. E. coli BL21(DE3) was made chemically competent as previously described. 
Described below is the double labelled growth for structure determination. A single labelled 
growth, 15N only, was previously conducted to determine CexE-6His viability for NMR 
structure determination. For this growth only 1 L was used and the 13C was replaced with D-
glucose (Sigma). All other steps were exactly the same. The plasmid pET26b-cexE was isolated 
as previously described. The plasmid was sequenced prior to transformation. E. coli 
BL21(DE3) was transformed by heat shock with pET26b-cexE. Successful transformants were 
streaked to single colonies on LBA100 µg/ml kanamycin. A single colony was inoculated into 
50 ml LB and grown overnight at 37ºC with aeration. M9 salts (6 g/L Na2HPO4, 3 g/L KH2PO4, 
0.5 g/L NaCl to pH 7.3) were made to 2 L. Prior to growth, nutrient mix was added to the M9 
salts at 20 ml per L of M9 salts. The nutrient mix contained 1 ml Thiamine (20 mg/ml), 0.4 ml 
3mM FeCl3, 1 ml metal mix (4 mM ZnSO4.7H2O, 1 mM MnSO4.5H2O, 4.7 mM H3BO3, 0.7 
mM CuSO4.5H2O made to 100 ml in deionised water), 2 ml 1M MgCl2, 0.1 ml CaCl2, 1 ml 
100 mg/ml kanamycin sulphate, 1 g 15N labelled ammonium chloride, and 2 g 13C glucose 
made to 20 ml. Complete M9 media was warmed to 37ºC. For the inoculum, 10 ml of overnight 
culture was centrifuged at 3,400 g for 5 minutes at 20ºC. The culture supernatant was removed 
and the pellet was resuspended in 1 ml warmed M9 media. The resuspended cells were used to 
inoculate the M9 media. When the culture had grown to an OD600 of 0.3 the culture was moved 
to 18ºC. The culture was allowed to cool for 30 minutes and IPTG was added to a concentration 
of 50 µM. Cultures were grown at 18ºC with aeration overnight. The CexE-6His protein was 
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purified as previously described. The double labelled CexE-6His was further purified by size 
exclusion prior to NMR experiments.  
 
2.8.2. NMR experiments 
A 1.83 mM sample of purified CexE-6His was dialysed into 20 mM NaP, 150 mM NaCl, 50 
mM L-arginine, 50 mM L-glutamine, 0.5 mM TCEP and 0.2 mM NaN3 at pH 6.5. The 
following experiments, using a 600 MHz magnet, were used for the determination of the 
structure of CexE-6His; 1H-15N-HSQC, HNCA, HNCOCA, HNCACB, HN(CO)CACB, 
HNCO, HNCACO, CCONH and HCCONH. The 900 MHz magnet was used for the final 
experiments, 1H-15N-HSQC, 13C- NOESY-HSQC and 15N-NOESY-HSQC.  
 
2.8.3. Shift assignments and structure calculation 
The backbone of the protein consisting of the amide, Cα and the carboxyl groups were assigned 
using 1H-15N-HSQC, HNCA, HNCOCA, HNCACB, HN(CO)CACB, HNCO and HNCACO. 
The shifts for the Cα were assigned using the HNCA and HN(CO)CA spectrum. The chemical 
shifts for the Cβ were assigned using the HNCACB and HN(CO)CACB spectra. The carbonyl 
groups were assigned using the HNCO and HNCACO spectra. The carbon side chains of the 
amino acids were assigned using the CCONH spectrum. The 13C- NOESY-HSQC was assigned 
using the chemical shifts determined from the experiments above. The 15N-NOESY-HSQC 
was not assigned. The CexE-6His structure was modelled using CYANA by Dr. Timothy 
Knowles.  
 
2.9. 32P Radioactive labelled DNA 
2.9.1. DNA fragment isolation 
Overnight cultures of strains containing pSRCC(−41.5) were used for plasmid isolation as 
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previously described. For the excision of the 100 bp fragment from pSRCC(−41.5) plasmid the 
following reaction was set up: 40 µl pSRCC(−41.5), 2 µl EcoRI-HF® (NEB), 2 µl HindIII-
HF® (NEB), 5 µl CutSmart® buffer (NEB) and 1 µl nuclease-free water. This reaction was set 
up in quintuplicate. The reaction was incubated at 37ºC for 2 hours. After 2 hours, restriction 
enzymes were heat inactivated by incubation of 85ºC for 5 minutes. After heat inactivation 
samples were cooled. Then 2 µl Alkaline Phosphatase, Calf Intestinal (CIP) (NEB), 1 µl 
CutSmart® buffer (NEB) and 7 µl nuclease-free water was added to each reaction. The reaction 
was incubated at 37ºC for a further two hours. For loading onto a 0.5x TBE 6% acrylamide gel 
15 µl 5x DNA Loading Buffer Blue (Bioline) was added to each sample. A working 
concentration of 0.5x TBE was made from a 5x TBE stock (54 g/L Tris base, 27.5 g/L boric 
acid and 20 ml/L 0.5 M EDTA (pH 8.0)). The gels were electrophoresis at 100 V. When the 
dye front was towards the bottom of the gel, the gels were removed from their casts and 
incubated in 0.5x TBE with Midori Green Advance (Nippon Genetics) for 5 minutes at room 
temperature. The bands were visualised and excised. The DNA was electroeluted from the 
excised gel fragments by placing the gel into dialysis tubing. A 100 V current was put across 
the tubing for 30 minutes. The DNA fragments were purified by phenol-chloroform 
precipitation, detailed below.  
 
2.9.2. Phenol-chloroform DNA precipitation 
Phenol-Chloroform mix was added 1:1 to DNA sample and vortexed vigorously. DNA was 
spun at 20,000 g for 2 minutes. After centrifugation, the upper layer was removed by pipetting 
and placed into a new tube. 3M sodium acetate was added to one tenth of the volume. 1M 
MgCl2 was added to one hundredth of the volume. Two volumes of 100% ice-cold ethanol 
were added to the DNA. DNA was incubated at −20ºC for 2 hours or −80ºC for 15 minutes. 
The DNA was then centrifuged at max speed for 15 minutes at 4ºC. Supernatant was removed 
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and the pellet was washed with 1 ml of 70% ice-cold ethanol. DNA was centrifuged at max 
speed for 15 minutes at 4ºC. The supernatant was removed and the remaining ethanol allowed 
to evaporate. Pellet was resuspended in 40 µl nuclease free water. 
 
2.9.3. 32P DNA labelling 
All of the CC(−41.5) DNA fragments were incubated with 2 µl T4 Polynucleotide Kinase 
(NEB), 5 µl T4 PNK Reaction Buffer (10X) (NEB) and 3 µl ATP, [γ-32P] (PerkinElmer). The 
final volume was made up to 50 µl. The reaction was incubated at 37ºC for 15 minutes. T4 
PNK was heat inactivated at 65ºC for 5 minutes. The DNA fragments were isolated using 
silicone columns. 
 
2.9.4. Electrophoretic mobility shift assay 
Electrophoretic Mobility shift assays were carried out as follows. Reactions were prepared in 
10 µl with the following concentrations 0.2 µl 32P labelled CC−41.5 DNA, 1 µl 10x Fis buffer 
(200 mM Tris-HCl (pH 7.0), 100 mM MgCl2, 1 mM EDTA, 1.2 M KCl and 20 mM DTT), 1 
µl 50% glycerol, 0.5 µl BSA (10mg/ml making a final concentration of 7 µM), 1 µl protein 
diluted to the appropriate concentration and 6.3 µl H2O. Reactions were left at room 
temperature for 15 minutes and run on 0.5x TBE 6 % acrylamide gel. A lane was reserved for 
5x DNA Loading Buffer Blue (Bioline). When the dye front was sufficiently progressed, the 
gel was removed. The gel was placed onto filter paper. The other side was covered with cling 
film and the gel was dried. The dried gel was then placed into a cassette facing the white side 











CHAPTER 3:  





A pathogen must be able to sense the host environment and change protein production 
accordingly. The expression of genes, encoding proteins required for virulence, is mainly 
modulated via transcription factors. Enteroaggregative E. coli (EAEC) are a major cause of 
disease worldwide (Huang et al., 2006; Rohde et al., 2011). EAEC form a characteristic 
‘stacked brick’ biofilm on HEp-2 cells  mediated by the aggregative adherence Fimbriae (AAF) 
(Nataro et al., 1987, 1992). The AAF and their transcription activator, AggR, are required for 
colonisation (Elias et al., 1999; Clements et al., 2012). In the prototypical EAEC strain, EAEC 
042, the genes that encode AggR and AAF/II are present on a plasmid, pAA2 (Chaudhuri et 
al., 2010). The pAA2 plasmid contains many genes encoding proteins required for the 
pathogenesis of EAEC 042. 
 
In previous studies on EAEC 042, Dudley et al. (2006) identified AggR as an activator for the 
transcription of a cluster of 25 genes termed aaiA-Y that are present on a pathogenicity island 
on the chromosome. These genes encode proteins that are homologous to a type VI secretion 
system (T6SS). AggR can induce transcription of genes on both the pAA2 plasmid and the 
chromosome. From this, Dudley et al. (2006) concluded that AggR is a global regulator. Using 
qRT-PCR and microarrays, Morin et al. (2013) identified 44 genes under positive 
transcriptional control of AggR in EAEC 042. These genes include the aai system, aafABCD, 
the aat system and aap. A number of other hypothetical genes were also shown to be under 
AggR control. In both of these studies, microarrays were used to provide information about the 
AggR regulon. Advances in sequencing technology have provided more sensitive techniques 
for the transcriptional profiling of an organism. In this study, RNA-Seq has been used to further 
characterise the AggR regulon. 
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RNA-Seq offers a number of benefits over previous methods of transcriptome profiling. 
Microarrays and qRT-PCR require hybridisation of probes to cDNA to identify transcripts. In 
contrast, in RNA-Seq the cDNA is sequenced and aligned to a reference genome. The 
alignment of reads to a reference genome is a quantitative method for the determination of 
abundance of individual transcripts. Microarrays and qRT-PCR use fluorescence to identify 
transcript hybridisation to specific probes. The reliance on fluorescence reduces the dynamic 
range of the technique. Transcripts with a low abundance will not be detected while transcripts 
with high abundance will be under-exposed (Cloonan and Grimmond, 2008). Non-specific 
hybridisation and probe bias can both influence the results from a microarray experiment but 
are not problematic for RNA-Seq (Kane et al., 2000; Cloonan and Grimmond, 2008). Thus, in 
RNA-Seq experiments, this bias is removed and the dynamic range is increased. 
 
In an RNA-Seq experiment, RNA is extracted and contaminating DNA removed by DNase I 
treatment (Fig. 3.1). To improve the power of the experiment ribosomal RNA (rRNA) is 
removed from the sample. The high abundance of rRNA in a transcriptome (up to 95%) results 
in the majority of reads being aligned to genes for ribosomal RNA instead of mRNA 
(Giannoukos et al., 2012). Depletion of the rRNA from an RNA sample reduces the cost of 
sequencing and increases the power of the experiment for the identification of mRNA 
transcripts. cDNA is synthesised from the depleted RNA and is sequenced. The reads are 
aligned to the reference genome. The number of reads that align to each gene is counted. The 
count for each gene is compared between either growth conditions or a parental strain and a 
mutant. From this comparison genes that are differentially expressed can be identified. In this 
study, RNA-Seq was used to confirm the previously identified AggR regulon and identify new 




Figure 3.1: The general outline of an RNA-Seq experiment. RNA is harvested from a 
bacterial culture. Contaminating DNA is removed by DNase I treatment. Ribosomal RNA is 
depleted, cDNA is then synthesised and the library is sequenced. The resulting reads provide a 





3.2.1. Comparison of growth of an aggR mutant with the parental strain. 
Ideally RNA for RNA-Seq analysis should be isolated from the test and control cultures of 
bacteria growing exponentially at similar rates. Initial experiments were therefore designed to 
determine the stage of growth at which samples of the aggR mutant and its parent strain should 
be harvested for RNA isolation. Triplicate overnight cultures were transferred to fresh DMEM 
high glucose (DMEM) and grown at 37°C with aeration. Samples were removed at 30 min. 
intervals, and a growth curve was constructed (Fig. 3.2). Both cultures grew exponentially at 
almost identical rates until the OD600 had reached 0.6. Growth of the parent strain then 
gradually stopped, reaching a final cell density of 0.8. In contrast, growth of the aggR mutant 
continued to a final cell density of about 1.3. It was concluded that in subsequent experiments, 
samples for RNA isolation should be harvested at an OD600 of 0.6. 
 
3.2.2. RNA isolation and DNA removal 
Triplicate overnight cultures of the aggR mutant and the parental strain were transferred to 
DMEM and grown at 37°C with aeration, as described above. At an OD600 of 0.6, a 2 ml sample 
from each culture was harvested by centrifugation. RNA was isolated from the bacterial pellet. 
Following removal of contaminating DNA from the samples using DNase I, PCR was used to 
check for any residual DNA contamination. PCR primers 27F and 1492R were used to amplify 
the DNA encoding 16S ribosomal RNA. Each of the following were used as the template for 
separate PCR reactions: 2 µl of each of the six RNA samples; a positive control of 2 µl of 
Staphylococcus aureus chromosomal DNA; and a negative control of 2 µl of nuclease free 
water. The PCR products were separated by agarose gel electrophoresis. No PCR product was 




Figure 3.2: Growth curve of aggR mutant and parental strain in DMEM high glucose. 
Triplicate overnight cultures were inoculated in DMEM high glucose and grown at 37ºC with 
aeration. The growth curve was constructed with OD600 readings every 30 minutes. Each time 
point was the mean of the OD600 readings taken. Error bars represent the standard deviation 
between replicates. 
  



















amplified for S. aureus chromosomal DNA (Fig. 3.3). From this, it was concluded that there 
was no DNA present in the RNA samples that was detectable by PCR. 
 
3.2.3. Quantity and quality of isolated RNA 
Only concentrated, high-quantity RNA samples will provide useful information on the 
expression of genes. The quantity of each RNA sample was tested using Qubitä RNA BR 
Assay kit. The total quantities of RNA in each 50 µl sample A to F were 8.1, 26.58, 14.64, 
11.34, 7.02 and 11.22 µg, respectively (Table 3.1). To determine the quality of each sample 1 
µl was loaded into a separate well of the Agilent 6000 Nano Chip. The RNA Integrity Number 
(RIN) for each sample was 9.5, 9.8, 9.1, 10, 8.1 and 8.5, respectively (Table 3.1). The first 
major peak at around 1,500 nucleotides (nt) is the 16S rRNA the second peak at 2,000 nt is the 
23S rRNA. No signs of degradation in sample D resulted in a perfect RIN score of 10 (Fig. 
3.4). Samples E and F were of a lower quality. Degradation products of the 16S were present 
at 1,000 nt. Although the RNA in samples E and F were slightly degraded, this was not 
substantial. A RIN of above 8 was required for RNA-Seq. Thus, the RNA samples were of a 
sufficient quantity and quality for use in RNA-Seq. 
 
3.2.4. Ribosomal RNA depletion and depleted RNA quantification 
Removal of rRNA from RNA samples prior to cDNA synthesis increases the dynamic range 
of the experiment. Ribosomal RNA was depleted from 3.5 µg of total RNA from samples A to 
F using the RiboZero rRNA Removal kit (Bacteria) from Illuminaâ. After depletion of rRNA, 
1 µl of each sample was analysed using the Agilent RNA 6000 Pico kit. For the samples A, C, 
D, E and F the peaks for 16S and 23S rRNA were completely depleted (Fig. 3.5). In sample B, 
the rRNA peaks were still present, indicating that the rRNA depletion of sample B was 




Figure 3.3: Detection of ribosomal DNA in RNA samples by PCR. No ribosomal DNA was 
detectable by PCR for any of the six samples. The size of the DNA fragments was estimated 
using Bioline 1kb Hyperladder. The product generated in the positive control (+) at 1,500 bp 
was the result of the successful amplification of the 16S gene from a genomic DNA sample of 








Table 3.1: Summary of RNA isolation, cDNA synthesis and sequencing. 
Strains EAEC 042 EAEC 042ΔaggR 
RNA Samples A B C D E F 
Total RNA isolated (µg in 50 µl) 8.1 26.58 14.64 11.34 7.02 11.22 
RIN 9.5 9.8 9.1 10 8.1 8.5 
Total RNA after depletion (ng in 20 µl) 3.29 27.2 23.5 29.3 26.3 34.8 
Average fragment size (bp) 280 287 268 265 279 281 
Concentration of cDNA (ng/µl) 3.56 82.14 18.01 21.59 18.12 21.45 
Generated Reads 8,385,714 12,508,003 7,853,859 8,204,480 8,867,535 8,361,035 
Filtered Reads 8,217,784 12,255,016 7,752,998 8,095,882 8,701,142 8,201,872 
Percentage of reads successfully aligned (%) 96.66 93.26 92.57 90.48 90.78 93.26 
Number of reads aligned to genes in the correct orientation 6,333,037 3,719,671 6,023,878 6,208,206 6,726,054 6,378,786 
Percentage of aligned reads that aligned to genes in the correct 




Figure 3.4: Total isolated RNA from EAEC 042 and EAEC 042DaggR replicates. The 
panels are labelled based on the sample. Three biological replicates of EAEC 042 (A, B and 
C) and EAECDaggR (D, E and F) are shown. For each sample, 1 µl was used to determine the 






Figure 3.5: Post rRNA depletion of RNA of EAEC 042 and EAEC 042DaggR. Samples A 
to F on were analysed for rRNA depletion using the Agilent Bioanalyzer Pico 6000 RNA chip. 
In all of the samples, except sample B, rRNA was successfully depleted. Significant amounts 
of rRNA were still present in sample B. However, some rRNA had been depleted as peaks 







Fig. 3.4. The fluorescence of the 16S and 23S peaks were also reduced from 53 and 66 FU to 
22.5 and 25 FU (Fig. 3.4 and Fig. 3.5). Therefore, the rRNA has been partially depleted in 
sample B. The rRNA still present in sample B is not ideal but reads that align to the rRNA 
could be removed in the analysis and would therefore not invalidate the final result. Thus, the 
RNA samples were considered to be sufficiently depleted to continue with cDNA synthesis. 
 
The amount of depleted RNA must be quantified for cDNA synthesis. RNA was quantified 
using the Qubitä RNA HS kit. From the samples A to F, 1 µl was taken after rRNA depletion 
to assess the amount of RNA. The total depleted amount of RNA in 20µl was found to be 3.29, 
27.2, 23.5, 29.0, 26.3 and 34.8 ng, respectively (Table 3.1). Despite the low quantity of RNA 
in sample A, it was still sufficient for cDNA synthesis.  
 
3.2.5. Synthesis of cDNA 
RNA must be converted into cDNA before it can be sequenced. From each of the samples B to 
F, 10 ng of RNA was used for cDNA synthesis. For sample A, the entire amount of 3.29 ng 
was used. RNA was reverse-transcribed into cDNA using True-Seq Stranded Total RNA LT 
Sample Prep Kit. For DNA sequencing, the average fragment size should be 260 bp. Using the 
Agilent High Sensitivity DNA Kit, the average fragment size was found to be 280bp, 287bp, 
268bp, 265bp, 279bp and 281bp for samples A to F (Fig. 3.6, Table 3.1). The concentration of 
cDNA for each sample was 3.56, 82.14, 18.01, 21.59, 18.12 and 21.45 ng/µl, respectively 
(Table 3.1). For samples B, D and F a subpopulation of the DNA library appeared to have a 
larger fragment size (Fig. 3.6). However, the majority of the fragments were an acceptable size 
for sequencing. The low input amount of RNA for sample A resulted in a low yield of cDNA. 





Figure 3.6: Reverse transcribed cDNA fragments of wild-type and aggR replicates. The 
average fragment size for each sample was determined using the Agilent High Sensitivity DNA 
Kit. The lower concentration of cDNA in sample A was due to low concentration of depleted 






However, only a small amount of cDNA, 4 pM, is required for sequencing. Thus, the cDNA 
synthesised was sufficiently concentrated for sequencing. 
 
3.2.6. Sequencing and alignment of reads to EAEC 042 genome 
The cDNA was pooled and sequenced using the MiSeq Reagent Kit v3 (Illuminaâ). Pair-end 
reads of 75 bases were generated. The samples A to F generated 8,385,714, 12,508,003, 
7,853,859, 8,204,480, 8,867,535 and 8,361,035 reads, respectively (Table 3.1). The higher 
number of reads generated from sample B was probably due to a higher concentration of 
cDNA. Despite the lower concentration of cDNA in sample A, a relatively similar number of 
reads was obtained after sequencing. Each sample generated enough reads to provide useful 
information about the AggR regulon. 
 
Low quality reads were removed using Trimmomatic-0.36. The number of reads for samples 
A to F after filtering were 8,217,784, 12,255,016, 7,752,998, 8,095,882, 8,701,142 and 
8,201,872, respectively (Table 3.1). The majority of the reads, 98%, were of a sufficient quality 
for genome alignment. The reads were then aligned to the EAEC 042 genome using Burrows-
Wheeler Aligner. The percentage of reads successfully aligned for samples A to F to the 
genome was 96.66, 93.26, 92.57, 90.48, 90.78 and 93.26, respectively (Table 3.1). Thus, in 
conclusion, there was sufficient coverage of the transcriptome for differential gene expression 
analysis. 
 
3.2.7. Differential gene expression analysis.  
Differential expression of a gene is calculated by comparing the number of reads aligned to 
that gene in the mutant with the parental strain. The amount of reads that align to each gene 
was counted using featureCounts. Reads that aligned to ribosomal RNA were not counted. For 
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samples A to F the total number of reads that aligned to genes was 6,333,037, 3,719,671, 
6,023,878, 6,208,206, 6,726,054 and 6,378,786, respectively (Table 3.1). The percentage of 
aligned reads that aligned to genes in the correct orientation for each sample was 77.07, 30.35, 
77.70, 76.68, 77.30 and 77.77, respectively (Table 3.1). The lower number of reads mapped 
for sample B was due to the high level of rRNA after rRNA depletion (Fig. 3.5). Although, this 
was not ideal, this could be resolved by normalisation of transcripts per gene. 
 
Differential gene expression was calculated using the R package DESeq2. Genes that contained 
no aligned reads in any of the samples were removed. The number of aligned reads to each 
gene was normalised. The number of reads that aligned to a gene was transformed onto a log2 
scale. The amount of variance of genes with low but variable read counts between the different 
samples was reduced by transformation, using the DESeq2 rlog function. In Fig. 3.7, each gene 
is represented by a point, dictated by the number of reads after transformation and 
normalisation for EAEC 042 on the y-axis and EAEC 042DaggR on the x-axis. Genes that were 
not differentially expressed in the aggR mutant compared to the parent strain form a straight 
line out of the origin at an angle of 45º. Genes activated by AggR fall above this line; those 
repressed by AggR fall below this line. Therefore, AggR activates transcription for more genes 
than it represses.  
 
The majority of genes, 4,908, were not differentially expressed in the aggR mutant compared 
to the parent strain. A total of 112 genes present on pAA2 and the chromosome were found to 
be differentially expressed, of which 4 were repressed by AggR: phoA; flu1; flu2; and 
EC042_4803, signified by a positive fold change in the wild-type compared to the mutant. 




Figure 3.7: Read counts of genes in EAEC 042 compared to EAEC 042DaggR. Sequencing 
reads aligned to each gene were counted using FeatureCounts. The counts were normalised in 
DESeq2. The counts for each gene were averaged across EAEC 042 and EAEC 042DaggR 




Table 3.2: Genes differentially expressed in the aggR mutant. 
Chromosomal genes 
Gene Name Function log2 fold change 
Adjusted 
p-value 
phoA alkaline phosphatase 1.44 4.97E−09 
bssS biofilm regulator −2.76 2.29E−15 
flgN negative regulator of flagellin 
synthesis 
−2.12 4.21E−09 
flgM anti-sigma factor −1.97 4.60E−06 
flgA flagellar basal body P-ring formation 
protein 
−3.29 2.92E−22 
flgB flagellar basal-body rod protein −6.05 1.72E−51 
flgC flagellar basal-body rod protein −5.60 2.40E−47 
flgD flagellar biosynthesis, initiation of 
hook assembly 
−5.19 2.67E−42 
flgE flagellar hook protein −5.23 1.06E−52 
flgF flagellar basal-body rod protein −4.27 1.34E−31 
flgG flagellar basal-body rod protein −4.33 6.68E−40 
flgH flagellar L-ring protein −3.32 3.01E−21 
flgI flagellar P-ring protein −2.74 3.81E−20 
flgJ putative peptidoglycan hydrolase −2.78 6.54E−19 
flgK peptidoglycan hydrolase −2.37 1.80E−14 
flgL flagellar hook-filament junction 
protein 1 
−2.17 9.47E−11 
cspI cold shock-like protein −2.02 4.47E−07 
anmK anhydro-N-acetylmuramic acid kinase −1.18 6.58E−06 
flhA flagella biosynthesis protein −2.13 1.40E−11 
flhB flagellar biosynthesis protein −3.13 4.47E−15 
cheW chemotaxis protein −1.86 6.29E−07 
cheA chemotaxis protein −2.03 8.37E−11 
flhC flagellar biosynthesis protein −2.13 1.34E−17 
flhD flagellar transcriptional activator −2.05 3.35E−18 
fliZ DNA-binding transcriptional regulator −3.35 6.62E−18 
fliA flagellar sigma factor −5.09 3.97E−38 
fliE flagellar hook-basal body complex 
protein 
−2.93 1.88E−17 
fliF flagellar M-ring protein −4.99 2.38E−47 
fliG flagellar motor switch protein  −4.48 3.43E−36 
fliH flagellar assembly protein −4.12 2.30E−31 
fliI flagellum-specific ATP synthase −4.11 3.44E−28 
fliJ rod/hook and filament chaperone −3.62 8.58E−22 
fliK flagellar hook-length control protein −3.90 4.79E−22 
fliL flagellar basal body-associated protein −4.08 1.13E−28 
fliM flagellar motor switch protein −4.43 5.29E−42 
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fliN flagellar motor switch protein −4.19 2.08E−24 
fliO flagellar protein −3.27 9.41E−14 
fliP flagellar biosynthetic protein −2.63 1.32E−08 
EC042_2219 conserved hypothetical protein −2.07 1.07E−07 
flu1 antigen 43 1.99 8.24E−20 
EC042_2249 conserved hypothetical protein −3.00 7.94E−12 
EC042_3179A conserved hypothetical protein −1.57 6.27E−08 
EC042_3180 conserved hypothetical protein −2.88 1.09E−30 
EC042_3181 putative transcriptional regulator −2.44 4.95E−15 
EC042_3182* ParB-like nuclease −3.38 4.19E−45 
EC042_3183 conserved hypothetical protein −4.35 2.26E−45 
EC042_3184* conserved hypothetical protein −3.73 2.43E−25 
EC042_3185 pseudogene −3.99 6.55E−34 
EC042_3187 putative helicase −4.09 1.86E−78 
EC042_3188 transposase −4.91 6.15E−61 
EC042_3476 conserved hypothetical protein −2.27 5.13E−06 
EC042_4006* putative exported protein −4.16 9.37E−43 
EC042_4430 putative signal transduction protein −2.89 1.59E−23 
flu2 antigen 43 2.32 4.49E−14 
EC042_4562* putative type VI secretion protein −4.41 2.72E−74 
EC042_4563* putative type VI secretion protein −4.14 6.55E−59 
EC042_4564* putative type VI secretion protein −3.99 2.88E−43 
EC042_4565* putative type VI secretion protein −3.33 1.00E−34 
EC042_4566* putative type VI secretion protein −3.14 2.04E−29 
EC042_4568* putative type VI secretion protein −3.00 2.24E−27 
EC042_4569* putative type VI secretion protein −3.21 1.51E−33 
EC042_4570* putative type VI secretion protein −3.16 4.03E−41 
EC042_4571* putative type VI secretion protein −2.75 1.40E−20 
EC042_4572* putative type VI secretion protein −2.86 3.34E−32 
EC042_4573* putative type VI secretion protein −2.99 1.05E−35 
EC042_4574* putative type VI secretion protein −2.90 1.96E−27 
EC042_4574A* putative type VI secretion protein −2.74 1.64E−28 
EC042_4575* putative type VI secretion protein −2.86 1.46E−33 
EC042_4576* putative type VI secretion protein −2.94 1.48E−26 
EC042_4577* putative type VI secretion protein −2.78 6.92E−27 
EC042_4578 pseudogene - transposase −1.22 8.93E−06 
EC042_4579A pseudogene - transposase −1.88 1.18E−12 
EC042_4580* conserved hypothetical protein −1.21 1.39E−07 
EC042_4581* conserved hypothetical protein −2.19 6.55E−18 
EC042_4581A pseudogene - transposase −1.98 2.46E−16 
EC042_4581B pseudogene - transposase −1.67 4.97E−09 
EC042_4582* hypothetical protein −1.91 1.45E−17 
EC042_4583* hypothetical protein −1.70 6.01E−16 
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EC042_4584 pseudogene - transposase −1.67 1.86E−08 
EC042_4585 transposase −1.68 6.97E−09 
EC042_4585A pseudogene - transposase −1.83 1.26E−08 
EC042_4587 pseudogene - transposase −1.57 3.54E−09 
EC042_4803 antigen 43  4.29 3.63E−81 
pAA2 genes 
Gene Name Function log2 fold change 
Adjusted 
p-value 
EC042_pAA003* hypothetical protein −4.54 1.51E−56 
EC042_pAA004* putative isopentenyl-diphosphate delta-
isomerase 
−4.13 4.81E−64 
EC042_pAA005* hypothetical protein −5.34 1.53E−103 
EC042_pAA005A* hypothetical protein −5.56 2.78E−80 
EC042_pAA006 pseudogene - transposase −1.58 9.06E−10 
aatP* permease −5.52 4.37E−50 
aatA* TolC-like protein −6.05 2.72E−85 
aatB* membrane fusion protein −4.68 2.68E−40 
aatC* ATPase −4.55 2.36E−48 
aatD* required for Aap secretion −3.47 2.06E−28 
EC042_pAA019 conserved hypothetical protein 
pseudogene 
−3.60 8.04E−50 
EC042_pAA020* conserved hypothetical protein −3.28 5.15E−41 
shf* polysaccharide deacetylase −3.04 1.23E−32 
EC042_pAA022* glycosyl transferase −3.24 1.42E−28 
virK virulence protein −3.01 1.79E−29 
aafB* afimbrial adhesin −4.53 5.18E−43 
aafC* aggregative adherence fimbria II usher 
protein 
−4.53 6.08E−65 
afaB* pseudogene −6.68 2.91E−144 
EC042_pAA033 transposase −2.28 2.62E−06 
aafD* chaperone protein −7.49 8.21E−95 
EC042_pAA047* hypothetical protein −9.19 3.65E−198 
aafA* major fimbrial subunit of aggregative 
adherence fimbria II 
−8.16 1.51E−208 
EC042_pAA051 transposase −4.94 1.37E−35 
aggR* transcriptional activator −5.47 2.40E−111 
EC042_pAA053 pseudogene - transposase −1.65 1.28E−10 
aap* dispersin −9.36 1.51E−208 
aar* AggR antivirulence factor −3.55 6.46E−33 
EC042_pAA061 conserved hypothetical protein −3.25 9.29E−24 
EC042_pAA105 pseudogene - transposase −2.05 5.12 E−10 




expressed in an aggR mutant compared to the parent strain except for EC042_pAA056, a 
hypothetical gene of unknown function.  
 
3.2.8. Chromosomal genes differentially expressed in the aggR mutant compared to the 
parental strain 
AggR is known to activate pathogenicity islands on the EAEC 042 chromosome (Dudley et 
al., 2006; Morin et al., 2013). A total of 112 genes were differentially expressed in the mutant 
compared to the parental strain, 83 of which are located on the chromosome and 39 on the 
pAA2 plasmid. Only 4 of the 83 genes appeared to be repressed by AggR; these were flu1, 
flu2, EC042_4803, and phoA. Three of these genes, flu1, flu2, and EC042_4803, encode Agn43 
paralogs an autotransporter that promotes aggregation of cells in liquid broth (Diderichsen, 
1980). Due to phase variation, these genes show variable levels of expression in randomly 
chosen populations of bacteria (Owen et al., 1996). Therefore, it is presumed that the difference 
in the number of transcripts for these genes, between the aggR mutant and the wild-type, is 
stochastic and simply represents phase variation events. PhoA is alkaline phosphatase. PhoA 
is produced in response to phosphate starvation (Torriani, 1960). No other genes involved in 
phosphate starvation were differentially expressed. Thus, the differential expression of flu1, 
flu2, EC042_4803, and phoA was not thought to be due to the presence of AggR. 
 
Amongst the 83 differentially expressed genes on the chromosome, the products of 34 are 
involved in motility. A notable absence from the list of differentially expressed flagellar genes 
is fliC. The log2-fold change for fliC was −0.72. Differences in motility of the aggR mutant and 
wild-type have not been reported previously. The apparent activation of motility genes in the 
experiment is not thought to be due to the presence of AggR but due to the stochastic nature of 




In agreement with Dudley et al. (2006) and Morin et al. (2013) the 16 genes (EC042_4562 to 
EC042_4577) encoding a putative type 6 secretion system (T6SS), present in ROD69 
(Chaudhuri et al., 2010), were differentially expressed. In fact, a total of 28 genes 
(EC042_4562 to EC042_4587) in ROD69 were differentially expressed in the aggR mutant 
compared to the wild-type. These 12 extra genes were 7 pseudogenes, 1 gene encoding a 
transposase, and 4 genes encoding hypothetical proteins. The 4 hypothetical proteins 
EC042_4580, EC042_4581, EC042_4582, and EC042_4583. EC042_4580, EC042_4581, and 
EC042_4583 are conserved in E. coli strains with no detectable homology to a family of 
proteins. The C and N-terminus of EC042_4582 are homologous to the pfam groups ImpA_N 
(PF06812) and VasL (PF12486), respectively. These pfam groups encode proteins of unknown 
function which are involved in T6SS and are commonly associated together.  
 
Amongst the remaining differentially expressed chromosomal genes, 12 encode hypothetical 
proteins. Of the 12 genes, 8 formed a cluster on the chromosome. EC042_3179A to 
EC042_3187, which are in ROD48 (Chaudhuri et al., 2010), were differentially expressed in 
the presence of AggR (Fig. 3.8). The possible function of each of the proteins that the gene 
cluster encodes was investigated using a BLAST search. EC042_3179A, EC042_3180 and 
EC042_3184 are conserved proteins present in E. coli strains. There was no homology to a 
known family of proteins. EC042_3181 is a putative transcription regulator identified as 
homologous to PerC from enteropathogenic E. coli (EPEC). PerC directly activates the 
transcription of LEE1 in EPEC (Knutton et al., 1997). EC042_3182 encodes a ParB-like 
nuclease domain. The N-terminal region of EC042_3183 is homologous to YbdN, a putative 
phosphoadenosine phosphosulfate sulfurtransferase. The C-terminal region of EC042_3182 




Figure 3.8: Expression of the genes EC042_3179A to EC042_3187. A, the number of 
normalised reads aligned to each gene in the aggR mutant and parental strain. The number of 
reads aligned to each sequence were normalised to the number of reads for each replicate. Thus, 
the normalised reads aligned to each gene are a measure the relative mRNA abundance of each 
gene. The error bars represent the standard deviation between the replicates of each strain. B, 




EC042_3187 was identified by BLAST as a UvrD-like helicase. Whether any of these proteins 
have a function in the colonisation of EAEC 042 is currently unknown. In conclusion, the 
expression of EC042_3179A to EC042_3187 was activated by AggR. 
 
The remaining 4 differentially expressed hypothetical genes were not clustered together. The 
possible functions of the proteins encoded by these genes were investigated by BLAST 
searches. The C-terminus of EC042_2219 was homologous to the β domain of inverse 
autotransporters (pfam11924). EC042_2067 and EC042_3476 have no homology to proteins 
of known function. EC042_2067 is conserved in E. coli strains, both pathogenic and non-
pathogenic strains. EC042_3476 is present in many E. coli pathogens. EC042_3476 is 99% 
identical to c3944 from UPEC CFT073 and EcE24377A_3672 from ETEC E24377A. 
However, while expression was activated by AggR their role in pathogenesis is unknown.  
 
EC042_4006 is another differentially expressed gene encoding a hypothetical protein. The 
EC042_4006 product is a protein of 97 amino acids known as YicS in E. coli MG1655 K-12. 
EC042_4006 is adjacent to nlpA, nlpA is thought to be repressed by CfaD and AggR (Bodero 
et al., 2007). In this analysis, nlpA was not found to be differentially expressed. A log2-fold 
change of −0.74 was calculated for nlpA. It was concluded that, in agreement with previous 
studies, the expression of EC042_4006 was activated by AggR.  
 
3.2.9. Differential expression of genes on the pAA2 virulence plasmid in the presence of 
AggR 
On the pAA2 plasmid, 29 genes were differentially expressed. Of these genes, 9 encoded 
hypothetical proteins. There was a log2-fold difference of −4.54, −4.13, −5.34 and −5.56 for 
the genes EC042_pAA003 to EC042_pAA005A, respectively. Mutants of EC042_pAA003 
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and EC042_pAA004 affect the cell membrane and alter surface integrity, reducing EAEC 042 
ability to form biofilms (Morin et al., 2013). EC042_pAA005 and EC042_pAA005A encode 
proteins of 50 amino acids. Using a BLAST search, no homology to a known family of proteins 
was identified. The function of EC042_pAA005 and EC042_pAA005A therefore remain 
unknown. Thus, in agreement with previous studies, EC042_pAA003 to EC042_pAA005A 
were confirmed to be activated by AggR. 
 
The log2-fold differences of EC042_pAA019 to EC042_pAA023 were −3.60, −3.28, −3.04, 
−3.24 and −3.01, respectively. EC042_pAA019 is annotated as a pseudogene. However, an 
open reading frame of 107 residues is present for EC042_pAA019. The protein sequence of 
the open reading frame is conserved in E. coli, Shigella and Salmonella. EC042_pAA019 is 
homologous to YdfA, an uncharacterised conserved protein. No clear function has been 
associated with EC042_pAA019. EC042_pAA020 encodes a conserved hypothetical protein 
of 195 amino acids with no homology to a known family of proteins. Homologs of 
EC042_pAA020 were found in E. coli, Salmonella and Klebsiella. EC042_pAA021 is also 
known as shf. Shf is a polysaccharide deacetylase with homology to PgaB, an outer membrane 
N- deacetylase. EC042_pAA022 is a conserved glycosyl transferase similar to YqgM in 
Bacillus licheniformis. EC042_pAA023 is known as virK. VirK is a virulence protein in 
Shigella flexneri that is required for the expression or correct orientation of IcaA (VirG) on the 
outer membrane of the cell. This locus of shf, EC042_pAA022 and virK is found in the same 
order in Shigella and a large number of other E. coli strains. The locus is also present on the 
EAEC 042 chromosome. The chromosomal locus was not differentially expressed. Thus, it 
was concluded, that expression of shf, EC042_pAA022 and virK on the pAA2 plasmid was 




The log2-fold difference in expression of EC042_pAA061 was −3.25. EC042_pAA061 
encodes a protein of 76 amino acids. A BLAST search was unable to identify homology to any 
known family of proteins. However, many hypothetical proteins were homologous to 
EC042_pAA061 including AWZ91_24990 from Sh. sonnei, CBL21_10600 from Sh. flexneri 
and BEH79_07420 from K. pneumoniae. EC042_pAA061 is 65% or more identical in amino 
acid sequence to these three proteins. The conservation of this protein in pathogenic strains 
suggests that EC042_pAA061 may have a role in pathogenesis. No clear function for the 
hypothetical proteins identified could be attained from homology searches. In conclusion, 
EC042_pAA061 is a gene with a cryptic function that is expressed in response to AggR in 
EAEC 042. 
 
There were differences in expression of aggR and aar in the aggR mutant compared to the 
wild-type. The log2-fold difference of aggR was −5.47 in the mutant compared to the wild-
type. The log2-fold difference in expression of the gene encoding AggR antivirulence factor, 
aar, was −3.55. Thus, it is concluded, consistent with previous reports that AggR activates 
expression of aar. 
 
The production of the aggregative adherence fimbriae (AAF/II), encoded by aafABCD, are 
required for the characteristic aggregative adherence phenotype of EAEC. The log2-fold 
differences of aafA, aafD, aafB and aafC were −8.16, −7.49−4.54 and −4.54, respectively. The 
log2-fold difference of the pseudogene afaB, upstream of aafB, was −6.68. A gene encoding a 
hypothetical protein, EC042_pAA047, is positioned between aafA and aafD. The −9.19 log2-
fold difference of EC042_pAA047 was the second greatest for differentially expressed genes. 
EC042_pAA047 is predicted to code for a protein of 54 amino acids with no significant 
homologous protein or nucleotide sequences identified by blastp or tblastn, respectively. No 
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signal sequence or function could be predicted for EC042_pAA047. The increase in aligned 
reads at the start of EC042_pAA047 suggests that its expression was not due transcriptional 
read-through from aafD (Fig. 3.9). In conclusion, in agreement with previous studies 
transcription of afaB, aafABCD and EC042_pAA047 were activated by AggR. 
 
The greatest log2-fold difference, −9.36, was for the gene aap, that encodes the protein 
dispersin. In the wild-type strain, 2.42% of the normalised reads aligned to aap. A significant 
percentage of the mRNA transcriptome is used for the expression of aap. The genes that encode 
the system required for the secretion of Aap were also differentially expressed. The log2-fold 
change of aatP, aatA, aatB, aatC and aatD were −5.52, −6.05, −4.68, −4.55 and −3.47, 
respectively (Fig. 3.10A). The number of aligned reads across decreases across the operon in 
a 5¢ to 3¢ direction reflecting the orientation of the genes on the pAA2 plasmid (Fig. 3.10B). In 
conclusion, AggR activates expression of aap and the genes required for Aap secretion. 
 
3.2.10. Validation of differentially expressed genes by qRT-PCR 
In contrast to previous reports of the characterisation of the AggR regulon using microarrays, 
RNA-Seq indicated an activation of motility genes. The expression of 4 genes was also 
unexpectedly repressed in the presence of AggR. Triplicate overnight cultures of EAEC 042 
pBAD24, EAEC 042DaggR pBAD24 and EAEC 042DaggR pAggR were used to inoculate 
DMEM. Cultures were grown to an OD600 of 0.4 at 37ºC with aeration. The culture medium 
was supplemented with L-arabinose a final concentration of 2%. Cultures were grown for a 
further hour at 37ºC with aeration. RNA was harvested and extracted as previously described. 
Contaminating DNA was removed by a DNase I treatment. The samples were quantified and 
1.75 µg of total RNA was used to reverse transcribe cDNA. The template for each PCR was 




Figure 3.9: Aligned reads to pAA2 plasmid for the region between aafD and aafA. Each 
panel represents the number of aligned reads of each replicate of EAEC 042. Each panel is a 
histogram of the number of times a read aligns to a base in the sequence. The expression of 
aafA was substantially greater than that of aafD and EC042_pAA047. Thus, to visualise the 
expression of EC042_pAA047 the upper limit of the histogram was reduced. The position of 





Figure 3.10: Normalised read counts and gene localisation for aap and the aat system. A, 
the normalised read counts for the genes. Error bars were drawn using the standard deviation 





used as the reference gene; the mRNA of the aap gene was used as the positive control, which 
is known to be activated by AggR. The primers used were polA-1, polA-2, aap-1, aap-2, phoA-
1, phoA-2, fliA-1, fliA-2, flgB-1, flgB-2, fliC-1, fli-2, EC042_4803-1, EC042_4803-2, bssS-1 
and bssS-2. For each gene, a total of 10 reactions were prepared, 1 for each sample and a no 
template control. Relative gene expression was calculated using the 2DDCT method (Fig. 3.11, 
Table 3.3). 
 
As expected, the relative gene expression of aap was reduced in the aggR mutant compared 
with the parental strain and complemented by pAggR above wild-type levels. There was a 
slight increase in the level of phoA transcripts in the aggR mutant, but was even higher in the 
strain transformed with pAggR. Although there was an increase in expression of bssS in the 
aggR mutant, complementation of the aggR mutant further increased the amount of bssS 
transcripts. Levels of fliA, flgB, fliC, and EC042_4803 expression were not significantly 
different in the wild-type compared to the mutant. With the exception of the aap mutant, none 
of the qRT-PCR results confirmed the RNA-Seq data. Therefore, it was concluded that there 
was no effect by AggR on the expression of phoA, fliA, flgB, fliC, bssS, or EC042_4803. 




Microarrays have previously been used to determine the extent of the AggR regulon (Morin et 
al., 2013; Dudley et al., 2006). Here, the AggR regulon was characterised using RNA-Seq. 
Using RNA-Seq the genes previously included in the AggR regulon were confirmed except for 




Figure 3.11: Validation of RNA-Seq results by qRT-PCR. The relative gene expression of 
each gene was tested against polA using the 2DDCT method. Error bars represent standard 







Table 3.3: Relative gene expression of qRT-PCR validated genes. 
Relative gene expression aap phoA fliA flgB fliC EC042_4803 bssS 
EAEC 042 pBAD24 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
EAEC 042ΔaggR pBAD24 0.0041 1.7 1.2 1.1 1.1 1.7 3.0 
EAEC 042ΔaggR pAggR 4.5 2.0 1.5 1.4 1.5 1.4 5.0 
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genes encoding proteins associated with flagella and the genes that according to the RNA-Seq 
data appeared to be repressed could not be confirmed by qRT-PCR. Therefore, a total of 30 
genes were potential new candidates for AggR activation. The function of AggR as a repressor 
has been previously suggested by Bodero et al. (2007), who concluded that AggR, CfaD and 
Rns are able to repress nlpA. These conclusions were based on data from lacZ promoter fusions 
and DNase I foot printing. The repression of nlpA was mediated by the binding of Rns 
downstream of the transcription start site of nlpA, which prevented the synthesis of nlpA 
mRNA. However, whether AggR represses nlpA was not tested in EAEC 042. Instead, AggR 
repression of nlpA was shown using the strain EAEC 17-2. As the full genome sequence is not 
available for EAEC 17-2, the similarity of the region of nlpA and EC042_4006 between EAEC 
17-2 and EAEC 042 cannot be compared. Instead from the evidence presented here and that of 
Morin et al. (2013), it must be concluded that AggR does not repress the expression of nlpA in 
EAEC 042. 
 
The initial site for EAEC 042 cells to form a biofilm in the host is a highly competitive 
microbial environment. Commensal bacteria provide a defensive barrier against pathogens. As 
T6SS are associated with bacterial killing (Russell et al., 2014), the expression of the aai T6SS 
during the formation of AA by EAEC 042 is potentially used to remove commensal or 
competing bacteria from the environment. Thus, allowing EAEC 042 to cause disease. The Aai 
T6SS likely does not have a direct role in the formation of the characteristic aggregative 
adherence. However, in the host environment it would be required for the initial stages of 
EAEC 042 pathogenesis. 
 
There was a difference in expression of the duplicated shf, EC042_pAA022 and virK operons. 
On the chromosome EC042_pAA022 is termed EC042_4771. The nucleotide sequences of the 
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two operons are similar but not identical. During the analysis, reads that could be aligned to 
two separate regions in the genome were discarded. Therefore, the difference in regulation is 
likely real. The difference in regulation of these similar operons suggests that they are 
expressed in response to different conditions. The activation of this operon by AggR suggests 
that the proteins encoded are involved in EAEC 042 pathogenesis. 
 
A total of 21 hypothetical genes were identified by RNA-Seq to be differentially expressed. 
The expression of 9 of these genes were not previously associated with AggR. The activation 
of these genes by AggR and homology to genes in other pathogens suggest that they affect 
pathogenesis. AggR is the activator of a cluster of hypothetical genes, EC042_3179A to 
EC042_3187. The function of EC042_3179A to EC042_3187 is not clear. Although their 
homology to other genes suggests a pathogenic role. This region presents a promising area for 
further research into EAEC 042 pathogenesis.  
 
The AAF/II are required for the formation of aggregative adherence. The role of AggR in the 
activation of the genes encoding the AAF/II is well established. There has been no investigation 
into the function of EC042_pAA047. It is tempting to believe that due to the lack of 
conservation and the relatively small size of the protein that the expression observed is due to 
EC042_pAA047 position between aafD and aafA. The histogram of number of reads aligned 
to the aafD to aafA region indicates that EC042_pAA047 is not transcribed due to its position 
(Fig. 3.9). The second highest change in expression was observed in EC042_pAA047. 
EC042_pAA047 may have a role in the function of the AAF/II due to its position in the 
intergenic region of aafD and aafA. This gene presents itself as an interesting candidate for 
further research. However, the absence of homology suggests that this protein is only present 




The role of AggR in the formation of aggregative adherence is well documented (Clements et 
al., 2012). The highest changes in transcription occur in the genes directly involved in 
aggregative adherence, such as aafABCD, aatPABCD and aap. The greatest difference in 
expression between the aggR mutant and the wild-type was for aap. The Aap protein has been 
investigated in EAEC 042 (Sheikh et al., 2002; Velarde et al., 2007).  
 
AggR is a major transcription activator in EAEC. The mRNA transcriptome of an AggR 
producing strain is dominated by aap and aaf. AggR does not only affect the plasmid, on which 
it is encoded, by also the chromosome. AggR activates two major regions on the chromosome, 
the aai system and EC042_3179A to EC042_3187. The functions of these regions are yet to 
be understood. Thus, AggR is a global regulator. The study of the AggR regulon can lead to 
the identification of new mechanisms of EAEC 042 pathogenesis and present targets for 













CHAPTER 4:  
Characterisation of the CexE protein 





The RNA-Seq experiment, in Chapter 3, concluded that the greatest difference in expression 
between the aggR mutant and the wild-type was for the aap gene. A substantial proportion of 
mRNA was transcribed in the wild-type strain for the expression of aap hinting at the 
importance of Aap for the pathogenesis of EAEC. Aap was characterised in EAEC 042; it is 
required for the correct orientation of the AAF/II in EAEC 042 (Sheikh et al., 2002). Aap is 
secreted out of the cell and coats the outer membrane (Nishi et al., 2003). There it modulates 
the cell surface charge allowing the positively charged AAF/II to extend away from the 
negatively charged outer membrane (Velarde et al., 2007). When prototypical ETEC H10407 
was sequenced by Crossman et al., (2010) the cexE gene was identified as a homolog of aap. 
There is 18% identity between the protein sequences of CexE and Aap (Fig. 4.1).  
 
Compared to Aap there is very little information on the CexE protein and other homologs. The 
cexE gene is regulated by CfaD, a transcription activator similar to AggR (Gallegos et al., 1993; 
Pilonieta et al., 2007). CexE elicits an immune response when murine hosts are injected with 
outer membrane vesicles of ETEC H10407, which is similar to that of the heat labile toxin and 
EtpA (Roy et al., 2010, 2011). However, these papers did not report a functional analysis of 
the CexE protein. Therefore, the aims of this study were to investigate the prevalence of 
Aap/CexE homologs and the possible function of CexE in ETEC H10407. 
 
4.2. Results 
4.2.1. Variation between Aap and CexE homologs 
Other than reports from sequencing studies there is no information on the range and variation 
of the protein sequences of Aap and CexE homologs. Thus, a PSI-BLAST search was used to 




Figure 4.1: Alignment of CexE and Aap. The amino acid sequence of CexE and Aap from 
ETEC H10407 and EAEC 042, respectively, were aligned using clustal omega.   
CLUSTAL O(1.2.4) multiple sequence alignment 
 
 
CexE      MKKY---ILGVILAMGSLSAIAGGGNSERPPSVAAGECVTFNSKLGEIGGYSWKYSNDAC 
Aap       MKKIKFVIFSGILGI-SLNAFAGGS-GWNADNVDPSQCIKQSG-----VQYTYNSGVSVC 
          ***    *:. **.: **.*:***. . .  .*  .:*:. ..       *::: . ..* 
 
CexE      NETVAKGYAIGVAMHRTVNYEGGYSIQSSGIVKPGSDFIMKGGKTYKGHKKVSAGGDTPY 
Aap       MQGLNEGKVRGVSVSGVFYYNDGTTSNFKGVVTPSTPVNTNQDINKTNKVGVQKYRALTE 
           : : :* . **::  .. *:.* : : .*:*.*.: .  : . . ..:  *.        
 
CexE      WYK 
Aap       WVK 
          * * 
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to the Aap protein sequence. The sequences were clustered to 90% identity, using cd-hit, 
forming 22 clusters. A phylogram, with bootstrapping analysis, was constructed using RAxML 
(Fig. 4.2). There were three major clades for Aap and CexE. These clades can be broadly 
characterised into Aap homologs in EAEC strains, CexE homologs in ETEC strains, and CexE 
homologs in Yersinia enterocolitica strains. A single sequence commonly represented a large 
number of sequences that were more than 90% identical in each clade. For the Aap clade, the 
WP_032283735.1 E. coli (EAEC 042) Aap sequence represented 65 sequences. All of the Y. 
enterocolitica sequences were represented by a single sequence. This clade was termed 
Yersinia CexE. This clade contains the CexE protein from the mouse pathogen Citrobacter 
rodentium ICC168. This strain is typically used as a mouse model for EPEC pathogenesis.  
 
The majority of the Aap homologs were represented by a single sequence. The 
WP_032283735.1 E. coli (EAEC 042) tip contained many sequences of Aap homologs from 
EAEC O104:H4 that was responsible for the 2011 German outbreak of Shiga toxin producing 
EAEC. The AAF/III producing ancestor strain of the German outbreak strain, EAEC 55989 
(Rohde et al., 2011), was included in this cluster. The tip representing the second highest 
number of sequences in the Aap clade contain the strain NCTC86. This is the first strain of E. 
coli that was isolated by Theodor Escherich in 1886. Interestingly the nucleotide sequence for 
aap in this strain is 100% identical to 10 other sequences in the NCBI nucleotide database 
(Appendix I). These were clinical isolates from different sites around the globe, every continent 
excluding Asia, from 2003 to 2016. One strain, HVH202 was isolated from a patient with 
bacteraemia caused by a urinary tract infection. Information on the strains is limited. However, 
this is an appropriate example of the spread and longevity of the aap gene. The Aap clade also 
contained a subclade including a Salmonella enterica strain isolated in Cuba. The sequence of 




Figure 4.2: Phylogram of Aap/CexE homologs. Aap homologs were identified using 4 
iterations of a PSI-BLAST search. The sequences were clustered based on their sequence 
identity using cd-hit. Clustering refers to the identification of protein sequences that are more 
than 90% identical to each other. These sequences are grouped together and the longest amino 
acid sequence is then used to represent the other sequences in the cluster. The longest sequence 
is used as it is considered to contain the most information about the amino acid sequences in 
that cluster. The end of each branch is the sequence used to build the tree, this is referred to as 
the tip. Thus, all sequences at the tips of the above phylogram are less then 90% identical. 
Sequences were aligned using Clustal Omega. From the sequence alignment, a tree was 
constructed with the branch lengths representing the number of changes in the amino acid 
sequence per site between each sequence using RAxML. The bootstrapping values associated 
with each branch were included. The tree was drawn using iTOL. The bars on the right 
represent the number of sequences, other than the sequence in the tree, that are represented by 
each cluster. These include identical sequences and sequences that were more than 90% 
identical. The names of strains referenced in the text that were present in a cluster were included 
in brackets.  
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The third major clade was CexE from ETEC strains. The prototypical ETEC, H10407, and a 
number of other ETEC strains including, 1392/75, E24377A and B7A, also fell into this clade. 
There were a number of duplications of the cexE gene in some strains identified in the CexE 
clade. There were two sequences that were homologues to CexE for strains ETEC 1392/75 and 
ETEC E24377A. These duplications were present on separate plasmids in the strains. For 
ETEC 1392/75, the cexE duplications were on p748 and p1018 and for ETEC E24377A they 
were present on pETEC_73 and pETEC_80. The identities of the protein sequences for the 
duplicates was 59% and 61% for ETEC 1392/75 and ETEC E24377A, respectively. The two 
homologous CexE sequences from ETEC 1392/75 were in separate clusters, the same was true 
of ETEC E24377A. In fact, the separate clusters of the CexE homologs in ETEC 1392/75 were 
the same as the two CexE homologs from ETEC E24377A. This perhaps suggests not a double 
duplication event by a single duplication before the strains diverged. 
 
There were a small number of other sequences that did not fall within the three major clades. 
Little sequence identity is shared between these sequences. Another duplication event for the 
cexE gene was found in the strain TA280. Similarly, with ETEC 1392/75 and ETEC E24377A 
there is a difference between the sequence identity of the two CexE proteins of 28% in TA280.  
 
The bootstrapping values for some of the clades in the analysis are quite low, which reflects 
the low identity between the protein sequences. However, the bootstrapping values associated 
with each major clade are quite high: 100 for Yersinia CexE and Aap and 93 for CexE. 
Therefore, it can be confidently stated that the definition of the major clades is correct. The 
sequences of CexE and Aap have diverged. Sequences in separate clades correlated closely 
with the pathovar of the host in which they are found. Therefore, it is suggested that the function 




4.2.2. Construction of a cexE deletion mutant in the ETEC strain H10407 
It was hypothesised above that the function of the CexE protein is different to that of Aap. 
Thus, a cexE deletion was constructed in ETEC H10407 using the Datsenko and Wanner 
(2000) method. ETEC H10407 was transformed by electroporation with pKD46, a plasmid 
harbouring the λ-Red recombinase genes. The primers GDcexE-FW and GDcexE-RV were 
designed to amplify a kanamycin cassette with 50 bp of flanking homology directly upstream 
and downstream of the cexE gene. Instead of pKD4, a kanamycin resistance cassette was 
amplified from pDOC-K using the primers above. The PCR products were gel purified and 
eluted in nuclease-free water. 
 
An overnight culture of ETEC H10407 pKD46 was used to inoculate LB supplemented with 
0.2% L-arabinose to an OD600 of 0.05. The culture was grown to an OD600 of 0.6. Cells were 
harvested by centrifugation. The linear kanamycin cassette, with flanking homology to the 
cexE gene, was transformed into ETEC H10407 pKD46 using electroporation. Cells were 
recovered in SOC at 37ºC with aeration. Transformants were selected on LBA supplemented 
with kanamycin. Kanamycin resistant colonies were tested for the insertion of the kanamycin 
resistance cassette into the cexE gene using the primers cexE-F1 and cexE-R1, which annealed 
outside of the cexE gene. Colonies that contained a deleted cexE gene were isolated by 
streaking onto LBA supplemented with kanamycin. 
 
The isolation of a ETEC H10407 strain with a disruption of the cexE gene was confirmed by 
colony PCR. The primers cexE-FW1 and cexE-RV1 were used to amplify the region containing 
the cexE gene by PCR. The template DNA for the PCR were single colonies of ETEC H10407 
and ETEC H10407 with the deleted cexE gene. A negative control of nuclease-free water was 
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included. The approximate size of the PCR products was determined by agarose gel 
electrophoresis (Fig. 4.3). The size of the region containing the cexE gene in ETEC H10407 
was around 950 bp, as expected for the wild-type, and 2 kb for the cexE deletion mutant. The 
difference in size between the two templates was accounted for by the insertion of the 
kanamycin resistance cassette into the cexE gene. There was no PCR product for the nuclease-
free water. Therefore, it was concluded that the cexE gene had been deleted. Thus, the strain 
containing the deleted cexE gene was termed ETEC H10407DcexE.  
 
4.2.3. Construction of a plasmid for the expression of cexE 
In order to be able to detect CexE in protein samples specific antibodies were required. This 
required the production and purification of recombinant CexE protein. The cexE gene from 
ETEC H10407 was cloned into the expression vector pET26b using the primers CcexE-FW 
and CcexE-RV. The primers were designed so that when the cexE gene fragment was ligated 
into pET26b(+) the product would be CexE with a C-terminal 6His tag. The PCR product and 
pET26b(+) were digested with NdeI and XhoI. This retained the native signal sequence and 
removed the pelB signal sequence present in pET26b(+). The digested cexE PCR product and 
pET26b(+) were incubated with T4 ligase and then transformed into E. coli DH5α. The 
recovered cells were plated onto LBA supplemented with kanamycin and incubated overnight 
at 37ºC. Potential candidates for the insertion of cexE into pET26b(+) were screened using 
colony PCR with the primers T7F and T7R. A positive control of pET26b(+) and a negative 
control of nuclease-free water were included. The approximate size of the PCR products was 
determined (Fig. 4.4). The PCR products for two of the candidate colonies were larger than the 
PCR product of the pET26b(+) control. The difference in the size of the PCR products was 
equal to the expected difference for a successful insertion of the cexE gene. Therefore, these 




Figure 4.3: Construction of cexE gene deletion using λ-Red recombination. A, schematic 
of the λ-Red recombination system. The kanamycin resistance cassette is amplified using 
primers with homology regions of 50 bp (red) to the 5ʹ and 3ʹ ends of the target gene. B, PCR 
products of wild-type and suspected cexE deletion mutant. PCR products were separated on a 
1% agarose gel by electrophoresis. The size of each band on the ladder is indicted on the right 




Figure 4.4: PCR products of candidates for cexE insertion into pET26b(+). An overnight 
culture of E. coli DH5α pET26b(+) was used to isolate the pET26b(+) plasmid. The digested 
plasmid and cexE PCR product were purified by gel extraction. The cut vector and insert were 
ligated using T4 ligase and transformed E. coli DH5α. After recovery, cells were harvested by 
centrifugation and plated onto LB agar supplemented with kanamycin. The resulting colonies 
were used as the template for the PCR with primers external to the multiple cloning site of 
pET26b(+). PCR products were separated on a 1% agarose gel. HyperLadder 1kb (Bioline) 
was used for PCR product size approximation. An empty vector produces a PCR product of 
309 bp. A vector with the cexE gene inserted produces a PCR product of 543 bp. Two of the 
candidates produced a product under 600 bp and the empty vector produced a product under 




candidates suspected of containing the cexE gene were used to isolate plasmid DNA. The 
plasmids were sequenced, only one of which was found to contain the correct nucleotide 
sequence for the correct insertion of the cexE gene into pET26b(+). Therefore, it was concluded 
that cexE was successfully cloned into the pET26b(+) expression vector. Thus, this plasmid 
was termed pET26b-cexE. Protein produced using this plasmid with a C-terminal 6 histidine 
tag was termed CexE-6His. 
 
4.2.4. Optimisation of induction concentration for CexE-6His production 
Protein production varies with the concentration of the inducer. Both pET26b(+) and pET26b-
cexE were isolated and transformed into E. coli BL21(DE3). Cells were recovered and plated. 
PCR, with the primers T7F and T7R, was used to check for successful transformation. 
Overnight cultures of E. coli BL21(DE3) containing either pET26b-cexE or the empty vector 
were used to inoculate cultures of LB that were grown at 37ºC with aeration to an OD600 of 0.3. 
Protein production was induced in separate cultures of E. coli BL21(DE3) containing pET26b-
cexE by the addition of IPTG to 250 µM, 50 µM and 10 µM. A non-induced control was 
included. For each culture of E. coli BL21(DE3) pET26b-cexE a control culture of pET26b(+) 
was induced at the same concentration of IPTG. Cultures were grown at 37ºC with aeration. 
After 4 hours, proteins in whole cell lysate samples were separated by electrophoresis on Tris-
tricine gels. Gels were stained with Coomassie Brilliant Blue or used for western blotting to 
determine the production of CexE-6His (Fig. 4.5). In the Coomassie Brilliant Blue stained gel 
a band was present at the approximate size for CexE-6His in each of the whole cell lysates of 
cultures containing pET26b-cexE, but absent from the negative control cultures. The 
westernblot confirmed that these bands CexE were tagged with 6His. Note that there was 
production of CexE-6His without any IPTG induction. This was comparable to the amount 




Figure 4.5: The effect of IPTG concentration on the production of CexE-6His. BL21 
pET26b-cexE and BL21 pET26b(+) are represented by + and −, respectively. A, Coomassie 
stain of whole cell lysate sample separated on a Tris-tricine gel electrophoresis. B, western blot 
using anti-His antibodies. Arrows indicate the position of CexE-6His protein produced.
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µM IPTG induction. However, it was not substantially more than the production of CexE-6His 
in the presence of 50 µM IPTG. At both of these concentrations there was a larger molecular 
weight band present on the western blot than for 250 µM IPTG and the non-induced whole cell 
lysate. The detection of this band by western blotting with anti-His antibodies, but not in the 
negative control proteins samples, confirmed that it is the CexE-6His protein. It was not clear 
what was responsible for the higher molecular weight band but it was proportional to the 
amount of CexE-6His produced. Thus, the larger band was believed to be a dimer of CexE-
6His due to the high amount of production. The optimal concentration for CexE-6His 
production was concluded to be 10µM IPTG. However, it was decided that as the differences 
between the production of CexE-6His with 50 µM and 10 µM induction were not substantially 
different, both of these concentration of IPTG induction would be used. 
 
4.2.5. Optimal temperature for the production of CexE 
Lower temperatures can reduce the amount of protein in inclusion bodies and thus increase the 
yield of soluble protein available. Overnight cultures of E. coli BL21(DE3) containing either 
pET26b-cexE or pET26b(+) were used to inoculate LB supplemented with kanamycin. 
Cultures were grown at 37ºC with aeration to an OD600 of 0.3 and were cooled to 16ºC or 10ºC. 
After 30 minutes, cultures transformed with pET26b-cexE were induced with 50 µM or 10 µM 
IPTG. Negative control pET26b(+) cultures were not induced. Cultures were grown at 16ºC or 
10ºC with aeration. Whole cell lysate samples were taken after 4 hours and overnight post-
induction. The production of CexE-6His was determined as described above (Fig. 4.6). In the 
samples from three of the cultures, bands in the Coomassie Brilliant Blue stain were more 
intense than at the same position in the negative control. These bands were confirmed to be 
CexE-6His by detection by western blotting with the anti-His antibody. After 4 hours of 




Figure 4.6: Production of CexE-6His at 16ºC and 10ºC. BL21 pET26b-cexE was grown for 
4 hours and overnight in LB supplemented with 50 µM or 10 µM  IPTG (labelled 50 and 10, 
respectively) at 16ºC or 10ºC. BL21 pET26b(+) was grown for 4 hours and overnight in LB 
without IPTG (labelled 0) at 16ºC or 10ºC. A, Coomassie stain of whole cell lysates separated 
on a Tris-tricine gel. B, the primary antibody for the western blot was against 6His tag a 
duplicate Tris-tricine gel.   
 
 131 
overnight growth, CexE-6His was produced at both 16ºC and 10ºC with 50 µM IPTG 
induction. It was not produced with 10 µM IPTG induction at either 16ºC or 10ºC. The 
production of CexE-6His after overnight growth with 50 µM IPTG induction was relatively 
similar at 16ºC and 10ºC. However, the yield of biomass at 10ºC was less than at 16ºC. 
Therefore, it was concluded that the optimal conditions for the production of CexE-6His was 
at 16ºC with 50 µM IPTG induction. 
 
4.2.6. Purification of the CexE-6His protein 
The positively charged C-terminal histidine residues can be used for the purification of protein 
using Ni-Sepharose columns. An overnight culture of E. coli BL21(DE3) pET26b-cexE was 
used to inoculate six 1 L LB cultures. The cultures were grown at 37ºC with aeration to an 
OD600 of 0.3 and then cooled to 16ºC for 30 minutes. Protein production was induced with 50 
µM IPTG. After overnight growth at 16ºC with aeration, cells were harvested by centrifugation. 
The cell pellet was resuspended in binding buffer. DNase I was added to ease lysis. Cells were 
lysed using a EmulsiFlex-C3. Undisrupted cells were removed by centrifugation. The 
remaining supernatant was subjected to further centrifugation to pellet the membrane 
components. The soluble protein fraction was removed, filtered and loaded into a 5 ml 
HisTrap™ HP column. The filtrate was left to flow through the column overnight at 4ºC. The 
column was washed with binding buffer, 50 mM and 100 mM wash buffer and the protein 
eluted using 500 mM imidazole. Fractions of 5 ml were collected throughout. From each 
fraction, a 10 µl sample was taken and mixed with an equal volume of 2x Laemmli sample 
buffer. Each fraction was analysed by electrophoresis using a Tris-tricine gel for the 
purification of the CexE-6His protein (Fig. 4.7). There was protein present in the binding, wash 
and elution fractions of expected molecular weight of the CexE-6His protein. In the binding 




Figure 4.7: Purification of CexE-6His. A, column washed with binding buffer (20 mM 
imidazole). B, the column was first washed with 50 mM imidazole wash buffer and then with 
100 mM imidazole wash buffer. C, the CexE-6His protein was eluted off of the column with 
500 mM imidazole. 
 
 133 
mM imidazole wash this was decreased, but there was still contaminating proteins present. The 
supernatant samples were prepared by centrifugation. The fractions 3, 4, 5, and 6 of the 100 
mM imidazole wash contained substantial amounts of CexE-6His protein with little to no 
contamination. The larger molecular band present in these fractions was the same size as those 
observed in Fig. 4.5. Therefore, these bands were thought to be CexE-6His. Fractions 1 and 2 
of the elution buffer did not contain any contamination. There were larger molecular weight 
bands present in elution fractions 3, 4, 5, and 6. However, there was large amounts of CexE-
6His. Thus, the elution fractions and fractions 3, 4, 5, and 6 of the 100 mM imidazole wash 
were concentrated by membrane filtration. Imidazole was removed from the protein sample by 
dialysis. The protein sample was further purified by size exclusion. Fractions containing pure 
CexE-6His were concentrated again by membrane filtration. The concentration was determined 
using the absorbance at A280. The concentration of CexE-6His protein was 20.3 mM. The 
protein was diluted to 2 mM prior to storage. Thus, CexE-6His was successfully been purified. 
 
4.2.7. Primary antibody production for CexE 
Primary antibodies enable a protein to be detected specifically. Aliquots of purified CexE-6His 
protein at 200 µg/100 µl were sent to Eurogentec for 28-day speedy rabbit antibody production. 
Sera 872 and 873 were produced for the CexE protein. The specificity and ability of these sera 
to detect CexE was assessed. Overnight cultures of ETEC H10407 and ETEC H10407DcexE 
were used to inoculate LB. Cultures were grown at 37ºC for 6 hours. Whole cell lysate samples 
were prepared by centrifugation of the cells and resuspension in Laemmli buffer. Culture spent 
medium was aspirated and filtered. The proteins in the culture supernatant were precipitated 
by the addition of TCA. The precipitated proteins were harvested by centrifugation. The 
precipitated protein pellets were washed with methanol, pelleted and resuspended in Laemmli 
sample buffer. A dilution series of the purified CexE-6His protein was prepared. The whole 
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cell lysate, culture supernatant samples and CexE-6His dilution series were subjected to 
electrophoresis on a Tris-tricine gel. Two separate gels were transferred to nitrocellulose for 
western blotting with the serum 872 and 873 as the primary antibody for each membrane. The 
specificity and detection of the CexE protein by the serum was assessed (Fig. 4.8). The two 
sera were able to detect the purified CexE-6His protein. There was a band at around the size 
expected for CexE in the whole cell lysate sample for ETEC H10407 for both sera. This band 
was present in the cexE mutant as well. Therefore, it was a non-specific interaction and not the 
CexE protein. There was not a band for CexE in the supernatant for ETEC H10407. There was 
sustainably fewer non-specific bands for serum 872 compared to serum 873. There was greater 
signal of purified CexE-6His for serum 872 compared to 873. Thus, it was concluded that 
serum 872 would be used as the primary antibody for the detection of CexE. 
 
4.2.8. Replacement of the aap gene in EAEC 042 with cexE from ETEC H10407 under 
transcriptional control of the aap promoter 
A phenotype for the cexE mutant in ETEC H10407 could not be identified under typical 
laboratory conditions. Therefore, it was decided to investigate whether cexE could complement 
an aap mutant. A linear fragment containing the cexE gene and a kanamycin resistance cassette 
was constructed using overlapping PCR. The fragment containing the cexE gene and 
kanamycin resistance cassette was flanked by 50 bp homologous to 5ʹ and 3ʹ ends of the aap 
gene (Fig. 4.9). The cexE gene was cloned with ETEC H10407 as the template using the 
primers Fwdaap-aap/cexE and Revaap-kan/cexE. The kanamycin cassette from pKD4 was 
used as the template for a PCR with the primers Fwdaap-cexE/kan and Revaap-aap/kan. The 
two PCR products were purified. The PCR products were quantified. Separate PCR containing 
50 ng, 100 ng and 250 ng of both the cexE gene fragment and the kanamycin resistance cassette 




Figure 4.8: Testing of sera 872 and 873 for the detection of the CexE protein. The 
membranes were incubated in Blotto (50 g skimmed milk powder, 1 g sodium azide in 1 L 
TBS) prior to primary antibody application. The serum 872 or 873 was used as the primary 
antibody at a concentration of 1 in 1,000 in Blotto. The membranes were incubated fully 
immersed overnight at 4ºC with agitation. The membranes were washed with TSBT. Secondary 
antibody consisted of goat anti-rabbit IgG linked with HRP at a concentration of 1 in 10,000 
in Blotto. Membranes were incubated with anti-rabbit secondary antibody conjugated with 
HRP for 2 hours with agitation and washed with TSBT. ECL was used for the detection of 





Figure 4.9: Construction of cexE gene under the aap promoter in EAEC 042. The linear 
fragment containing cexE and the kanamycin cassette is flanked by 50 bp regions of homology 
to the aap gene (red). The fragment is designed so that the start codon of aap was replaced 
with the start codon of cexE. The cexE was expressed at the same conditions in EAEC 
042Daap::cexE as aap in EAEC 042. The linear fragment was incorporated into the EAEC 042 




Revaap-PCREx were added. The product was purified and termed cexE-kan. A second PCR 
using Fwdaap-PCREx and Revaap-PCREx was used to increase the yield. EAEC 042 was 
transformed by electroporation with pKD46. An overnight culture of EAEC 042 pKD46 was 
used to inoculate LB supplemented with 0.2% L-arabinose. The culture was grown to an OD600 
of 0.6 and the cells harvested. The cells were made electrocompetent and transformed with the 
cexE-kan linear fragment. The cells were recovered and plated onto LBA containing 
kanamycin. Colonies that grew were checked for the insertion of the cexE-kan into the aap 
gene by colony PCR. PCR products with sizes corresponding to the expected size for the 
insertion of cexE-kan were termed EAEC 042Daap::cexE. 
 
4.2.9. Effect of CexE production on EAEC 042 aggregation 
Aap is known to disperse EAEC 042, thus preventing aggregation (Sheikh et al., 2002). It was 
hypothesised that if the function of CexE is similar to Aap, the production of CexE would be 
able to complement an aap mutant. Thus, triplicate overnight cultures of EAEC 042Daap, 
EAEC 042Daap::cexE and the parental strain were grown at 37ºC with aeration in LB. After 
overnight growth cultures were normalised to an OD600 of 3 in 5 ml LB. Cultures were kept 
stationary. OD600 readings were taken from just under the meniscus of the culture. The readings 
were taken every 5 minutes for the first 30 minutes and then every 15 minutes for the following 
45 minutes. As a measure of aggregation, the average percentage of the starting OD600 for each 
culture was calculated. Each average was plotted against time (Fig. 4.10A). The rate of 
aggregation of the aap mutant was initially comparable to the wild-type. During the course of 
the experiment the rate of aggregation increased compared to the parental strain resulting in a 
greater amount of sedimented cells. Thus, the aggregation of EAEC 042Daap was greater than 
that of the wild-type as previously described by Sheikh et al. (2002). However, when aap was 




Figure 4.10: Aggregation of EAEC 042, EAEC 042Daap and EAEC 042Daap::cexE. A, 
aggregation assay of EAEC 042, aap and cexE insertional mutants. The amount of aggregation 
of each culture was measured by calculating the percentage of the initial OD600 using a 100 µl 
sample taken from the meniscus at each time point of three biological replicates. B, the 
aggregated cell sediments shown were representative of the three replicates of each strain after 
75 minutes. C, Coomassie stained gel and western blot for Aap and CexE of whole cell lysates 
of the strains from A and B.   
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aggregation of EAEC 042Daap::cexE was higher in the first 30 minutes compared to the last 
45 minutes, the majority occurring within the first 25 minutes. This was not comparable to the 
aap mutant or the parent strain. The final amount of sedimented cells was slightly greater for 
the aap mutant compared to the wild-type but this was substantially less than the cexE 
insertional mutant (Fig. 4.10B). The production of Aap and CexE was assessed from whole 
cell lysates of each replicate by Coomassie Brilliant Blue stain and western blotting (Fig. 
4.10C). The production of Aap and CexE in the expected strains was confirmed by western 
blotting with anti-Aap and anti-CexE antibodies, respectively. There was a double band 
produced for CexE in EAEC 042Daap::cexE. The larger band was not comparable in size to 
that produced during CexE-6His production (Fig. 4.5). The cause of the double band for CexE 
was not clear. From these results, it was concluded that the production of CexE did not 
complement an aap mutant. However, it did increase the rate and amount of aggregation. 
Therefore, the function of CexE is not the same as that of Aap. 
 
4.2.10. Comparison of ETEC H10407 and cexE mutant biofilm formation 
Due to the aggregation phenotype of CexE produced in EAEC 042 it was suggested that CexE 
could play a role in biofilm formation. Strains ETEC H10407 and ETEC H10407DcexE were 
transformed by electroporation with the pJB39 plasmid that constitutively produced GFP. Prior 
to cell preparation, a flow biofilm system was incubated at 37ºC filled with M9 glucose 
medium. Overnight cultures of ETEC H10407 pJB39 and ETEC H10407DcexE pJB39 were  
used to inoculate LB. Cultures were grown at 37ºC with aeration to an OD600 of 0.3. The cells 
were harvested and injected into the chambers of the flow biofilm system. The cells were 
allowed to adhere to the flow cells prior to the commencement of the liquid flow. After 
overnight incubation at 37ºC with a constant flow, the flow chambers were inspected for the 




Figure 4.11: Confocal microscope images of ETEC H10407 biofilm. Bacterial biofilms 
were grown in triplicate; panel A and B  are representative of biofilms grown in triplicate from 
separate experiments. A, 2D images taken from a vertical position of the ETEC H10407 pJB39 
and ETEC H10407DcexE pJB39 biofilm. B, 3D images of ETEC H10407 pJB39 and ETEC 
H10407DcexE pJB39 biofilm from different angles. 
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intensity of the GFP signal present in each of the three flow cell chambers containing the cexE 
mutant compared to those containing the wild-type (Fig. 4.11A). Successive horizontal planes 
of the biofilm were imaged. These were compiled into a z-stack. Leica Application Suite X 
was used create a 3D image of the biofilm using the z-stack (Fig. 4.11B). The images presented 
are representative of the biofilm for the cexE mutant and the wild-type. The images are of the 
same section of biofilm from different angles. The 3D structure of the cexE mutant biofilm was 
different to that of the wild-type. The cexE mutant biofilm lacks the 3D structure of the wild-
type. Therefore, it was concluded that CexE was involved in biofilm formation.  
 
4.2.11. Electrophoretic mobility shift assay of CexE 
Extracellular DNA is a major component of bacterial biofilms (Flemming et al., 2016). A 
protein with the ability to bind DNA would aid the formation of a biofilm. Thus, a dilution 
series of purified CexE-6His was made to examine whether CexE can bind DNA. Each dilution 
in the series was incubated separately with a 32P labelled CC(−41.5) DNA fragment for 15 
minutes at room temperature. The CC(−41.5) fragment is a derivative of the melR promoter 
that has a CRP site 41.5 base pairs upstream transcription start site (Gaston et al., 1990). A no 
protein control was included. Each sample was loaded onto an acrylamide TBE gel, and the 
DNA with or without protein attached were separated by electrophoresis. The gel was dried 
and the position of the radioactive DNA was visualised using a phosphor screen. The ability of 
CexE-6His to retard migration of the CC(−41.5) fragment in the gel was assessed (Fig. 4.12). 
 
At the first concentration of CexE-6His (0.5 µM) there was a reduction in the intensity of the 
32P labelled DNA band compared to the no protein control. The intensity of the DNA fragment 
decreased proportionally with the increase in CexE-6His concentration. The retardation of the 




Figure 4.12: Retardation of 32P labelled DNA after incubation with CexE-6His. CexE-
6His was incubated for 15 minutes at room temperature with the CC(−41.5) DNA fragment. 
The concentrations of CexE-6His indicated were the final concentration of CexE-6His in each 
reaction. The above figure is representative of two replicates of the same experiment.
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there was signal indicating retention of DNA fragment in the wells of the gel. This increased 
with CexE-6His concentration to the upper concentration of 100 µM. At 12.5 µM there was a 
smear of DNA in the lane. The start of the smear increased in height with concentration. The 
retardation of DNA in an EMSA increased with the concentration of CexE-6His. Therefore, it 
was concluded that CexE-6His binds to DNA. 
 
4.2.12. Purification and assessment of CexE homologs to impair the migration of DNA in 
an electrophoretic mobility shift assay 
To investigate whether the DNA binding was common to other CexE homologs, Aap and CexE 
from C. rodentium ICC168 (from now on termed CexEICC168), were purified. Expression 
plasmids for the production of Aap and CexEICC168 were made as described for CexE. In brief, 
aap and cexEICC168 were cloned from EAEC 042 and C. rodentium ICC168, respectively, using 
the primers 042/aap/Clone-FW, 042/aap/Clone-RV, ICC168/cexE/Clone-FW and 
ICC168/cexE/Clone-RV. The PCR products were purified and ligated into the pET26b(+) 
plasmid. The completed ligation reactions were transformed into E. coli DH5α. Successful 
ligations were sequenced. Plasmids with the correct sequence were termed pET26b-aap and 
pET26b-cexEICC168 for aap and cexEICC168, respectively. Plasmids were transformed into E. coli 
BL21(DE3). Overnight cultures of E. coli BL21(DE3) containing the respective plasmid were 
used to inoculate, separately, 2 L LB. Cultures were grown as described for the production of 
CexE-6His. Cells were harvested and lysed. Intact cells were removed by centrifugation. 
Membranes were removed by high speed centrifugation. The soluble protein fractions were 
filtered and the filtrate was cycled through a 1 ml HisTrap™ HP column at 4 ºC. Columns were 
washed and the protein was eluted with imidazole. The eluted samples of purified Aap-6His or 





The Aap protein modulates the cell surface charge to allow the extension of the AAF/II 
(Velarde et al., 2007). If the charge of the homologous CexE protein was responsible for DNA 
binding, it was hypothesised that Aap would also bind DNA. Thus, Aap-6His was incubated 
with 32P labelled CC(−41.5) DNA fragments at room temperature as described for CexE-6His. 
The reactions were separated by electrophoresis on an acrylamide TBE gel. The gel was 
visualised using a phosphor screen for the retardation of the DNA fragment (Fig. 4.13). There 
was no retardation of the DNA fragment after incubation with Aap-6His up to 50 µM. There 
was a reduction in the intensity of the DNA fragment signal 100 µM Aap-6His. There was 
slight smearing and retention in the well at the same concentration. However, the concentration 
required for those slight effects was very high. It was not comparable to that of the CexE-6His 
protein. Therefore, it was concluded that Aap-6His did not bind DNA. 
 
The CexEICC168 protein sequence did not clade with Aap or CexE. It was unknown if the 
CexEICC168-6His could bind DNA. Thus, as described for Aap and CexE, CexEICC168 was 
incubated with 32P labelled DNA at room temperature. The reactions were separated by 
electrophoresis. The gel was visualised for retardation of the DNA fragment (Fig. 4.14). The 
intensity of the DNA band decreased slightly with an increase in protein concentration. There 
were faint bands present in samples that had been incubated with 10 µM CexEICC168-6His, that 
were clearer at 15 µM. However, there was only substantial retardation of the DNA band at 50 
µM and 100 µM CexEICC168-6His. At 100 µM CexEICC168-6His there was still DNA present 
that was not retarded when compared to the no protein control. The retardation of DNA by 
CexEICC168-6His was not comparable to the CexE-6His protein. Therefore, it was concluded 





Figure 4.13: Retardation of 32P labelled DNA after incubation with Aap-6His. Aap-6His 
was incubated for 15 minutes at room temperature with the DNA fragments. The above figure 




Figure 4.14: Retardation of 32P labelled DNA after incubation with CexEICC168-6His. 
CexEICC168-6His was incubated as described for Aap. The above figure is representative of two 
replicates of the same experiment.  
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4.2.13. Comparison of the ability of Aap-6His, CexEICC168-6His and CexE-6His to retard 
DNA in an electrophoretic mobility shift assay 
To confirm the results above the Ability of the three proteins, Aap-6His, CexEICC168-6His and 
CexE-6His, to bind DNA were compared in the same experiment. The DNA fragment 
incubated with the Aap-6His protein were not retarded in the gel at all (Fig. 4.15). There was 
no difference in the intensity of the DNA band of the no protein control to that incubated with 
50 µM Aap-6His. There was a decrease in the signal intensity of the DNA fragment with an 
increase in concentration of CexEICC168-6His. There was a slight reduction of DNA signal at 
12.5 µM compared to the no protein control and a substantial reduction at 50 µM CexEICC168-
6His. The decrease in signal intensity due to an increase in protein concentration was 
substantially more for CexE-6His compared CexEICC168-6His. The DNA signal was decreased 
at 2.5 µM CexE-6His. When incubated with 5 µM CexE-6His, a smear was apparent indicating 
DNA retardation. The migration of the DNA fragment was completely retarded at 50 µM 
CexE-6His. The DNA was present as a smear. The retardation of the DNA fragments incubated 
with CexE-6His was not comparable to Aap-6His or CexEICC168-6His. Therefore, it was 
concluded that CexE-6His was able to bind DNA to a substantially greater affinity than the 
other proteins tested. 
 
4.3. Discussion 
Aap and CexE were distributed in three main pathovars: Y. enterocolitica; EAEC and ETEC. 
Multiple copies of aap or cexE in a single genome were common. Therefore, aap or cexE are 
highly mobile genes. The mobility of the aap or cexE genes lead to examples of single strains 
within a species containing the gene, such as those observed for Salmonella and Shigella. Sahl  
et al. (2011) failed to identify a cexE homolog in ETEC E24377A or ETEC B7A, possibly due 




Figure 4.15: Comparison of DNA binding ability. Aap-6His, CexEICC168-6His and CexE-
6His were incubated with 32P DNA in 20 mM Tris-HCl (pH 7.0), 10 mM MgCl2, 0.1 mM 
EDTA, 120 mM KCl, 2 mM DTT, 5% glycerol and 7 µM BSA for 15 minutes at room 
temperature. The reaction mixes were separated on a 6% acrylamide 0.5x TBE gel by 
electrophoresis. The migration of the radioactive DNA was visualised using phosphor screens. 




that current sequence annotation methods commonly missed genes encoding Aap or CexE. 
Thus, the full prevalence of aap and cexE is difficult to discern. If possible, an analysis 
including the unannotated aap/cexE genes is not thought to greatly affect the major clades in 
Fig. 4.2. It would instead change the numbers of aap/cexE genes attributed to each clade and 
sequence. 
 
The function of Aap is characterised as modulating the cell surface charge to allow the 
extension of the AAF/II (Velarde et al., 2007).  CexE does perform the same function when 
produced in EAEC. If CexE did have a similar function to allow the extension of the CFA/I 
from ETEC H10407 it would be expected to complement or not alter the aap mutant phenotype. 
Instead the production of CexE significantly increased the aggregation of EAEC 042. Thus, 
the CexE protein does not have a similar function to that of Aap in EAEC. It is inferred from 
the evidence presented here the CexE protein is involved in binding extracellular DNA, which 
in turn promotes the formation of biofilm an ETEC H10407. This is the first report of a cexE 
mutant not being able to form biofilm. Biofilm formation is not typically associated with ETEC 
pathogenesis. The biofilm investigated here was formed on an abiotic surface. It is not thought 
that CexE initiates the initial attachment to the abiotic surface. Instead it is thought to 
strengthen the biofilm formation. There is evidence of ETEC biofilms acting as a reservoir for 
infection (Ahmed et al., 2012). This suggests that CexE provides an advantage to ETEC strains 
to form biofilms on abiotic surfaces creating reservoirs for infection. 
 
ETEC H10407 would not produce CexE under normal laboratory conditions. It required 
growth in a flow biofilm environment before a phenotype could be observed. However, when 
the gene was cloned into pET26b there was production of CexE-6His without induction, which 
was to such a significant amount as to be clearly visible on a Coomassie Brilliant Blue stain of 
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a whole cell lysate. Although CexE-6His was produced from a multi-copy number vector in an 
overexpression strain, it is not typical to see proteins produced to a visible concentration 
without induction. This suggests a strong mechanism for the prevention of CexE production in 
ETEC H10407. The low GC content of the upstream region of cexE could enable H-NS binding 
to prevent transcription (Lucchini et al., 2006). This likely repression of cexE expression is 
relieved by CfaD (Pilonieta et al., 2007; Hodson et al., 2017). Another mechanism preventing 
the production of CexE could be present at the translation level. The start codon of cexE in 
ETEC H10407 is flanked by 4 adenosines before the ATG and 6 thymines after. It appears 
likely that when transcribed, a loop would form in the mRNA limiting access to the start codon 
and thus preventing translation. The upstream adenosines were removed when the cexE gene 
was cloned into pET26b. This is likely to relieve repression of cexE expression in the absence 
of induction. It is not clear if this possible loop is responsible for the lack of production of 
CexE in ETEC H10407. From the RNA-Seq data it is known that aap is highly expressed under 
the correct conditions. Aap is produced when EAEC 042 is grown overnight in LB. Thus, the 
expression of cexE appears to be more tightly controlled than that of aap. While not within the 
remit of this study, an investigation into the mechanism of CexE production in ETEC H10407 
is warranted. 
 
The extremely high concentration of purified CexE-6His attained indicates the inherent 
stability of the protein. The ability to purify high quantities of CexE-6His lends to structural 
analysis. Velarde et al., (2007) elucidated the structure of Aap. However, due to the low 
sequence identity between the proteins, this structure is unlikely to be predictive of the structure 













CHAPTER 5:  






The structure of the enterotoxigenic E. coli (ETEC) CexE homolog, Aap, in enteroaggregative 
E. coli 042 (EAEC) was previously determined (Crossman et al., 2010; Velarde et al., 2007). 
The structure of Aap is a β-sandwich, which consists of 6 β strands forming two antiparallel β 
sheets with two polar α helices (Fig. 5.1). As Aap is secreted by the Aat system, which is an 
atypical type I secretion system, it must traverse the AatA outer membrane protein (Nishi et 
al., 2003). The bullet-like structure of Aap, 50x20x20 Å, is amenable to exiting the cell via the 
AatA open pore that is ~20 Å in diameter (Velarde et al., 2007; Nishi et al., 2003). The 
structural analysis of Aap indicated an abundance of positively charged residues in one 
hemisphere of the protein (Fig. 5.2), which led to the hypothesis that the aggregative adherence 
fimbriae (AAF) are electrostatically attracted to the cell surface. Aap binds to the LPS 
electrostatically and blocks the AAF attraction, thereby allowing their extension (Velarde et 
al., 2007). However, the major subunits of the ETEC colonisation factor antigen I (CFA/I) and 
AAF do not have the same charge at a neutral pH (Velarde et al., 2007). Therefore, the function 
of CexE cannot be the same. 
 
In chapter 4, the CexE protein from the prototypical ETEC H10407 was found to bind DNA. 
The two homologous proteins tested, Aap and CexEICC168 from C. rodentium ICC168, could 
not bind DNA. Thus, CexE is functionally different from Aap. The determination of the 
structure of CexE can help elucidate the mechanism of DNA binding. The purification of high 
quantities of CexE-6His described in chapter 4 suggest that it might be possible to determine 
the structure of CexE. The aim of this work was to investigate the structure of CexE with 




Figure 5.1: Ensemble of Aap solved by Velarde et al. (2007). The 20 Aap NMR solution 
structures were downloaded from the PDB file 2jvu. The two images were taken from 180º 
turns of the 20 Aap structures. In numerical order from the N-terminus the secondary structure 
is labelled α 1 and 2 for the two α helices and β 1 to 6 for the six β strands. The labelling is the 




Figure 5.2: Electrostatic surface charge of Aap solved by Velarde et al. (2007). The 
electrostatic surface charge was calculated using PDB2PQR and APBS functions in Chimera 
from using the best representative conformer of Aap from the 2juv PBD file. The electrostatic 
surface charge calculated above is similar to that presented for Aap in Velarde et al. (2007). 
There is a localisation of positive charge in the lower hemisphere of Aap. The two images were 
taken from 180º turns of the Aap surface structure.  
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5.1.1. Principles of circular dichroism 
Circular dichroism uses light polarisation to estimate the secondary structure of proteins (Kelly 
et al., 2005). The oscillations of linearly polarised light are in a single plane. Polarised light is 
the sum of two linearly polarised light waves that are in the same phase at right angles to each 
other. If one of the linearly polarised light waves is out of phase by a quarter turn the resultant 
light wave will be helical, termed circularly polarised light. The turns of the helices will either 
be clockwise, left circularly polarised light, or counter-clockwise, right circularly polarised 
light. The superposition of the left and right circularly polarised light can be viewed as a linear 
polarised wave. Left and right polarised light are absorbed by chiral molecules by different 
amounts. This is called circular dichroism. After passage through a chiral sample the 
superposition of the left and right polarised light is no longer linearly polarised. The 
superimposed left and right circularly polarised light is now elliptical. The amount of circular 
dichroism can be compared between samples by measuring their ellipticity. The major radius 
of the ellipse is defined by the amplitude of the left and right circularly polarised light, while 
the minor radius is the difference between the left and right polarised light. The degree of 
ellipticity is the tangent of the ratio of the minor to major elliptical axis. The size of the degree 
of ellipticity (θ) is very small and is typically measured in millidegrees (mdeg). Over a range 
of wavelengths from 180 nm to 240 nm, a characteristic circular dichroism spectrum arises 
from protein folds like α helices and β sheets. Using algorithms, such as BeStSel, the circular 
dichroism spectra of protein structures determined by X-ray crystallography can be used to 
estimate the folding of a protein (Micsonai et al., 2015).  
 
5.1.2. Principles of nuclear magnetic resonance spectroscopy 
NMR spectroscopy can be used to determine the structure of a protein. NMR makes use of 
spin, which is a fundamental physical property possessed by all protons, neutrons, and 
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electrons. Spin is a form of angular momentum, which occurs when a particle has a twisting or 
rotating trajectory. The spin of a nucleus is determined by the composition of protons and 
neutrons. Both protons and neutrons have spin. If the total number of neutrons and protons in 
a nucleus is even (2H, 12C, 14N) the nucleus does not have spin. The spin of the protons and 
neutrons is paired and cancelled out, the nucleus is said to have a paired spin. When the nucleus 
of the atom contains an odd number of total protons and neutrons (1H, 13C, 15N) the nucleus of 
the atom has an overall spin, due to their being an unpaired spin. The spin of a nucleus is used 
by nuclear magnetic resonance (NMR) spectroscopy to provide chemical information about 
that atom. A spinning nucleus generates a magnetic field, which like the earth’s magnetic field 
is off centre. Nuclei with a spin producing a magnetic field have a nuclear magnetic moment 
in a magnetic field. When an external magnetic field is applied, it is energetically preferred for 
the magnetic moment to be aligned with the external magnetic field (Fig. 5.3A). These are 
referred to as the low-energy state, magnetic moment aligned with the external field, and the 
high-energy state, magnetic moment opposed to the magnetic field. The amount of energy 
required to move the nucleus from the low to the high-energy state is increased with the power 
of the magnet. A larger difference in energy is easier to observe. This is why NMR 
spectroscopy uses very powerful magnets. In an NMR experiment the energy required to align 
the magnetic moment against the magnetic field is comparatively low. Energy from collisions 
is sufficient to promote nuclei to the higher energy state. It is easier to consider the net magnetic 
moment of a sample or magnetisation vector. This is a sum of all the individual magnetic 
moments. The net magnetic moment of a sample will align with the external magnetic field 
along the z axis (Fig. 5.3B). If a pulse of electromagnetic radiation around the radio frequency 
is applied at 90º along the y axis to the external magnetic field the electromagnetic radiation 
with the required energy for an increase in energy state will be absorbed and the net magnetism 




Figure 5.3: Principles of NMR spectroscopy. A, the energy required to change the state of 
the spin of a nucleus in an external magnetic field. B, the net magnetisation moment is 
comprised of all the spin states of the sample. The net magnetisation moment aligns with the 
external magnetic field. C, a pulse of radio waves at 90º to the z axis is applied. The radio 
waves with the correct energy for a change in spin state (A) are absorbed. The magnetisation 
moment moves from the z axis to the xy plane. D, after the pulse is removed the magnetisation 
moment processes around the z axis at the Larmor frequency. E, the procession of the 
magnetisation moment decays and reaches equilibrium with the external magnetic field. F, the 
decay of the magnetic moment causes a change in the magnetic field in the sample. This causes 
a current in the coil surrounding the sample resulting in the detection of the free induction 
decay. This is transformed from time vector to a frequency using the Fourier transformation.  
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process around the z axis at the Larmor frequency. This frequency is different for different 
nuclei (Fig. 5.3D). The frequency of the electromagnetic radiation absorbed by the nucleus is 
equal to the Larmor frequency. Therefore, it is said to resonate. This procession degrades as 
the net magnetisation vector aligns with the magnetic field (Fig. 5.3E). The degradation in the 
procession around the z axis changes the magnetic field. This change in magnetic field causes 
a current to flow in the coils surrounding the sample. The signal generated due to the flow of 
current is known as the free induction decay (Fig. 5.3F). This is a time vector that is 
transformed into a frequency vector by Fourier transformation.  
 
The above example only considers a sample of one species of nuclei. This is not present in 
nature because nuclei are surrounded by electron density. The circulation of the electrons 
around the nucleus of the atom creates a magnetic force that opposes that of the external 
magnetism (Harris, 1983). The electron density around a nucleus is dependent on the molecule 
to which that atom is bound. For instance, the electron density of a hydrogen bound to the 
carbon atom on a methane molecule will be different to that on a methanol molecule. In fact, 
the three hydrogens bound to the carbon on the methanol molecule will be different to the one 
bound to the oxygen. The 1H nuclei of the molecules will have different frequencies. However, 
the frequency observed is dependent on the NMR machine used, temperature, magnetic field 
strength, and other variables. Therefore, the frequency of nuclei is not reported in hertz but 
instead in chemical shift (parts per million). Chemical shift is calculated by comparing the 
frequency of the molecule tested to that of a standard, which is typically tetramethylsaline 
Si(CH3)4. This allows the comparison of NMR spectra between different machines. The 
composition of an unknown sample can be determined if the chemical shifts have been 
previously observed in a known sample. Using these principles, the chemical shifts of amino 




The spin of a nucleus can be altered not just by the nuclei it is chemically bound to but also to 
those to which it is spatially close. The nuclear Overhauser effect (NOE) is used to define 
nuclei that are close in space to each other either due to chemical bonds or tertiary protein 
structure. The NOE is caused when the spin of a nucleus is promoted to the higher energy state 
by irradiation. This results in a change in the spin of nuclei nearby, located within a distance 
of 5Å. The spin of these nuclei can be observed. Using the chemical shifts from these 
alterations in spin, a three-dimensional structure of the protein can be calculated. 
 
5.1.3. NMR experiments for structure determination 
NMR spectra for protein determination are either 2D or 3D. These spectra are generated by the 
alteration of the time between a second 90º pulse. This provides separate planes of chemical 
shifts that can be built into a 2D or 3D spectrum. Since the chemical shifts of 1H are far easier 
to detect than 13C or 15N, a technique called insensitive nuclei enhanced by polarization transfer 
(INCPT) is used. In basic terms the magnetisation of the 1H is transferred to the nuclei of 
interest, i.e. 13C or 15N. After an amount to time required to gain information about the nuclei 
the magnetisation is returned to the 1H for detection.  
 
A number of NMR experiments are used to find the position of the residues relative to each 
other in space. These provide information about the chemical environment of each nucleus. A 
schematic of NMR experiments used in this Chapter, and spectra they generate, is provided in 
Fig. 5.4. The Cα are termed i and i−1, this denote the position of the Cα in relation to the amine 
group. A i Cα is the Cα bound to the amine, and the i−1 Cα is the Cα connected to the amine 
via the carbonyl group. In the 1H-15N-HSQC magnetisation is transferred from the HN group, 




Figure 5.4: NMR experiments for protein structure determination. Red arrows represent 
magnetisation transfer. The red coloured nuclei are those that chemical shift information is 
gathered. No chemical shift information is collected about the green nuclei. However, they are 
involved in magnetisation transfer. Uncoloured nuclei are not involved in the experiment. The 
spectrum generated is on the right of the molecular view of the experiment. Positive chemical 
shifts are in black and negative chemical shifts are in blue.  
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detection (Cavanagh et al., 2006). This provides a 2D spectrum with the 1H and 15N chemical 
shifts on the x and y axis respectively. From the chemical shifts of the 15N and 1H the chemical 
shift of the Cα in the i-1 and i residue can be obtained using the HNCA and HNCOCA. In 
HNCA, the magnetisation is passed from the HN to the 15N and to the Cα, a 3D spectrum is 
produced (Grzesiek and Bax, 1992). The HNCOCA is very similar however the magnetisation 
is passed from 15N to the Cʹ and then to the i-1 Cα, the only carbon chemical shift is that of the 
i-1 Cα (Grzesiek and Bax, 1992). Using the HNCA and HNCOCA spectra the chemical shifts 
of the i-1 and i Cα can be determined. In the HNCACB experiment the magnetisation is 
transferred from the Hβ to the Cβ and Hα to the Cα, magnetisation is then transferred from the 
Cβ to the Cα, then to the 15N and to the HN for detection (Grzesiek and Bax, 1992). The 
HNCOCACB similarly to the HNCOCA uses the carbonyl group to limit the chemical shifts 
to the i-1 residue (Grzesiek and Bax, 1992). Using these two spectra the chemical shift of the 
Cβ carbons can be obtained. In the HNCACO experiment the magnetisation is transferred to 
the 15N from the HN and via the i-1 Cα to the Cʹ it is then returned along the same path for 
detection at the HN (Bax and Ikura, 1991). Thus, the chemical shifts of the i-1 and i carbonyls 
are collected. The HNCO transfers magnetism from the HN to the 15N and then to the Cʹ 
(Muhandiram and Kay, 1994). The chemical shift of the i-1 carbonyl is defined.  
 
From these seven experiments the chemical shifts associated with the protein backbone can be 
identified. These chemical shifts are used with the CCONH spectrum to identify the chemical 
shifts of the other 13C in the amino acid side chain. Magnetisation is transferred from the 
associated 1H to the 13C nuclei of the side chain. This is then transferred down the side chain 
to the Cα. Magnetisation is then transferred to the carbonyl, then to the 15N and finally to the 
HN for detection (Grzesiek et al., 1993).  
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Now the chemical shifts of the 13C-NOESY-HSQC and 15N-NOESY-HSQC can be assigned. 
The chemical shifts of only one of the aliphatic or aromatic nuclei can be collected for the 13C-
NOESY-HSQC in a single experiment. These NOSEY experiments provide spatial information 
of the 1H in relation to one another in the protein. These experiments make use of the nuclear 
Overhauser effect to identify 1H that are located within 5 Å. Due to their position in the residue 
or tertiary structure. Magnetisation is exchanged between all of the 1H within 5 Å, and is then 
transferred to the 13C or 15N for detection on the Hα or HN for 13C-NOESY-HSQC and 15N-
NOESY-HSQC, respectively (Marion et al., 1989). The structure is modelled using these 
chemical shifts, the sequence of the protein, and peptide bond contortion angles. NMR 
modelling algorithms provide 20 models that best fit the experimental data provided. The 
similarity of these models to each other are reported by the root-mean-square deviation of 




5.2.1. N-terminal sequencing of CexE-6His 
The protein for structural determination should have its native fold, which can be dependent 
on the compartment it is purified from. The CexE protein was predicted, by SignalP, to be 
secreted by the general secretory pathway into the periplasm resulting the removal of the first 
20 N-terminal amino acids. The N-terminus of the CexE-6His was determined by sequencing 
five of the N-terminal amino acids. Purified CexE-6His, from Chapter 4, was separated by 
electrophoresis on Tris-tricine gels, then transferred to PVDF and stained with Ponceau S. 
There was a band at the expected molecular weight of CexE-6His. This region was excised, 
the stain was removed with NaOH and sent to Alta-Innovations at the University of 
Birmingham for N-terminal sequencing. The five N-terminal residues of CexE-6His were 
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GGGNS. These were the N-terminal residues predicted by SignalP after signal peptidase I 
cleavage of the full length CexE-6His protein. Therefore, it was concluded that CexE-6His 
purified was secreted into the periplasm similar to its native mechanism. 
 
5.2.2. Investigation of CexE-6His secondary structure using circular dichroism 
From the circular dichroism spectra of experimentally determined protein structures, the 
unknown secondary structure of a protein can be estimated. The CexE-6His protein, which was 
purified in chapter 4, was subjected to circular dichroism analysis. CexE-6His was diluted to a 
concentration of 0.1 mg/ml and buffer exchanged by membrane filtration. The degree of 
ellipticity of CexE-6His was measured at a range of wavelengths from 180 to 250 nm with 1 
nm increments and a curve between the degree of epilticity points was drawn (Fig. 5.5). The 
curve of the circular dichroism spectrum confirms that the protein is folded. The mdeg values 
were submitted to BeStSel for secondary structure estimation (Micsonai et al., 2015). Just 
below the majority, 47.9%, of the secondary structure of CexE-6His was estimated to be anti-
β sheet (4.9% left twisted, 15.5% relaxed and 27.5% right twisted). A substantial amount, 
38.9%, was not clearly estimated with the remainder estimated to be turns. These estimations 
suggest that the secondary structure of CexE is similar to that of Aap. 
 
5.2.3. Purification of CexE-6His composed of  13C and 15N nuclei 
The secondary structure of CexE was predicted to be similar to that of Aap but they have 
alternative functions. Therefore, to further investigate the structure of CexE the protein was 
produced for NMR spectroscopy. The carbon and nitrogen nuclei of proteins produced by 
cultures grown in LB have a paired spin, i.e. composed of 12C and 14N. For there to be an NMR 
signal the proteins must be made of atoms with unpaired spins, i.e. 13C and 15N. An overnight 




Figure 5.5: Circular dichroism and estimated secondary structure of CexE. The circular 
dichroism spectrum for CexE-6His is the curve at the top of the figure. Purified CexE-6His 
was buffer exchanged with 20 mM HEPES, 250 mM NaCl pH 7.3 and diluted to 0.1 mg/ml. 
The table included is the results of the secondary structure content estimated by BeStSel 
(Micsonai et al., 2015). The pie chart is a graphical representation of the estimation results.  
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centrifugation. The pellet was washed three times with PBS. The resuspended cells were used 
to inoculate 2 L of M9 salts supplemented with kanamycin and nutrient mix. The M9 medium 
was further supplemented with 13C glucose and 15N ammonium sulphate as the respective 
carbon and nitrogen sources. The cultures were grown to an OD600 of 0.3 at 37ºC with aeration, 
then cooled to 16ºC for 30 minutes, and the production of CexE-6His was induced with 50 µM 
IPTG. Cultures were grown overnight at 16ºC and cells were harvested by centrifugation. The 
cell pellet was resuspended in binding buffer and lysed using EmulsiFlex-C3. Unbroken cells 
were removed by centrifugation. Membranes were removed by high speed centrifugation and 
the soluble fraction was filtered. The filtrate was used to purify CexE-6His using a 5 ml 
HisTrap™ column, which was left to cycle through the column overnight at 4ºC. The column 
was washed with binding buffer and then successive wash buffers containing 50 mM and 100 
mM imidazole. The protein was eluted with 500 mM imidazole. Fractions containing purified 
CexE-6His were combined and concentrated by membrane filtration. The imidazole was 
removed by dialysis. Thus, CexE-6His with unpaired 13C and 15N nuclei was purified. The 
purified CexE-6His composed of 13C and 15N was referred to as double labelled CexE-6His.  
 
The removal of contaminating proteins from the sample reduces the noise in NMR spectra. The 
concentrated double labelled CexE-6His sample was filtered using a size exclusion column. 
The filtrate was collected in 4 ml fractions. The concentration of protein in the filtrate was 
measured using absorbance at 280 nm and plotted against the volume of the filtrate (Fig. 5.6). 
A single large peak was present corresponding to the double labelled CexE-6His protein. There 
were smaller amounts of larger proteins present but their peaks were not comparable to that of 
double labelled CexE-6His. The peak for double labelled CexE-6His was not defined. This was 
likely due to a high concentration of double labelled CexE-6His that prevented accurate 




Figure 5.6: Size exclusion of the double 13C and 15N labelled CexE-6His purified protein. 
The CexE-6His protein was buffer exchanged by dialysis into 50 mM NaP (27:73 NaH2PO4 to 
Na2HPO4), 250 mM NaCl, 0.5 mM TCEP-HCl, pH 7.3. The CexE-6His protein was loaded 
onto a size exclusion column and the absorbance of the filtrate was measured at a wavelength 
of 280 nm.  
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232 ml elution volume, were combined and concentrated by membrane filtration. Thus, it was 
concluded that double labelled CexE-6His had been purified sufficiently for NMR 
spectroscopy. 
 
5.2.4. Assignment of the chemical shifts to the backbone of CexE-6His  
With NMR spectroscopy, information about the chemical environment of each nucleus in 
CexE-6His with an unpaired spin can be obtained. Assigning the chemical shifts to the 
backbone moieties is critical for the determination of protein structure. The salt concentration 
and pH in the CexE-6His buffer were reduced by dialysis in preparation for NMR 
spectroscopy. The final concentration of double labelled CexE-6His for NMR structural 
analysis was 1.83 mM. The 1H-15N HSQC, HNCA, HNCOCA, HNCACB, HNCOCACB, 
HNCACO, and HNCO spectra were collected by Dr. Timothy Knowles on the Bruker 600 
Avance-IVDr at the Biomolecular facility at the University of Birmingham. The peaks for each 
spectrum were picked computationally with NMRFAM Sparky. There were 152, 213, 145, 
764, 289, 429, and 268 peaks for the 1H-15N-HSQC, HNCA, HNCOCA, HNCACB, 
HNCACBCO, HNCACO, and HNCO spectra, respectively. The spectra were used to assign 
the chemical shifts of the amine, Cα, Cβ, and carbonyl moieties to the backbone of CexE-6His, 
in NMRFAM Sparky. The chemical shift of a random peak in the 1H-15N-HSQC spectrum was 
used to provide the 1H and 15N chemical shifts used to specify the plane containing the 
corresponding Cα peak in the HNCA and HNCOCA spectra. The peak in the HNCA spectrum 
that was not present in the HNCOCA spectrum was assigned as the i position Cα. Using the 
HNCACB and HNCOCACB spectra, the same process was used to assign the i Cβ. A peak for 
the chemical shift of the i Cα was also present in HNCACB was only assigned when the 
chemical shift of 1H, 15N and 13C agreed with the HNCA spectrum. The 13C chemical shift of 
the i Cα in the HNCA was used to search the spectrum to identify the chemical shift when that 
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Cα was in the i−1 position (Fig. 5.7, blue lines). The 1H and 15N chemical shift of this peak 
was used to identify the corresponding peak in the 1H-15N-HSQC (Fig. 5.8). The carbonyl 
groups were assigned in the same way with HNCACO and HNCO spectra. Once 3 to 4 residues 
were fully assigned, NMRFAM Sparky was used to find the string of residues in the backbone 
of CexE-6His that best fit the chemical shifts observed. This was based on a database of already 
known chemical shifts for amino acids. These steps were repeated until the backbone of the 
protein was assigned. Excluding moieties prior to a proline residue, all Cα, Cβ, amine, and 
carbonyl groups from the Cα of G21 to the carbonyl of H123 were assigned. The Cα, Cβ, 
amine, and carbonyl moieties of G20 and the other histidines in the 6His tag could not be 
assigned. Therefore, these residues likely were likely unstructured. 
 
5.2.5. Assignment of the chemical shifts of the carbon atoms in the amino acid side chains 
of CexE-6His 
From the chemical shifts assigned to the backbone of CexE-6His above, the chemical shifts of 
the Cα and Cβ were known. The CCONH spectrum was collected as above by Dr. Timothy 
Knowles. The peaks in the CCONH spectrum were used to assign the chemical shifts of the 
amino acid side chain carbons (Fig. 5.9). There were 287 peaks in the CCONH spectrum. Peaks 
with the same chemical shifts as the Cα and Cβ from the backbone assignment were assigned 
as the respective Cα and Cβ of that residue. Any other peaks, on the same 15N plane with the 
same 1H chemical shift, were the chemical shifts of the other 13C nuclei in the amino acid side 
chain. These chemical shifts were assigned based on the comparison of their 13C chemical shift 
to the average chemical shift of that nuclei in the Biological Magnetic Resonance Data Bank 
(Ulrich et al., 2008). If there was ambiguity regarding the chemical shift 13C nucleus, 




Figure 5.7: Backbone assignment of CexE-6His. HNCA, progressive backbone assignments 
of the Cα, the blue lines are match 13C chemical shifts and the green lines are matching 1H 
chemical shifts for the residues N54 to C57. The HNCA spectra provides the chemical shifts 
of the atoms associated with the backbone of the protein. The HNCA spectra is viewed with 
the nitrogen chemical shift on the z-axis, the hydrogen chemical shift on the x-axis, and the 
carbon chemical shift on the y-axis. Each carbon atom in the protein backbone has two peaks 
in the HNCA spectra; as the Cα has a peak associated with it in the Ci and Ci−1 position, which 
change based on the associated amine group. The chemical shift of the Cα is exact same in 
every spectra. The HNCOCA spectra contains only the chemical shifts associated with the Ci−1 
carbons. Using the HNCA and HNCOCA spectra, a chain of the chemical shifts of the Cα 




Figure 5.8: 1H-15N-HSQC of backbone assigned CexE-6His. The 1H and 15N chemical shifts 
for the amino acids in the 1H-15N-HSQC are the same as those in the HNCA (Fig. 5.7). The 
nitrogen chemical shift is on the y-axis with hydrogen on the x-axis, there is no z-axis in the 
1H-15N-HSQC spectra. Each peak is an amine group. These can be in the protein backbone or 
side chains. The amine group of each amino acid in the protein backbone was assigned in 
conjunction with the HNCA and HNCOCA spectra. A peak is picked and assigned an amine 
group at random from the backbone of the protein. The chemical shifts that associate with this 
peak in the HNCA and HNCOCA spectra are assigned. After a chain of amino acid chemical 
shifts are assigned to peaks in the spectra NMRFAM-Sparky is used to search which chain of 
amino acids these chemical shifts are most likely to be based on a database of previously 













































































































































User:  lfrnax     Date:  Sun Sep 24 12:42:29 2017
Positive contours: low 5.63e+05  levels 14  factor 1.40




Figure 5.9: Examples of residue side chains in the CCONH spectrum. The example 
residues depicted are K41, I45, and V75. The chemical shifts of the Cα and Cβ are known for 
the assignment of the HNCA and HNCACB spectra. The Cδ, Cγ, and Cε if present were 
assigned using the average chemical shifts of the carbons in that residue form the Biological 
Magnetic Resonance Data Bank (Ulrich et al., 2008). The assignment of 13C with very similar 
chemical shifts was completed in conjunction with the aliphatic 13C-NOESY-HSQC spectrum.  
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vast majority of side chain carbon nuclei were assigned to a chemical shift in the CCONH 
spectrum. 
 
5.2.6. Chemical shift assignment of spatially proximal residues in CexE-6His 
A 13C-NOESY-HSQC makes use of the nuclear Overhauser effect (NOE) to identify residues 
in a protein that are within 5 Å of each other due to their bonding or the tertiary structure of 
the protein. A 13C-NOESY-HSQC spectrum can collect either the chemical shifts of aliphatic 
or aromatic moieties. The aliphatic 13C-NOESY-HSQC spectrum was collected by Dr. 
Timothy Knowles on the Bruker 900 MHz NMR spectrometer at the Biomolecular facility at 
the University of Birmingham. Peaks of chemical shifts were picked manually. The peaks in 
the 13C-NOESY-HSQC spectrum were assigned from the chemical shifts determined above 
and using the average chemical shift of each atom in the Biological Magnetic Resonance Data 
Bank repository (Ulrich et al., 2008). Once a chemical shift had been assigned to a nucleus of 
CexE-6His, all of the peaks with the same 1H chemical shift were picked manually. The peaks 
that were not assigned were the chemical shifts of the 1H that were located within 5 Å of the 
residue, these are known as NOEs. There were 3859 peaks in the 13C-NOESY-HSQC spectrum. 
Chemical shifts that did not agree with the expected standard deviation of average chemical 
shifts for that atom in that amino acid were subjected to further interrogation until the issue 
was resolved. The 1616 peaks of the chemical shifts in the 15N-NOESY-HSQC spectrum were 
picked computationally and not assigned. The peaks of the assigned 13C-NOESY-HSQC and 
15N-NOESY-HSQC were exported with all of the shifts in the 13C-NOESY-HSQC for use in 
structure calculation. 
 
5.2.7. Structure calculation of CexE-6His 
Dr. Timothy Knowles completed the final adjustments of aliphatic 13C-NOESY-HSQC and 
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15N-NOESY-HSQC spectra and then calculated the structure of CexE-6His using CYANA. 
CYANA used known torsion angles, the assigned chemical shifts provided, and the peaks of 
the aliphatic 13C-NOESY-HSQC and 15N-NOESY-HSQC spectra to calculate the best 20 
structure models. The top 20 models for the CexE-6His structure were calculated (Fig. 5.10). 
The root-mean-square deviation of atomic particle for the backbone of the CexE-6His of the 
best 20 models was 0.44±0.06 Å and 1.06±0.08 Å for heavy atoms, which accounts for all 
atoms except hydrogen. The surface charge for the structure of CexE was calculated using the 
PDB2PQR and APBS functions in Chimera (Fig. 5.11). There is a clear cleft of positively 
charged residues that may be responsible for the DNA binding phenotype observed. However, 
an anomalous fold in the CexE protein, between N39 and I45, could be responsible for this 
cleft. The reason for this fold was investigated. It was found that positions of the aromatic 
amino acids in the CexE-6His structure were not correctly calculated by CYANA as the NOEs 
of these residues were not present in the experimental data. According to the model that the 
aromatic moieties of CexE-6His were exposed and not in the hydrophobic core of the protein 
(Fig. 5.12). As this is unlikely to be correct a further aromatic 13C-NOESY-HSQC spectrum is 
required. Although the position of the aromatic residues in the structure was not correct, the 
structure of the other residues is not thought to substantially change with addition of the 
aromatic 13C-NOESY-HSQC spectrum. At the N-terminal of CexE-6His there is a helical turn 
from A32 to C35. This cysteine forms a disulphide bond with C57. There is an α helix from 
N55 to G64. There were four β strands: G68 to Y77; S82 to V89; K108 to D114; and Y117 to 
Y119. The final β strand is composed entirely of aromatic amino acids. With the addition of 
the aromatic 13C-NOESY-HSQC there will likely only be three β strands. These β strands are 
present on the other side of the protein from the N-terminus, where they form an anti-parallel 
β sheet. It was concluded, although subject to change with the addition of the aromatic 13C-




Figure 5.10: Ensemble of 20 models of CexE-6His as determined by CYANA. The 
unstructured 6His tag was removed from the structure calculation. Regions referred to in the 
text are labelled on the figure. The figure shows the solution structure of CexE and a 180º turn 
of the same structure. Amino acids are numbered from the N-terminus of the full length CexE 





Figure 5.11: Electrostatic surface charge of CexE. The electrostatic surface charge of CexE 
was calculated using the PDB2PQR and APBS functions in Chimera. The figure shows a 180º 
turn of the surface of the CexE protein with electrostatic surface charge. There is a clear 
concentration of positive charge, however it is not clear if this is due to the analysis fold present 




Figure 5.12: The aromatic residues exposed in the CexE structure. The bonds of the 
aromatic residues in CexE were represented as lines on the structure. They were coloured: pink 
for tryptophan; blue for tyrosine; yellow for histidine; and green for phenylalanine.  
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5.2.8. Comparison of preliminary CexE structure to the structure of Aap 
Alignment of two similar structures can reveal information about which region of a protein are 
responsible for function. The best representative conformer structure of Aap and CexE were 
aligned in Chimera by their amino acid sequences using Matchmaker. The structures of Aap 
and CexE were very similar (Fig. 5.13). The α helices, on the right in Fig. 5.13, of Aap and 
CexE were superimposable. The anti-parallel β sheets of CexE were superimposable onto the 
β sheets in Aap. The other β sheets in Aap were not present in CexE. In addition, the other α 
helix at the pole of Aap, on the left in Fig. 5.13, does not appear to be present in the CexE 
model. It is thought that the addition of the aromatic 13C-NOESY-HSQC spectrum will resolve 
anomalous folding calculated for the CexE protein. This misfolded region maybe the difference 
between CexE and Aap. The structure of CexE is bullet shaped. As described for Aap by 
Velarde et al. (2007). In conclusion despite the differences in amino acid composition the 
structure of CexE was almost identical to that of Aap. 
 
5.2.9. Position of conserved residues on the Aap structure 
Since CexE and Aap do not share function and there is comparatively little amino acid sequence 
identity for two structures that were superimposable, the residues conserved must have a 
structural role. The position of the conserved residues of Aap and CexE on the Aap structure, 
which was determined by Velarde et al. (2007), were identified. The predicted Sec signal 
sequence was removed from 70 non-identical Aap and CexE homologous sequences described 
in Chapter 4.2.1. by SignalP. The resultant sequences were aligned using T-coffee. Each 
residue in the best representative conformer structure of Aap was coloured according to its 
percentage of conservation in the Aap and CexE alignment. The amino acids were coloured in 
Chimera on a scale of red to white to blue, where red was 100%, white was 58%, blue was 




Figure 5.13: Comparison of Aap and CexE structures. The best representative conformer 
of Aap solved by Velarde et al. (2007) and a representative structure model of CexE were 
aligned by amino acid sequence in Chimera. The best representative conformer is a single 
structure that best represents the group of 20 Aap structures calculated. The structures were 
coloured blue and orange for Aap and CexE, respectively.  
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more than 80% conserved. The surface of Aap and CexE was not conserved (Appendix II). 
Instead the conserved residues were present in the hydrophobic core of Aap (Fig. 5.14). The 
hydrophobic core of Aap was previously described by Velarde et al. (2007). However, they did 
not identify the conservation of these residues. The disulphide bridge is conserved in the 
majority of Aap/CexE proteins (Fig. 5.14; C36 and C53 and B, Fig. 5.15; residues 17 and 41). 
Two conserved prolines, P33 and P87, cause turns in the structure. A hydrophobic region at 
this pole is very conserved, which consists of W26, A28, V65, V85, and W114. The amino 
acids at the other pole of Aap are not as well conserved. Only Y73 was present in over 80% of 
the sequences, likely forming another hydrophobic region. Interestingly the unstructured N-
terminal residues of Aap were highly conserved. The initial amino acid was invariably glycine, 
the next was either a serine or a glycine. The first 6 amino acids of the N-terminus after the 
predicted signal peptidase cleavage site were glycine rich and to a lesser extent serine (Fig. 
5.15). The major similarity between Aap and CexE is there suspected mechanism of secretion, 
which has not been confirmed for CexE. Therefore, it was concluded that the conserved 




The NMR structure of the CexE protein requires further refinement based upon additional 
experimental data. The inclusion of an aromatic 13C-NOESY-HSQC spectrum would define 
the CexE structure. Dr. Timothy Knowles has collected the aromatic 13C-NOESY-HSQC 
spectrum for CexE-6His and is currently assigning the peaks. 
 
The preliminary structure of CexE presented here is very similar to that of Aap, which is 




Figure 5.14: Structure of Aap coloured by percentage conservation. The signal sequence 
of non-identical sequences from Chapter 4 were removed by SignalP. The resulting sequences 
were aligned using T-coffee. The best representative conformer of the 20 Aap models specified 
in the file, 2jvu (Velarde et al., 2007), was coloured by percentage conservation according to 
the alignment. The scale for which is located in the top right of the figure. Residues coloured 
red are highly conserved while blue residues are not. The atoms of the residues with over 80% 




Figure 5.15: WebLogo of the residues in the Aap and CexE aligned sequences. The height 
of the letter indicates the level of conservation in the alignment. The numbering of the residues 








































































































































































































































































































































































































































































































































































































































































































































































































































sequence identity to have superimposable structures (Rost, 1999). These structures are 
relatively unique. Therefore, it is very likely, as first hypothesized by Velarde et al., (2007), 
that the structure of Aap and now CexE is a requirement for secretion by the Aat system. 
Interestingly there were highly conserved residues that were not part of the structure. The N-
terminus of the Aap/CexE proteins after the signal sequence cleavage is highly glycine rich. It 
is unlikely that the unstructured residues at the N-terminus have a role in Aap or CexE function. 
The rest of the conserved residues between Aap and CexE are required for a structure that can 
be secreted by the Aat system. Therefore, it is suggested that the conservation of the N-terminal 
glycine rich region is also required for Aat secretion. 
 
The secretion of Aap is by the Aat system (Nishi et al., 2003). There is no information on the 
mechanism of CexE secretion. In the current work, it was confirmed that CexE is secreted into 
the periplasm by the general secretory pathway but the next steps in CexE secretion are 
unknown. It is postulated that due to the specific structure of CexE presented here and the 














CHAPTER 6:  
Secretion of CexE and Aap in EAEC 





In the RNA-Seq experiments from chapter 3, like aap, transcription of the aat system was 
significantly lower in the aggR mutant compared to the wild-type. The Aat system is required 
for the secretion of Aap (Nishi et al., 2003). The Aat system is comprised of 5 proteins: AatP; 
AatA; AatB; AatC; and AatD. AatP and AatC are the permease and ATPase domain of an ABC 
transporter. AatA is a homolog of TolC (Nishi et al., 2003). A function for AatB was not 
suggested by Nishi et al. (2003). However, recent annotations of AatB have identified it as a 
membrane fusion protein of the type associated with T1SS (see Chapter 1). The function of 
AatD is unknown. Based on the homology of these proteins, Nishi et al. (2003) proposed that 
Aap requires an atypical T1SS for extracellular localisation (Fig. 6.1). Like Aap, CexE 
possesses a Sec-dependent signal sequence for translocation to the periplasm. Recent 
investigations have demonstrated that CexE can be found in the extracellular milieu of ETEC 
H10407 (Roy et al., 2011). However, a secretion mechanism for CexE is unknown. 
 
Therefore, the aim of the work presented in this Chapter was to investigate the association 
between CexE and Aat-mediated protein secretion. Bioinformatic approaches were used to 
examine the prevalence and organisation of the aat gene cluster and its association with genes 
encoding Aap/CexE-like molecules. A role for Aat in CexE secretion was demonstrated.  
 
6.2. Results 
6.2.1. Prevalence of the aat genes 
The Aat system is proposed to function together, if all proteins are required then they will be 
encoded in a single strain. A PSI-BLAST search identified 717, 725, 663, 470, and 689 
sequences homologous to AatP, AatA, AatB, AatC, and AatD, respectively. The vast majority 




Figure 6.1: Mechanism of the Aat system proposed by Nishi et al. (2003). This figure was 
previously presented as Fig. 1.15, it is reproduced here. A, Aap is produced in the cytoplasm. 
B, Aap is secreted into the periplasm via the general secretory pathway. The signal sequence 
is cleaved by signal peptidase I. C, an as yet unknown function of AatD is required for the 
secretion of Aap. Aap access the Aat pore via the periplasm. D, Aap is secreted out of the cell 
and electrostatically attaches to the LPS.   
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loci were also found in S. enterica, Providencia alcalifaciens, Y. enterocolitica, and C. 
rodentium. The genomic regions encoding these proteins were inspected. It was noted that aatP 
and aatA are well annotated. In contrast, aatB and/or aatC were not annotated or annotated 
incorrectly. Furthermore, the majority (96%) of the aat genes identified in this study were 
associated with strains that do not have a complete genome. Therefore, there remains the 
possibility that intact aat loci exist in these strains but nucleotide sequence data for specific aat 
genes was not obtained during sequencing. This explains the lower number of sequences 
homologous to AatB and AatC that were identified by PSI-BLAST.  
 
The functional association of Aap with the Aat system suggested the aat loci identified above 
were atypical T1SS. Therefore, the nucleotide sequences of these strains were examined for 
the co-occurrence of aap and aat loci. Only 290 of the strains contained a gene encoding a Aap 
homolog; this includes ETEC H10407 which possessed CexE and AatPABCD. However, 
manual inspection revealed that the aat loci frequently contained an unannotated aap/cexE 
gene, and the incomplete nature of the majority of the genomes meant that it could not be 
certain aap homologs were absent from these strains.  Therefore, further analysis was limited 
to strains with complete genomes; 28 strains with complete genomes were found to contain 
homologs of the aat system. The presence or absence of each of the aat and aap homologs was 
visualised using a heatmap (Fig. 6.2). All of the genomes contained a complete aat system and 
an aap or cexE gene, except E. coli MRE600. An ORF that contained an aap or cexE 
homologous sequence could not be identified on any of the three plasmids or the chromosome 
in MRE600. However, it remains possible that a divergent aap is present in the genome but 
was undetected using the bioinformatic approaches employed in this investigation. There were 
two duplication events in the ETEC stains E24377A and FORC_31. Therefore, it is 




Figure 6.2: Prevalence of the aat system and aap/cexE. A red block indicates the gene 
indicated was present in the strain sequence. A white block indicates that a homologous gene 
could not be detected. Only strains with complete genomes were included in this analysis. 
Homology was detected using BLASTp.  
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6.2.2. Organisation of the aat cluster and aap/cexE in strains from the analysis of the 
prevalence of the Aat proteins 
The operon structures of the aat cluster differ between EAEC 042 and ETEC H10407. Thus, 
the organisation of genes aatP, aatA, aatB, aatC, aatD, and aap or cexE in relation to each 
other was investigated (Fig. 6.3). The GC content of the regions encoding these genes was 
around 30%. This was typical for all of the genes in the aat cluster, but lower than the overall 
GC content of the genomes in which they were present. What was clear from the analysis is 
that the aat cluster is organised in three main ways. There is a full cluster, these contained all 
of the aat genes with aap or cexE upstream. Two examples are S. enterica subsp. diarizonae 
and E. coli E22. In these instances, the aat cluster is flanked by genes encoding hypothetical 
proteins. In the second group, the aap or cexE genes are distant from the aatPABCD operon. 
For example, in E. coli NCT86 and EAEC 042, the aap/cexE gene was 38 and 32 kb away, 
respectively. In the final organisation, there are significant gaps between aatD and aap/cexE 
and aatPABC, which are fully conserved as a single operon. The genes were flanked by 
transposable elements, similar to NCTC86 and EAEC 042. In summary, both aatD and 
aap/cexE are always present with an aatPABC operon, but they are not necessarily closely 
linked.  
 
6.2.3. Possible mechanism of function of AatP inferred from protein homology 
Homology to characterised proteins can suggest a biological function. Since BLAST did not 
detect any homology of AatP to domains of proteins with known function, a hidden Markov 
model (HMM) of AatP was used to search the Swissprot database. This search identified 126 
protein sequences homologous to AatP. MacB was the major protein identified with 91 
sequences. Other well characterised proteins such as LolC, LolD and FtsX were also identified. 




Figure 6.3: Examples of the aat and aap/cexE loci organisation. The genes were drawn to 
the scale indicated in the bottom right. Grey arrows indicate transposable elements, such as 
transposons or other insertion elements. The black arrows were ORF that were annotated as 
encoding hypothetical proteins. The aat cluster was present on the chromosome of the strain 
unless otherwise stated in the name.   
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Clustering refers to the grouping of sequences with more than 70% identity, the longest 
sequence is used to represent the cluster. The number of changes between each sequence was 
calculated using RAxML. A phylogram was constructed of the AatP homologs and AatP (Fig. 
6.4). Further analysis revealed that the transmembrane and periplasmic regions of MacB, but 
not the nucleotide binding domain, are homologous to AatP (Appendix III). The MacB clade 
contained two uncharacterised proteins, YnzK and YvrN, both from Bacillus subtilus 168. 
These proteins contain an N-terminal MacB periplasmic domain (PF12704) and a C-terminal 
FtsX-like domain (PF02687). These two domains were again present in the uncharacterised 
proteins, Y1507_METJA and Y797_METJA, from Methanocaldococcus jannaschii and 
YCLI_BACSU and YTRF_BACSU from B. subtilus. A group of uncharacterised 
Mycobacteria proteins were identified by the search: Y072_MYCTO; Y2593_MYCBO and 
Y2563_MYCTO and genes encoding FtsX (Fig. 6.4). The closest homolog of AatP was FtsX 
of the Mycobacteria; FtsX of E. coli MG1655 was not a significant hit. However, the E. coli 
MG1655 proteins LolC and LolE were identified as homologs of AatP. These proteins are 
involved in the extraction of lipoproteins from the inner membrane. This suggests that AatP 
might be involved in the release of acylated proteins from the inner membrane. 
 
6.2.4. Phylogenetic analysis of the AatA protein  
AatA is homologous to TolC (Nishi et al., 2003). However, the relationship of AatA to the 
other outer membrane proteins is not understood. Homologs of AatA were identified using a 
HMM of AatA. The search of the Uniprot database with the AatA HMM identified homologous 
3,563 sequences. As there were too many sequences for individual further analysis, an HHpred 
search was used to identify AatA homologs.  This analysis revealed that AatA is homologous 
to outer membrane proteins involved in type I secretion and efflux. For each homolog of AatA 




Figure 6.4: Results of search using AatP HMM. A HMM using AatP sequences was built in 
HMMER and used to search the Swissprot database. In the resulting homologous sequences 
there was a high proportion of MacB sequences (91 out of 126). To reduce the amount of 
analysis the MacB sequences were represented by clusters that had less than 70 identity to other 
clusters of MacB sequences. The remaining sequences were aligned using Clustal Omega. 
Branch lengths were calculated using RAxML. The tree was drawn using iTOL. The tree was 
left unrooted. Clades were assigned based on the function of the protein sequences present.   
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changes between each sequence was calculated and a phylogram was drawn (Fig. 6.5). The 
branch lengths between the outer membrane proteins involved in T1SS, AprF/PrfT, TolC, and 
CyaE, were small compared to the other outer membrane proteins. The same was true of the 
outer membrane proteins involved in efflux, CmeC, VceC, CusC, OprM, OprJ, and MtrE. 
However, the AatA clade is more divergent from any other clade in the analysis. Therefore, it 
was concluded that the function of AatA is likely to be distinct from the other characterised 
T1SS or efflux outer membrane protein. 
 
6.2.5. Inference of the function of AatB from protein homology 
The function of AatB is not understood. A HMM of AatB was created, which was then used to 
search the Uniprot database. In this search, 7,586 sequences were identified. These sequences 
were mostly membrane fusion proteins. However, the number of sequences identified was not 
conducive to further analysis. Therefore, HHpred was used to find homologs of AatB. The 
most significant hits were to membrane fusion proteins. An E-value less than 1e-16 was 
associated with the MFPs: AcrA, MacA, ZneB, CusB and HlyD. This suggests that AatB is the 
membrane fusion protein of the Aat system. 
 
The relationship between AatB and other membrane fusion proteins is not understood. The 
distance between each sequence was calculated. A phylogram was drawn with the branch 
lengths indicating the distance between each sequence (Fig. 6.6). Similar to the outer 
membrane proteins, the membrane fusion proteins form clades based on their function in efflux 
or type I secretion (Fig. 6.5). AcrA, MacA, CusB and ZneB are involved in efflux systems and 
HlyD is required for haemolysin secretion. However, the distance for the AatB clade was 
greater than that for any other clade. Therefore, the mechanism of action of AatB is different 




Figure 6.5: Phylogram of the relationship of AatA to other OMPs. HHpred was used to 
identify homologs of AatA using the EAEC 042 AatA protein sequence as the query. 
Representative sequences of each homolog were used to construct a phylogram. Sequences 
were aligned with Clustal Omega, the variation in sequences was calculated with RAxML and 




Figure 6.6: Relationship of AatB to membrane fusion proteins. HHpred was used to 
identify homologs of AatB using the EAEC 042 AatA protein sequence as the query. 
Representative sequences for each homolog were aligned using Clustal Omega, branch lengths 
were calculated with RAxML and drawn using iTOL.   
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6.2.6. Homology searches for AatC 
Previously, it was suggested AatC is an ATPase (Nishi et al., 2003). A BLAST search revealed 
AatC possessed the COG1136, cd03255, TIGR03608, PRK10535, pfam00005 and smart00382 
protein domains. All of these domains correspond to an ATPase domain. These domains are 
found in LolD (lipoprotein export), MacB (macrolide efflux), FtsE (cell division), and other 
ABC transporters. Although AatC is homologous to MacB, AatC is not homologous to the 
same region of MacB as AatP. The sequence of AatC aligns with the N-terminal nucleotide 
binding domain of MacB (Appendix IV). Thus, it is very likely that AatC is an ATPase. 
 
6.2.7. Identification of characterised proteins homologous to AatD 
The function of AatD in Aap secretion is unknown. AatD homologs were not found in 
association with other known T1SS. A hidden Markov model of AatD was built, which was 
then used to search the Uniprot database. From the hidden Markov model search of the Uniprot 
database 71 sequences, including AatD, were identified. The sequences were aligned. The 
number of changes between each sequence was calculated and a phylogram was drawn (Fig. 
6.7). The non-AatD proteins were apolipoprotein N-acyltransferases (Lnt). While Lnt of E. coli 
MG1655 was identified by this search, it was not included in the phylogram analysis as it fell 
below the threshold for significance. Lnt in E. coli MG1655 is involved in the addition of acyl 
groups onto the C-terminus of lipoproteins prior to their LolE-mediated extraction from the 
inner membrane. This suggests that AatD is involved in protein acylation. 
 
Proteins with similar functions often have conserved residues. Although, E. coli MG1655 Lnt 
was not a significant hit for AatD it is the best studied apolipoprotein N-acyltransferase. The 
residues required for the catalytic function of Lnt are known. Thus, the sequences of AatD 




Figure 6.7: Phylogram of AatD and apolipoprotein N-acyltransferase. A HMM of AatD 
was constructed using the AatD sequences identified by PSI-BLAST. The results of the Uniprot 
database search were aligned using Clustal Omega. The phylogram was calculated using 
RAxML. The tree was drawn with iTOL. For easier interpretation of the data the tree was 
rooted between the AatD and apolipoprotein N-acyltransferase.  
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Lnt from E. coli MG1655, AatD from EAEC 042 and AatD from ETEC H10407 were aligned 
and compared with the conserved sequence logo of AatD. The residues known to be required 
for Lnt function were compared to the consensus sequence of AatD (Fig. 6.8). The catalytic 
residues of Lnt are known to be E267, K335 and C387 (Nakayama et al., 2012). The residues 
of the active site were all conserved in AatD. Thus, it was concluded that the catalytic residues 
required for the acylation of proteins by Lnt were conserved in AatD. 
 
6.2.8. Aap production in EAEC 042  
In the work by Nishi et al. (2003) the mutants were not complemented to show restoration of 
Aap secretion. Therefore, to confirm the previous observations. Overnight cultures of aap, 
aatA, aatC and aatD mutants with corresponding complements for the aat mutants and the 
parental strain were used to inoculate pre-warmed DMEM high glucose. The cultures were 
grown at 37ºC with aeration. After 5 hours of growth, Triton X-100 was added to cultures to 
remove Aap from the cell membrane. Cultures were grown for another hour. For whole cell 
lysates, samples were harvested by centrifugation and resuspended in Laemmli buffer. The 
culture supernatant was retained for protein precipitation. Whole cell lysates were separated on 
Tris-tricine gels to determine the production of Aap. Gels were stained with Coomassie 
Brilliant Blue or transferred for western blotting using anti-Aap antibodies (Fig. 6.9). On the 
Coomassie Brilliant Blue stained gel, Aap was not visible (Fig. 6.9A). On the western blot, 
Aap was detected in all of the strains except the aap mutant (Fig. 6.9B). The amount of Aap 
was relatively similar in each of the aat mutants. There was a slight increase in the amount 
observed for the aatA mutant. The aatA mutant was complemented with pJNW, a single copy 
number vector with the aat system under native expression. In the complemented aatA mutant 




Figure 6.8: Conservation of Lnt catalytic residues in AatD. A sequence logo was created of 
AatD sequences identified by PSI-BLAST. The height of the residue indicates the level of 
conservation. The catalytic residues E267, K335, and C387 are indicated in this figure as E254, 




Figure 6.9: Whole cell lysates of EAEC 042 and aat mutants. EAEC 042, aap mutant, and 
aat mutants with and without the pJNW plasmids were grown in DMEM high glucose for 6 
hours. The complementation plasmid pJNW contains the entire aat cluster on a single copy 
number plasmid, pZC320. Whole cell lysate samples were prepared and separated on Tris-
tricine gels. A, the Coomassie stained gel. B, the western blot with primary antibodies specific 
for Aap. This experiment was repeated twice with the same results.  
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double band was present for Aap. The double band consisted of a wild-type sized Aap and a 
band that appeared to be of a higher molecular weight. Less Aap was present in the whole cell 
lysate in the aatC mutant than in the wild-type. Complementation of the aatC mutant reduced 
the amount of the retarded band present for Aap. In the aatD mutant, the Aap protein was 
retarded in the gel. Aap in the aatD mutant was the same size as the higher molecular weight 
band in the aatC mutant. In the complemented aatD mutant, Aap migration was comparable to 
the wild-type. The wild-type molecular weight Aap was only fully absent in the aatD mutant. 
It is hypothesised that the appearance of the high molecular weight protein species in the aatC 
mutant is due to polar effects on aatD expression. There was a reduced amount of AatD present 
in the aatC mutant due to the alteration of aatD transcription because of the insertion of the 
suicide vector into aatC. From this data, it is concluded that AatD was responsible for altering 
the electrophoretic mobility of Aap.  
 
6.2.9. Secretion of Aap via the Aat system from EAEC 042 
Nishi et al. (2003) reported that the aat system was required for the secretion of Aap. Proteins 
in the supernatant, from the cultures described above, were concentrated by TCA precipitation. 
Pellets were washed with methanol and resuspended in Laemmli buffer. Resuspended proteins, 
henceforth referred to as the supernatant fraction, were separated by electrophoresis on Tris-
tricine gels and the presence of Aap was detected by staining with Coomassie Brilliant Blue 
and western blotting with Aap antibodies (Fig. 6.10). In the Coomassie Brilliant Blue stained 
gel, Aap was apparent in the parental strain and the complemented aat mutants but not the 
individual mutants (Fig. 6.10A). The western blot confirmed that the bands present in the 
Coomassie Brilliant Blue stained gel were the Aap protein (Fig. 6.10B). On the western blot, 
as expected, more Aap was observed in the wild-type samples and the complemented mutants 




Figure 6.10: Supernatant of EAEC 042, aap and aat mutants. EAEC 042, aap mutant, and 
aat mutants with and without the pJNW plasmid were grown in DMEM high glucose for 6 
hours. Culture supernatant fractions were prepared by TCA precipitation. Protein samples were 
separated on Tris-tricine gels. A, Coomassie Brilliant Blue stained gel. B, western blot with 




aatA and aatC mutants. In the supernatant of the aatC mutant, a double band was present for 
Aap, similar to the double band observed in the whole cell lysate (Fig. 6.10). The 
complementation of the aatC resulted in a single band for Aap at a comparable size to that of 
the wild-type. The small amount of Aap present in the supernatant of the aatD mutant had an 
altered electrophoretic mobility; this was similar to the single retarded band in the aatD mutant 
whole cell lysate (Fig. 6.9). The complementation of the aatD mutant with pJNW restored Aap 
to a similar size and amount to the wild-type.  
 
These data suggest that Aap exists in three forms. The first form is the fully translated protein 
containing the signal sequence (pre-pro-Aap). The second form occurs post Sec secretion after 
single sequence has been cleaved (pro-Aap). The third form is the mature Aap after AatD-
mediated modulation of the protein. Modification to this latter form is required for secretion 
into the culture supernatant. As Aap was produced in each of the EAEC 042 mutant strains, 
except aap mutant, but was only secreted when the aat system was intact, it was concluded 
that the aat system is required for the secretion of Aap. However, the work presented here 
revealed a previously undocumented post-translational modification of Aap.  
 
6.2.10. Production of CexE in ETEC H10407 
Before a secretion of a protein can be attributed to a secretion system the protein must be 
produced. In Chapter 4, it was shown that the CexE protein was not produced in ETEC H10407 
that had been grown aerobically at 37ºC (Fig. 4.8). Different conditions were tested to find the 
conditions under which ETEC H10407 produces CexE. CexE was detected not in any of the 




It is known that the cexE expression is activated by CfaD (Pilonieta et al., 2007). The cfaD 
gene was cloned into pBAD/myc-His A expression plasmid under the transcriptional control 
of the ara promoter to drive the production of CexE, by Sammi McKean. The cexE mutant and 
the parental strain were transformed with the resulting recombinant plasmid, pCfaD. Cultures 
of ETEC H10407 pCfaD and ETEC H10407DcexE pCfaD were grown overnight at 37ºC with 
aeration in LB supplemented with 0.2% L-arabinose. Whole cell lysates were prepared by 
centrifugation and resuspension in Laemmli buffer. Culture supernatants were harvested by 
centrifugation and proteins were precipitated by TCA. Whole cell lysate and supernatant 
protein samples were separated by electrophoresis on Tris-tricine gels. CexE was detected by 
staining gels with Coomassie Brilliant Blue and transferring gels for western blotting with anti-
CexE antibodies (Fig. 6.11). For the Coomassie Brilliant Blue stain, a band at around the size 
of the CexE protein (10.6 kDa) was clearly visible in the wild-type supernatant. There was 
more protein present in the culture supernatant of the wild-type than the mutant. However, 
there was no protein in the supernatant fraction of the mutant that potentially could be CexE. 
The band in the wild-type supernatant was confirmed to be CexE by the western blot. The 
apparent mass of the protein identified in the western blot as CexE in the whole cell lysate was 
smaller than that in the supernatant. There was no band at the same size in the cexE mutant. 
Thus, it was concluded that the expression of cfaD from pCfaD was able to drive expression 
and subsequent secretion of CexE in ETEC H10407. 
 
6.2.11. Construction of aat gene deletions in ETEC H10407 
Crossman et al. (2010) had previously reported an aat system in ETEC H10407. It was 
hypothesised that this Aat system was required for the secretion of CexE. Mutants defective in 
the aat system were constructed in ETEC H10407 using λ Red recombination to test this 




Figure 6.11: Production of CexE from pCfaD transformed ETEC H10407. A cexE mutant 
and wild-type strain transformed with pCfaD were grown in LB supplemented with 0.2% L-
arabinose for 6 hours. Whole cell lysates and culture supernatant fractions were prepared from 
the same culture. Protein samples were separated on Tris-tricine gels. The Coomassie stained 
gel is on the left and the western probing for CexE is on the right. WCL were whole cell lysates 
and SUP were the culture supernatant. Anti-CexE antibodies with secondary HRP conjugate 




homology to the target gene. Homology regions were targeted to the start codon and the last 7 
codons of the target gene. Linear fragments for each primer pair were amplified containing a 
kanamycin resistance cassette from pDOC-K. An overnight culture of ETEC H10407 pKD46 
was used to inoculate LB supplemented with 0.2% L-arabinose. Cells were harvested by 
centrifugation. The cells were made electrocompetent. The linear fragments were transformed 
into ETEC H10407 pKD46 by electroporation. Cells were recovered in SOC at 37ºC with 
aeration and were plated on to LBA supplemented with kanamycin. After overnight growth at 
37ºC, kanamycin resistant colonies were streaked to single colonies on LBA supplemented 
with kanamycin. A colony PCR using primers external to the gene of interest was used to 
confirm the successful mutation of the aat genes. For each candidate aat mutant, a wild-type 
colony was used as a positive control and nuclease free-water was used as a negative control. 
A single colony from the streaked plate was used to test for the presence of the mutation. For 
each of the five mutants, aatP, aatA, aatB, aatC, and aatD, the PCR product was smaller in the 
parent strain, confirming the construction had been successful (Fig. 6.12A). For extra 
confirmation of the external PCR, primers with homology to regions inside of the gene of 
interest were used as primers for a second PCR. The templates described above were used for 
a successive set of PCRs. The presence of a PCR product indicated that the gene was still 
present (Fig. 6.12B). No PCR product was present for the aat genes. As the strains streaked to 
single colonies were not contaminated with the wild-type, it was concluded that the mutation 
of the aat genes had been successful. 
 
6.2.12. CexE production in ETEC H10407 aat mutants 
Before proteins can be secreted they must be produced in the cell. Overnight cultures of cexE, 
aat mutants and the parental strain were used to inoculate LB supplemented with 0.2% L-




Figure 6.12: PCR products for the aat genes and cexE. For each gene, 3 reactions were set 
up; wild-type, insertion mutant and nuclease free water control. In section A, the primers are 
designed to anneal to positions outside of the target gene. In section B, the primers are design 
to anneal to regions inside the target gene.  
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centrifugation. Protein samples were assessed for the presence of CexE by western blot (Fig. 
6.13). The b' subunit of RNAP was used as a loading control. The amount of b' subunit of 
RNAP in each lane was comparable. The CexE protein was produced in each of aat mutants 
and the parental strain. However, in all of the mutants, except the aatD mutant, CexE was 
present in two forms with differences in electrophoretic mobility. In the aatD mutant, all of the 
CexE protein migrated at the higher molecular weight of the two wild-type forms. Thus, the 
larger band was termed pro-CexE and the smaller, presumably mature form, was termed CexE. 
Therefore, it was concluded, that like Aap in EAEC 042, the Aat system is required for CexE 
secretion and AatD is responsible for the post-translational maturation of CexE in ETEC 
H10407.  
 
6.2.13. Differences in the secretion of CexE between the aat mutants and wild-type in 
ETEC H10407 
As cell lysis occurs during growth, proteins that are not secreted appear in the culture 
supernatant. Overnight cultures of ETEC H10407 pCfaD and ETEC H10407DaatA pCfaD 
were used to inoculate LB supplemented with 0.2% L-arabinose. Cultures were grown at 37ºC 
with aeration, culture supernatant were prepared as above from the overnight culture without 
induction and after 2 and 3 hours of growth with induction. The production of CexE in the 
samples was assessed by Coomassie Brilliant Blue stain and western blot as described above. 
No CexE protein detected in the overnight culture supernatant (Fig. 6.14AB). After 2 hours of 
growth the presence of 0.2% L-arabinose, CexE was produced. No CexE was detectable in the 
aatA mutant supernatant at this time. After 3 hours of growth, there was more CexE in the 
supernatant of the wild-type strain compared to the aatA mutant. However, the CexE that was 
present in the supernatant of the aatA mutant was pro-CexE. Thus, it was hypothesised that the 




Figure 6.13: CexE production in ETEC H10407 and aat mutants. Cultures of aat and cexE 
mutants and the parental strain transformed with pCfaD were grown in LB supplemented with 
0.2% L-arabinose. After 6 hours of growth, whole cell lysate samples for each culture were 
prepared. Protein samples were separated on NuPAGE Bis-Tris 4-12% protein gels. Proteins 
were transferred to nitrocellulose and western blotted with anti-CexE and βʹ RNAP antibodies. 
For the secondary antibodies, a HRP conjugate was used. The presence of only the larger band 




Figure 6.14: CexE secretion in ETEC H10407 and aat mutants. A, Coomassie Brilliant 
Blue stain of ETEC H10407 and aatA culture supernatants after overnight growth and 2 and 3 
hours post L-arabinose induction. B, western blot for the detection of CexE for the samples in 
A. C, western blot for the detection of CexE in the culture supernatants of ETEC H10407, 
cexE, and aat mutants after 2 hours growth in LB supplemented with 0.2% L-arabinose.   
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presence of pro-CexE in the supernatant was due to cell lysis rather than active secretion. 
Therefore, supernatants for the examination of CexE secretion were taken after 2 hours of 
growth in LB supplemented with 0.2% L-arabinose. The Aat proteins were hypothesised to be 
required for the secretion of CexE from ETEC H10407. Overnight cultures of wild-type, cexE 
mutant and the aat mutants were used to inoculate LB supplemented with 0.2% L-arabinose. 
Strains were grown for 2 hours at 37ºC with aeration. Culture supernatants were harvested as 
previously described. CexE was detectable by western blot only in the culture supernatant of 
the parental strain (Fig. 6.14C). Therefore, it was concluded that the Aat system must be fully 
intact for the secretion of mature CexE into the supernatant.  
 
6.3. Discussion 
From the prevalence analysis, it appears that aap or cexE homologs co-occur with the aat 
system. There are few examples S. enterica strains harbouring the aat system, whereas there 
are many ETEC, EAEC and Y. enterocolitica strains that do. From the current analysis, it 
appears there are no aat systems outside of the Enterobacteriaceae. Therefore, the function of 
Aap/CexE is thought to be more important for these species. 
 
The bioinformatic analysis of the Aat proteins indicates that the current model of Aap/CexE 
secretion by the Aat system requires modification. Nishi et al. (2003) proposed that Aap is 
secreted into the periplasm and then enters the Aat system in the periplasm (Fig. 6.1). From 
their bioinformatic analysis, they concluded that AatA was the outer membrane pore, AatC 
was the ATPase and AatP the permease. Sufficient similarity with other proteins in the database 
was not detected to assign possible functions for AatB and AatD. Improvements in computation 
power, homology search algorithms and database size enabled the detection of the homology 
of AatB to membrane fusion proteins and AatD to apolipoprotein N-acyltransferase. Therefore, 
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an alteration of the Aat secretion model is proposed, in which the function of AatP, AatA and 
AatC are retained, as the outer membrane protein, permease, and ATPase, respectively. AatB 
and AatD are assigned updated putative functions based on their homology. AatB is confirmed 
as the membrane fusion protein of the Aat system. Membrane fusion proteins interact with the 
OMP and ABC transporters to form a pore through which an unfolded protein can be secreted 
(Kanonenberg et al., 2013). AatD is thought to be present in the inner membrane. While the 
AatD-dependent alteration of Aap/CexE is yet to be determined it is known that it is required 
for secretion. However, the differences in size of both Aap and CexE in EAEC 042DaatD and 
ETEC H10407DaatD confirm that there is an as yet unknown modification. Previous studies 
of the Aat system did not report that Aap is post-translationally modified after Sec secretion. 
The reason why it was identified in this study is thought to be due to the change in protein gel 
systems. Previously high acrylamide concentration, 20%, Tris-glycine gels were used (Nishi 
et al., 2003). In this analysis, Tris-tricine gels were used. This was due to the improved 
resolution of Tris-tricine gel separation of low molecular weight proteins (Schägger, 2006). In 
EAEC 042, the mutation of aatC resulted in a double band for Aap similar to that observed for 
ETEC H10407. However, it is thought that the organisation of the aat cluster in EAEC 042 is 
responsible for the double band present in the aatC mutant (Fig. 6.9 and Fig. 6.13). The mutants 
used in this experiment were insertional mutants donated by Nishi et al. (2003). Thus, the 
insertion into the aatC gene resulted in the incorrect expression of aatD. In EAEC 042, 
aatPABCD are present as a single operon, the single-crossover insertion of plasmid pJP5603 
is likely to have disrupted native aatD expression. Therefore, insufficient quantities of AatD 
were produced for full maturation of Aap. It was for this reason that the conclusion was that 
AatD was responsible for Aap post-translational modification. This conclusion was confirmed 
in ETEC H10407. The double bands for CexE in the ETEC H10407DaatC mutant were 
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comparable to the other CexE producing mutants and wild-type except for the aatD mutant 
(Fig. 6.13). 
 
Experimental evidence for the alteration of CexE/Aap by AatD was presented here. The exact 
modulation of CexE/Aap was not clear. Further investigations into the modified CexE/Aap 
protein is required. Purification of the CexE and Aap protein from EAEC 042 and ETEC 
H10407 wild-type and aatD mutants will reveal the exact change. The suspected maturation 
event, implied from homology searches, is the addition of a lipid group onto the N-terminus of 
Aap/CexE. The mutation of aatD in EAEC 042 and ETEC H10407 results in what appears to 
be a smaller protein. The actual addition and position of attachment is yet to be determined. 
Attempts to isolate the matured Aap and pro-Aap protein from the supernatant of EAEC 042 
and EAEC 042DaatD were not successful. Therefore, it is suggested that cultures of EAEC 
042DaatD, ETEC H10407DaatD, and their parental strains are grown in conditions for the 
production of Aap and CexE, respectively. From the lysed cells the pro- and mature forms of 
Aap and CexE are purified using their isoelectric points. This approach allows the purification 
of the proteins without any additions. With the use of mass spectrometry, the actual size change 
and the position in which it is occurring can be defined.  
 
If this speculation is correct this would also explain the homology of AatP to LolC and LolE 
in the lipoprotein release system. LolE in known to capture lipoproteins from the inner 
membrane after the final acylation by Lnt (Mizutani et al., 2013b). After this, the lipoprotein 
is passed to LolA (Okuda and Tokuda, 2009). The homology of AatD to Lnt and AatC to LolD 
support this theory, albeit ATPase protein sequences are very similar to each other. However, 
the next steps in lipoprotein transport do not bear any resemblance to proteins in the Aat system. 
These speculations currently do not explain the roles of AatA and AatB. Though these proteins 
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are distinct from their T1SS homologs. There is still much yet to understand about the secretion 



















7.1. Remaining questions about the CexE protein 
Prior to the investigation of CexE in ETEC H10407 the only information available was that the 
gene encoding it was activated by CfaD and it elicited an immune response in mouse 
colonisation experimets (Pilonieta et al., 2007; Roy et al., 2011). The results presented in 
Chapter 4 strongly indicated that CexE is an extracellular DNA binding protein required for 
ETEC H10407 biofilm formation. The main problem faced when investigating CexE function 
in ETEC H10407 was the inability to produce CexE in the wild-type. However, this issue was 
resolved in Chapter 6 by transformation of ETEC H10407 with pCfaD which enabled the 
control of cfaD expression in response to L-arabinose. The pCfaD plasmid was not constructed 
until late in the study. At the time a decision was made to prioritise the investigation of the 
secretion of CexE instead of the function in ETEC H10407. The immediate experiments 
following this thesis should be to compare the phenotypes of ETEC H10407 and the cexE 
mutant when cfaD is expressed. 
 
The prioritisation of CexE secretion lead to a fascinating result. AatD was responsible for an 
apparent reduction in molecular weight of CexE which was clearly shown in the ETEC H10407 
aatD mutant (Fig. 6.13). Interestingly this was also true when CexE was produced in EAEC 
042 (Fig. 4.9). The causation of the double band in CexE was not investigated in EAEC 042, 
however it is very likely that the AatD protein was responsible. From this point on, in the 
interests of clarity AatD042 and AatDH10407 are the AatD proteins from EAEC 042 and ETEC 
H10407, respectively. The above result indicated a fascinating possibility that the AatD042 
recognises and alters the CexE protein from ETEC H10407. Therefore, AatD042 and AatDH10407 
must be recognising the same signal from Aap and CexE. It is hypothesised that reverse of the 
experiment in Chapter 4 would result in AatDH10407 modulating the Aap protein when produced 
in ETEC H10407. At the time, this experiment was not possible as there was no mechanism to 
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produce CexE in ETEC H10407. However, it is now viable with the pCfaD plasmid. The 
modulation of CexE by AatD042 raises the interesting possibility that Aat proteins from 
different pathovars could function together. For instance, would AatD042 complement a ETEC 
H10407 aatD mutant for the secretion of CexE? 
 
While it is clear that AatDH10407 and likely AatD042 are responsible for the double bands of 
CexE it is not clear the underlying reason for this phenotype. There are thought to be two 
potential mechanisms responsible for this. The first, and simplest mechanistically, is that the 
double band of CexE is due to the inherent nature of the CexE protein. The second, and more 
likely, possibility is that a high production of CexE in both strains prevents the completion of 
the maturation process. In EAEC 042 the CexE protein is foreign and not designed to function 
with the Aat system that is present. While cexE is expressed similarly to aap in EAEC 
042Daap::cexE the efficiency of the modulation of CexE by AatD042 is unlikely to be equal to 
that of Aap. The result of acylating some but not all of the CexE produced is a double band. In 
ETEC H10407 the production of CexE is driven by the expression of cfaD from the pCfaD 
expression vector, which is unlikely to be similar to the native cexE expression as other factors 
that would typically activate cfaD expression are not present. Therefore, it is possible that the 
large amount of CexE being produced overloads the Aat system preventing complete 
modulation. Again, resulting in a double band. Altering of the L-arabinose induction 
concentration may remove the double band observed. This suggests a difference in the 
regulation of aap/cexE and the aat system which was confirmed in the RNA-Seq experiment. 
 
7.2. Regulation of the aat genes and aap/cexE 
From the RNA-Seq data of EAEC 042, presented here, and ETEC H10407, by Hodson et al. 
(2017), it is clear that aap/cexE are expressed differently to the aat system. Suggesting a reason 
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for the positioning of the aap/cexE genes in the genome. While frequently in close proximity 
aap/cexE never form part of the aatPABC operon (Fig. 6.3). This is clearly due to the difference 
in expression required of these genes likely because of a single Aat system being able to export 
multiple copies of Aap/CexE proteins. In EAEC 042 all of the genes in the aat operon were 
expressed relatively equally (Fig. 3.10). Interestingly this does not appear to be true for the aat 
genes in ETEC H10407. The data produced by RNA-Seq on ETEC H10407 by Hodson et al. 
(2017) indicated that the expression of aatD was higher than the genes in the aatPABC operon. 
This difference in the expression of aatD to the aatPABC genes is likely common amongst 
strains where aatD does not form part of an operon with the other aat genes. The separation of 
aatD from the other aat genes suggests that its expression needs to be different in these strains, 
likely indicating the importance of AatD in Aap/CexE secretion.  
 
7.3. Hypothesised mechanism for the secretion of proteins by the Aat system 
The function of the AatD is critical to understanding the Aat secretion mechanism. Unlike 
AatPABC, AatD is not homologous to any protein in the T1SS but is instead homologous to 
Lnt in the lipoprotein transport partway. While the actual modulation is still unknown it is 
likely that AatD functions similarly to Lnt. Like Lnt (Jackowski, 1986), AatD is presumably 
adding a fatty acid group onto the Aap/CexE protein resulting in the change in size (Fig. 6.9 
and Fig. 6.13). Since this modulation of CexE can be catalysed by both AatD042 and AatDH10407, 
it is reasonable to speculate that both CexE and Aap have a similar signal which is recognised 
by AatD. The conserved residues of Aap and CexE seemed to be predominantly required for 
structure. However, the N-terminus after Sec signal cleavage was consistently glycine rich 
(Fig. 5.15). In fact, the N-terminal residue of these proteins after Sec signal cleavage was 
invariably a glycine. Being the only conserved residue that is no embedded in the structure it 
is thought that this glycine is the residue acylated by AatD. This forms the basis for the 
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proposed model for Aap/CexE secretion (Fig. 7.1). Aap/CexE is translated in the cytoplasm 
(Fig. 7.1A). The protein is translocated into the periplasm. Here is it able to fold into a bullet 
like structure (Velarde et al., 2007). AatD then acrylates the folded protein. This attachment of 
a fatty acid retains the protein at the inner membrane (Fig. 7.1B). This typically would not be 
conducive to secretion, however AatP, like its LolE homolog (Mizutani et al., 2013b), can 
capture this protein out of the membrane (Fig. 7.1C). ATP hydrolysis by AatC powers the 
system resulting in a release of the acylated Aap/CexE protein into the AatA, AatB pore. Once 
secreted, Aap/CexE can position itself in the outer leaflet of the outer membrane similar to a 
lipoprotein (Fig. 7.1D). This modulation and insertion into the outer leaflet of the outer 
membrane may explain the ciprofloxacin sensitivity observed for strains producing Aap 
(Mortensen et al., 2013). It might be possible that the insertion of the acylated Aap into the 
outer membrane disrupts the surface barrier enabling easier access to the cytoplasm. 
 
This proposed mechanism of secretion is not like any other T1SS. The modification mediated 
by AatD is proposed to be the reason why Aap and CexE are secreted atypically. The structures 
of Aap (Velarde et al., 2007) and CexE have evolved to so that after this modification the 
protein can be secreted through AatA. The AatD modulation keeps the Aap and CexE proteins 
attached to the cell surface. In the mechanism hypothesised unmodulated Aap/CexE protein 
cannot be secreted. In other T1SS, like HlyBD-TolC, acylation is not required for secretion 
(Nicaud et al., 1985). Therefore, the acylation of Aap/CexE is a requirement for their function 
and not just a mechanism for secretion.  
 
7.4. Future investigation into the Aat system 
Conformation of AatD mediated acylation is a priority in future investigations of the Aat 




Figure 7.1: Proposed mechanism for the Aat secretion system. The distance between AatD 
and AatPABC is only for illustrative purposes, as the true interactions are not known. A, the 
substrate protein is translated in the cytoplasm and secreted by the Sec machinery into the 
periplasm. AatD transfers a fatty acid onto the N-terminal glycine residue. The fatty acid of the 
substrate protein is inserted into the inner membrane. C, AatP captures the substrate protein 
from the inner membrane. The protein is then secreted out of the cell by the AatA pore. D, the 




secretion. The next steps should be to identify how the disruption of the aat genes affects the 
position of Aap/CexE in the cell. For example, in an aatD mutant the Aap/CexE would be 
expected to be in the periplasm of the cell while in an aatP mutant the Aap/CexE would be 
expected to be predominantly in the inner membrane of the cell. Other experiments into the 
interactions of the Aat proteins with each other should be considered. 
 
While these proposed experiments would better define the mechanism of Aat secretion there 
are still many questions remaining. Since the function of AatD is not the only oddity of the Aat 
system investigation of the other components would likely provide fascinating results. The 
structure of the Aat proteins is suspected to be different from many in the current databases as 
there are no other examples of this secretion system or anything similar. AatA would be of 
particular interest, as if the above speculation is correct the secretion of a hydrophobic region 
due to AatD acylation via a water filled barrel like TolC is curious. It is known from the 
bioinformatic analysis that the AatA protein is distinctly separated from the other TolC 
homologs potentially indicating a different mechanism. Similar to AatA, the AatB protein 
sequence was in a distinct clade from the other membrane fusion proteins. This is unsurprising 
as allowing access via the periplasm is unheard of for membrane fusion proteins of T1SS and 
efflux pumps. Therefore, AatB must have a peculiar operation which is worthy of further 
investigation. 
 
This work has provided new insights and provided a foundation for further investigation into 
the Aat secretion system. The AggR virulence regulator was further characterised and its role 
aap expression clarified. A homolog of this highly-expressed gene was cexE. The investigation 
into CexE revealed that these two proteins with a similar structure had opposite functions. Here 
the first experimental evidence of CexE secretion by the Aat system was provided. Finally, the 
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first steps necessary to determine the mechanism of the Aat system were completed and the 
importance of AatD in understanding Aap/CexE secretion was realised. Aap, CexE, and their 
respective Aat system are highly-expressed in many pathogenic strains in response to 
environmental signals that activate virulence. Therefore, understanding the secretion of Aap 






Appendix I: Nucleotide alignment of aap gene from NCTC86 and other identical genes 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
 
NCTC86             atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
13.1-R1_2009       atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
ICBEc10_2013       atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
ICBECAM5_2016      atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
HVH_202_2003       atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
BWH49_2014         atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
BWH50_2014         atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
221_2015           atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
ECOR50_2016        atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
E1526_P2017        atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
E390_P2017         atgaaaaaacttaatgtgtcaattttttctattgcggcttgttttagtcttaatgtattt 
                   ************************************************************ 
 
NCTC86             gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
13.1-R1_2009       gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
ICBEc10_2013       gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
ICBECAM5_2016      gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
HVH_202_2003       gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
BWH49_2014         gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
BWH50_2014         gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
221_2015           gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
ECOR50_2016        gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
E1526_P2017        gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
E390_P2017         gctggtggaggaggatggaattcggatcttgtagatccgcaacaatgtgtaaaattgtca 
                   ************************************************************ 
 
NCTC86             ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
13.1-R1_2009       ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
ICBEc10_2013       ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
ICBECAM5_2016      ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
HVH_202_2003       ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
BWH49_2014         ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
BWH50_2014         ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
221_2015           ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
ECOR50_2016        ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
E1526_P2017        ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
E390_P2017         ggtgcacagtatacatataatagctcttctaataaatgtatgcaaggtatcaacgaaggg 
                   ************************************************************ 
 
NCTC86             aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
13.1-R1_2009       aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
ICBEc10_2013       aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
ICBECAM5_2016      aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
HVH_202_2003       aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
BWH49_2014         aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
BWH50_2014         aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
221_2015           aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
ECOR50_2016        aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
E1526_P2017        aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
E390_P2017         aaagtccatggtgtttcattatttggaacattctattatggcgatggcagccaagggact 
                   ************************************************************ 
 
NCTC86             tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
13.1-R1_2009       tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
ICBEc10_2013       tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
ICBECAM5_2016      tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
HVH_202_2003       tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
BWH49_2014         tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
BWH50_2014         tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
221_2015           tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
ECOR50_2016        tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
E1526_P2017        tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
E390_P2017         tttaaaggaagagtttccccggggacaacactgaatacaaatcaagatatgaacaaaact 
                   ************************************************************ 
 
NCTC86             aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
13.1-R1_2009       aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
ICBEc10_2013       aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
ICBECAM5_2016      aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
HVH_202_2003       aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
BWH49_2014         aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
BWH50_2014         aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
221_2015           aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
ECOR50_2016        aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
E1526_P2017        aataaatatggcgtgaaatataaggttattactgagtgggttagataa 
E390_P2017         aataaatatggcgtgaaatataaggttattactgagtgggttagataa 










Appendix III: Alignment of AatP to MacB. The AatP sequence from EAEC 042 was aligned 
to the MacB sequence for E. coli MG1655 using Clustal Omega. 
 
 
CLUSTAL O(1.2.4) multiple sequence alignment 
 
 
MacB      MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA 
AatP      ------------------------------------------------------------ 
                                                                       
 
MacB      TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQ 
AatP      ------------------------------------------------------------ 
                                                                       
 
MacB      RLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSG 
AatP      ------------------------------------------------------------ 
                                                                       
 
MacB      EEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGGTEPV 
AatP      ------------------------------------------------------------ 
                                                                       
 
MacB      VNTVSGWRQFVSGFNEALTMAWRALAANKM-------RTLLTMLGIIIGIASVVSIVVVG 
AatP      ---MTTLHY---YLNEALL----NIIENRRQNFAFLVFLSLSFIGIIITDSLIYSVSLKA 
             ::  :     :****      :  *:           *:::****  : : *: : . 
 
MacB      DAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVS 
AatP      EEE--L---KVHSDKVIFVKLYRPKTVGYITEKFIT---VSKVLSFSKSAFL-------- 
          :    :   .::*  .  :.:*  * .*    ::      ..::::.*. ::         
 
MacB      QNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLF 
AatP      ------------YVSDTPFSGELFSVNGIDKLGLNTEYSGDLNDKYNGNVAIVNESSPFF 
                       .* . .**: *.* *:     **  . :**.: :  *   *    :* 
 
MacB      PHKADVVGEVILVGNMPARVIGVAEEKQSMFGSS-------KVLRVWLPYSTMSGRVMGQ 
AatP      SK------KQIFINGVPFKIIGVRLNSKTDFLDSLGLKASQSDEHIFIPLETMFKVKLDN 
           :      : *::..:* ::***  :.:: * .*       .  ::::* .**    :.: 
 
MacB      SWLNSITVRVKEGFDSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLT 
AatP      R-VNAVKIFLDNIVTK-RDINNVKRVLY----DNDIRKFDIVTSLNAKEAVDRVLERFSL 
            :*::.: :.: . . .  :::.*:*     .:*: .:::   *:: * . *.*: *   
 
MacB      LVA---VISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVL---VC 
AatP      LTNSVYVILTLSASVTCFILSKRSFYSRRVELSLKIIHGTEKKEITVLIIIESLIMLSVC 
          *.    **  : ..:  : :   *. .*  *:.:::  *:. .::   ::**:::   ** 
 
MacB      LVGGAL--GITLSLLIAFTLQLF--LPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNA 
AatP      LFISVIYAGVIMH-IIKYFLDVTISIRTTMITISLANVLLVFIS---ANIIFGRL----F 
          *. ..:  *: :  :* : *::   :    * :*   :**.*:.   :.*:** *      
 
MacB      ARLDPVDALARE-- 
AatP      FSINPVNAIKGKIE 




Appendix IV: Alignment of AatC to MacB. The sequence of AatC from EACE 042 was 
aligned with the sequence of MacB from E. coli MG1655 using Clustal Omega. 
 
  
CLUSTAL O(1.2.4) multiple sequence alignment 
 
 
MacB      MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA 
AatC      ---MIRVKIH----KKPIENRTILNNSTIEIKEGSFNIITGPSGVGKTSLLNIIGLLDNA 
             ::.:*          *:  :*:. :::*  *.:  *.* ** **::*:**:* **:* 
 
MacB      TSGTYRVAGQDVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEV----PAVYAGL 
AatC      FVGEYELFGKKVEIKDNSITTYIRRKYFGFIFQDSLINVKQNVLRNILCSVDSQNIIAAR 
            * *.: *:.*   * .  : :**::******   :  : .. :*:        : *.  
 
MacB      ERKQRLLRAQELLQRLGLEDRTEYYPAQLSGGQQQRVSIARALMNGGQVILADEPTGALD 
AatC      ------ERINEVLVSVGLSNIN-NNVSFLSGGEKQRLALARALIKKPSILLADEPTASLD 
                 * :*:*  :**.: .    : ****::**:::****::  .::******.:** 
 
MacB      SHSGEEVMAILHQLRDRGHTVIIVTHDPQVAAQAERVIEIRDGEIVRNPPAIEKVNVTGG 
AatC      IKNKKLVMNILSEYNNQGGTVVMVTHDLELIDENMTLIQLLNT----------------- 
           :. : ** ** : .::* **::**** ::  :   :*:: :                   
 
MacB      TEPVVNTVSGWRQFVSGFNEALTMAWRALAANKMRTLLTMLGIIIGIASVVSIVVVGDAA 
AatC      ------------------------------------------------------------ 
                                                                       
 
MacB      KQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQKQPWVASATPAVSQNL 
AatC      ------------------------------------------------------------ 
                                                                       
 
MacB      RLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRRQLFPHK 
AatC      ------------------------------------------------------------ 
                                                                       
 
MacB      ADVVGEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRV 
AatC      ------------------------------------------------------------ 
                                                                       
 
MacB      KEGFDSAEAEQQLTRLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVG 
AatC      ------------------------------------------------------------ 
                                                                       
 
MacB      GIGVMNIMLVSVTERTREIGIRMAVGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAF 
AatC      ------------------------------------------------------------ 
                                                                       
 
MacB      TLQLFLPGWEIGFSPLALLLAFLCSTVTGILFGWLPARNAARLDPVDALARE 
AatC      ---------------------------------------------------- 
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